{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#  AI ML Cohort 4 : Group 1\n",
    "\n",
    "## Un-Supervised Learning : Mini Project 2 - D1\n",
    "\n",
    "##  Student Names :\n",
    "\n",
    "    ## Chandresh Khaneja | 2020AIML062 \n",
    "    ## Sudhir Valluri    | 2020AIML001\n",
    "    ## Sudheendran T L   | 2020AIML003\n",
    "\n",
    "## File Name : Final_Miniproject2_Group1.ipynb \n",
    "\n",
    "## Date of Submission : Sun 06-Jun-2021"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Declaration of libraries as required"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "%matplotlib inline\n",
    "\n",
    "import os\n",
    "import json\n",
    "import glob\n",
    "import nltk\n",
    "import sklearn\n",
    "import re\n",
    "import math\n",
    "from scipy import stats\n",
    "from random import sample\n",
    "from math import isnan\n",
    "\n",
    "# Import Library to perform PCA / TSNE (for Dimensionality Reduction)\n",
    "from sklearn.decomposition import PCA\n",
    "from sklearn.manifold import TSNE\n",
    "\n",
    "# Import Library to perform some metrics\n",
    "from sklearn import metrics\n",
    "\n",
    "#Import Library to perform Clustering\n",
    "from sklearn.cluster import KMeans\n",
    "from sklearn.metrics import silhouette_score\n",
    "from sklearn import datasets\n",
    "from sklearn.neighbors import NearestNeighbors\n",
    "from scipy.spatial.distance import cdist\n",
    "\n",
    "# Import Libraries related to nltk\n",
    "from nltk.corpus import stopwords\n",
    "from nltk.tokenize import word_tokenize\n",
    "\n",
    "# Import libraries related to vectorization\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "\n",
    "# Import Libraries related to apriori algorithim\n",
    "from mlxtend.frequent_patterns import apriori, association_rules\n",
    "from apyori import apriori"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import warnings\n",
    "warnings.filterwarnings('ignore')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Data Acquisition / Collection / Extraction : Retrieve Metadata"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Clinical features of culture-proven Mycoplasma...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Nitric oxide: a pro-inflammatory mediator in l...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Surfactant protein-D and pulmonary host defense</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Role of endothelin-1 in lung disease</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Gene expression in epithelial cells in respons...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                               title\n",
       "0  Clinical features of culture-proven Mycoplasma...\n",
       "1  Nitric oxide: a pro-inflammatory mediator in l...\n",
       "2    Surfactant protein-D and pulmonary host defense\n",
       "3               Role of endothelin-1 in lung disease\n",
       "4  Gene expression in epithelial cells in respons..."
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv('CORD19-10k.csv',names=['title'])\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Clinical features of culture-proven Mycoplasma...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Nitric oxide: a pro-inflammatory mediator in l...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Surfactant protein-D and pulmonary host defense</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Role of endothelin-1 in lung disease</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Gene expression in epithelial cells in respons...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                               title\n",
       "0  Clinical features of culture-proven Mycoplasma...\n",
       "1  Nitric oxide: a pro-inflammatory mediator in l...\n",
       "2    Surfactant protein-D and pulmonary host defense\n",
       "3               Role of endothelin-1 in lung disease\n",
       "4  Gene expression in epithelial cells in respons..."
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(10000, 1)"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.shape"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Pre - processing / Feature Engineering"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Checking for Info of Cord19-10k Dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 10000 entries, 0 to 9999\n",
      "Data columns (total 1 columns):\n",
      " #   Column  Non-Null Count  Dtype \n",
      "---  ------  --------------  ----- \n",
      " 0   title   10000 non-null  object\n",
      "dtypes: object(1)\n",
      "memory usage: 78.2+ KB\n"
     ]
    }
   ],
   "source": [
    "df.info()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Data Cleaning : Check for Null values of Cord19-10k Dataset "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### To Confirm nature of Title Column for any presence of NULL / NaN / Missing values etc. in any columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "False"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.isnull().values.any()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Data Cleaning : Check for Missing Values of Cord19-10k Dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "title    0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "#!pip install nltk"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "title    10000\n",
       "dtype: int64"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.isna().count()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Q1).\tYou take the CORD19-10k as input, and convert titles into corresponding feature vectors as below. [4 points]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Q1a).\tPerform pre-processing step of stopword removal from title text of all articles.  [1 pt]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "stop = nltk.corpus.stopwords.words('english')\n",
    "extraStopWords = ['The', 'A', 'in','et','al', 'al.', '(', ')', ',', '.', ':', ';', '%', '#', '@', '&', '!', '?', '[', ']', \"''\", \"``\", \"'\", '..', '...', '/', '-', '--', '>', '<', '=', '+', '\\\\']\n",
    "stop.extend(extraStopWords)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "df['title'] = df['title'].astype(str).apply(lambda x: ' '.join([word for word in x.split() if word not in (stop)]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['Clinical features culture-proven Mycoplasma pneumoniae infections King Abdulaziz University Hospital, Jeddah, Saudi Arabia',\n",
       "       'Nitric oxide: pro-inflammatory mediator lung disease?',\n",
       "       'Surfactant protein-D pulmonary host defense', ...,\n",
       "       'Integrated bus transit scheduling Beijing bus group based unified mode operation',\n",
       "       'Antiviral Antibodies Dogs Netherlands',\n",
       "       'Structural Functional Characterization Gene Products Encoded Human Genome Homology Detection'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['title'].values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "clean_text = []\n",
    "\n",
    "def normalizeDoc(txt):\n",
    "    for i in range(0,len(txt)):\n",
    "        myText = txt[i]\n",
    "        myText = re.sub(r'[^a-zA-Z0-9\\s]','', myText, re.I) #Says match anything EXCEPT letters and numbers or whitespaces and turn them into blanks.\n",
    "        myText = re.sub(r'\\b[a-zA-Z]\\b', '', myText, re.I) #removes single letters like ' a ' ' b ' surrounded by spaces\n",
    "        myText = re.sub(r'\\b\\d*\\b', '', myText) #Matches any number surrounded by word boundaries and removes them.\n",
    "        myText = re.sub(r'\\b\\d.*\\b', '', myText) #Matches any word starting in a number, and removes them. There is a LOT of junk like 2n, 2r, 3bc, 3d7, stuff like that.\n",
    "        myText = re.sub(r'\\b[a-zA-Z]\\d*\\b', '', myText) #Matches works like a12334 and a11111111, b24, stuff like this. These words tend to reference specific antibodies, compounds, etc. Not super useful for clustering.\n",
    "        myText = myText.lower()\n",
    "        myText = myText.strip()\n",
    "        myText = ''.join([j if ord(j) < 128 else ' ' for j in myText])\n",
    "        tokens = nltk.word_tokenize(myText)\n",
    "        clean_tokens = [t for t in tokens if t not in stop]\n",
    "        clean_text.append(' '.join(clean_tokens))\n",
    "        if i % 100 == 0:\n",
    "            print(\"text \" + str(i) + \" tokens cleaned (\"+ str(round(i/len(txt)*100,ndigits=2)) + \"% complete)\")\n",
    "        if i == len(txt) - 1:\n",
    "            print(\"text \" + str(i) + \" tokens cleaned (100% complete)\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "text 0 tokens cleaned (0.0% complete)\n",
      "text 100 tokens cleaned (1.0% complete)\n",
      "text 200 tokens cleaned (2.0% complete)\n",
      "text 300 tokens cleaned (3.0% complete)\n",
      "text 400 tokens cleaned (4.0% complete)\n",
      "text 500 tokens cleaned (5.0% complete)\n",
      "text 600 tokens cleaned (6.0% complete)\n",
      "text 700 tokens cleaned (7.0% complete)\n",
      "text 800 tokens cleaned (8.0% complete)\n",
      "text 900 tokens cleaned (9.0% complete)\n",
      "text 1000 tokens cleaned (10.0% complete)\n",
      "text 1100 tokens cleaned (11.0% complete)\n",
      "text 1200 tokens cleaned (12.0% complete)\n",
      "text 1300 tokens cleaned (13.0% complete)\n",
      "text 1400 tokens cleaned (14.0% complete)\n",
      "text 1500 tokens cleaned (15.0% complete)\n",
      "text 1600 tokens cleaned (16.0% complete)\n",
      "text 1700 tokens cleaned (17.0% complete)\n",
      "text 1800 tokens cleaned (18.0% complete)\n",
      "text 1900 tokens cleaned (19.0% complete)\n",
      "text 2000 tokens cleaned (20.0% complete)\n",
      "text 2100 tokens cleaned (21.0% complete)\n",
      "text 2200 tokens cleaned (22.0% complete)\n",
      "text 2300 tokens cleaned (23.0% complete)\n",
      "text 2400 tokens cleaned (24.0% complete)\n",
      "text 2500 tokens cleaned (25.0% complete)\n",
      "text 2600 tokens cleaned (26.0% complete)\n",
      "text 2700 tokens cleaned (27.0% complete)\n",
      "text 2800 tokens cleaned (28.0% complete)\n",
      "text 2900 tokens cleaned (29.0% complete)\n",
      "text 3000 tokens cleaned (30.0% complete)\n",
      "text 3100 tokens cleaned (31.0% complete)\n",
      "text 3200 tokens cleaned (32.0% complete)\n",
      "text 3300 tokens cleaned (33.0% complete)\n",
      "text 3400 tokens cleaned (34.0% complete)\n",
      "text 3500 tokens cleaned (35.0% complete)\n",
      "text 3600 tokens cleaned (36.0% complete)\n",
      "text 3700 tokens cleaned (37.0% complete)\n",
      "text 3800 tokens cleaned (38.0% complete)\n",
      "text 3900 tokens cleaned (39.0% complete)\n",
      "text 4000 tokens cleaned (40.0% complete)\n",
      "text 4100 tokens cleaned (41.0% complete)\n",
      "text 4200 tokens cleaned (42.0% complete)\n",
      "text 4300 tokens cleaned (43.0% complete)\n",
      "text 4400 tokens cleaned (44.0% complete)\n",
      "text 4500 tokens cleaned (45.0% complete)\n",
      "text 4600 tokens cleaned (46.0% complete)\n",
      "text 4700 tokens cleaned (47.0% complete)\n",
      "text 4800 tokens cleaned (48.0% complete)\n",
      "text 4900 tokens cleaned (49.0% complete)\n",
      "text 5000 tokens cleaned (50.0% complete)\n",
      "text 5100 tokens cleaned (51.0% complete)\n",
      "text 5200 tokens cleaned (52.0% complete)\n",
      "text 5300 tokens cleaned (53.0% complete)\n",
      "text 5400 tokens cleaned (54.0% complete)\n",
      "text 5500 tokens cleaned (55.0% complete)\n",
      "text 5600 tokens cleaned (56.0% complete)\n",
      "text 5700 tokens cleaned (57.0% complete)\n",
      "text 5800 tokens cleaned (58.0% complete)\n",
      "text 5900 tokens cleaned (59.0% complete)\n",
      "text 6000 tokens cleaned (60.0% complete)\n",
      "text 6100 tokens cleaned (61.0% complete)\n",
      "text 6200 tokens cleaned (62.0% complete)\n",
      "text 6300 tokens cleaned (63.0% complete)\n",
      "text 6400 tokens cleaned (64.0% complete)\n",
      "text 6500 tokens cleaned (65.0% complete)\n",
      "text 6600 tokens cleaned (66.0% complete)\n",
      "text 6700 tokens cleaned (67.0% complete)\n",
      "text 6800 tokens cleaned (68.0% complete)\n",
      "text 6900 tokens cleaned (69.0% complete)\n",
      "text 7000 tokens cleaned (70.0% complete)\n",
      "text 7100 tokens cleaned (71.0% complete)\n",
      "text 7200 tokens cleaned (72.0% complete)\n",
      "text 7300 tokens cleaned (73.0% complete)\n",
      "text 7400 tokens cleaned (74.0% complete)\n",
      "text 7500 tokens cleaned (75.0% complete)\n",
      "text 7600 tokens cleaned (76.0% complete)\n",
      "text 7700 tokens cleaned (77.0% complete)\n",
      "text 7800 tokens cleaned (78.0% complete)\n",
      "text 7900 tokens cleaned (79.0% complete)\n",
      "text 8000 tokens cleaned (80.0% complete)\n",
      "text 8100 tokens cleaned (81.0% complete)\n",
      "text 8200 tokens cleaned (82.0% complete)\n",
      "text 8300 tokens cleaned (83.0% complete)\n",
      "text 8400 tokens cleaned (84.0% complete)\n",
      "text 8500 tokens cleaned (85.0% complete)\n",
      "text 8600 tokens cleaned (86.0% complete)\n",
      "text 8700 tokens cleaned (87.0% complete)\n",
      "text 8800 tokens cleaned (88.0% complete)\n",
      "text 8900 tokens cleaned (89.0% complete)\n",
      "text 9000 tokens cleaned (90.0% complete)\n",
      "text 9100 tokens cleaned (91.0% complete)\n",
      "text 9200 tokens cleaned (92.0% complete)\n",
      "text 9300 tokens cleaned (93.0% complete)\n",
      "text 9400 tokens cleaned (94.0% complete)\n",
      "text 9500 tokens cleaned (95.0% complete)\n",
      "text 9600 tokens cleaned (96.0% complete)\n",
      "text 9700 tokens cleaned (97.0% complete)\n",
      "text 9800 tokens cleaned (98.0% complete)\n",
      "text 9900 tokens cleaned (99.0% complete)\n",
      "text 9999 tokens cleaned (100% complete)\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "10000"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "normalizeDoc(df['title'].values)\n",
    "len(clean_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['clinical features cultureproven mycoplasma pneumoniae infections king abdulaziz university hospital jeddah saudi arabia',\n",
       " 'nitric oxide proinflammatory mediator lung disease',\n",
       " 'surfactant proteind pulmonary host defense',\n",
       " 'role endothelin1 lung disease',\n",
       " 'gene expression epithelial cells response pneumovirus infection',\n",
       " 'sequence requirements rna strand transfer nidovirus discontinuous subgenomic rna synthesis',\n",
       " 'debate transfusing normal haemoglobin levels improve outcome',\n",
       " '',\n",
       " 'heme oxygenase1 carbon monoxide pulmonary medicine',\n",
       " 'technical description rods realtime public health surveillance system',\n",
       " 'conservation polyamine regulation translational frameshifting yeast mammals',\n",
       " 'heterogeneous nuclear ribonucleoprotein regulates rna synthesis cytoplasmic virus',\n",
       " 'method identify p62s uba domain interacting proteins',\n",
       " 'vaccinia virus infection disrupts microtubule organization centrosome function',\n",
       " 'site origin influenza pandemic public health implications',\n",
       " 'multifaceted multi-versatile microarray simultaneous detection many viruses expression profiles',\n",
       " 'herpes simplex virus type normal protein permeability lungs critically ill patients case low pathogenicity',\n",
       " 'logistics community smallpox control contact tracing ring vaccination stochastic network model',\n",
       " 'protection pulmonary epithelial cells oxidative stress hmyh adenine glycosylase',\n",
       " 'bioinformatic mapping alkb homology domains viruses',\n",
       " 'managing emerging infectious diseases federal system impediment effective laws',\n",
       " 'protein secretion lactococcus lactis efficient way increase overall heterologous protein production',\n",
       " 'detection characterization horizontal transfers prokaryotes using genomic signature',\n",
       " 'comparisons substitution insertion deletion probes resequencing mutational analysis using oligonucleotide microarrays',\n",
       " 'gene encoding sialicacidspecific acetylesterase found human adult testis',\n",
       " 'role mast cells pathogenesis pain chronic pancreatitis',\n",
       " 'recombination every day abundant recombination virus single multicellular host infection',\n",
       " 'torsional restraint new twist frameshifting pseudoknots',\n",
       " 'correcting errors synthetic dna consensus shuffling',\n",
       " 'towards standardization rna quality assessment using userindependent classifiers microcapillary electrophoresis traces',\n",
       " 'factors affecting translation programmed ribosomal frameshifting site cocksfoot mottle virus rna vivo',\n",
       " 'australian public health policy',\n",
       " 'gideon comprehensive webbased resource geographic medicine',\n",
       " 'globalization health',\n",
       " 'polysemous codon codon multiple amino acid assignment caused dual specificity trna identity',\n",
       " 'universal bmvbased rna recombination system search general rules rna recombination',\n",
       " 'neutrophil elastase acidindependent serine protease facilitates reovirus uncoating infection promonocyte cells',\n",
       " 'influence locked nucleic acid residues thermodynamic properties',\n",
       " 'draft versus finished sequence data dna protein diagnostic signature development',\n",
       " 'ontology immune epitopes application design broad scope database immune reactivities',\n",
       " 'evaluation potential reference genes realtime rtpcr studies atlantic salmon',\n",
       " 'relevance human metapneumovirus exacerbations copd',\n",
       " 'bioethical implications globalization international consortium project european commission',\n",
       " 'public awareness risk factors cancer among japanese general population populationbased survey',\n",
       " 'sequence specific visual detection lamp reactions addition cationic polymers',\n",
       " 'injection drug use hivaids china review current situation prevention policy implications',\n",
       " 'development humanized monoclonal antibody therapeutic potential west nile virus',\n",
       " 'local public health workers perceptions toward responding influenza pandemic',\n",
       " 'pandemics duty care whose duty cares',\n",
       " 'epicatechins purified green tea camellia sinensis differentially suppress growth gender-dependent human cancer cell lines',\n",
       " 'markers exacerbation severity chronic obstructive pulmonary disease',\n",
       " 'scientific abstracts',\n",
       " 'society general internal medicine',\n",
       " 'clinical vignettes',\n",
       " 'clinical vignettes',\n",
       " 'abstracts',\n",
       " 'clinical vignettes',\n",
       " 'differentially profiling lowexpression transcriptomes human hepatoma using novel sshmicroarray approach',\n",
       " 'functional genomics functional immunomics new challenges old problems big rewards',\n",
       " 'transmission patterns smallpox systematic review natural outbreaks europe north america since world war ii',\n",
       " 'reliability case definitions public health surveillance assessed roundrobin test methodology',\n",
       " 'ventilator associated pneumonia infection control',\n",
       " 'sentinel surveillance human enterovirus sarawak malaysia lessons first years',\n",
       " '',\n",
       " 'modelbased design growthattenuated viruses',\n",
       " 'delivery systems direct application sirnas induce rna interference rnai vivo',\n",
       " 'electrochemical molecular analysis without nucleic acid amplification',\n",
       " 'identification new participants rainbow trout oncorhynchus mykiss oocyte maturation ovulation processes using cdna microarrays',\n",
       " 'object simulation model modeling hypothetical disease epidemics epiflex',\n",
       " 'multiplexed genetic analysis using expanded genetic alphabet',\n",
       " 'antisenseinduced ribosomal frameshifting',\n",
       " 'gene archaeal fucosidase expressed translational frameshifting',\n",
       " 'role rna helicases hiv1 replication',\n",
       " 'mimox web tool phage display based epitope mapping',\n",
       " 'endogenous cell repair chronic demyelination',\n",
       " 'automated identification multiple microorganisms resequencing dna microarrays',\n",
       " 'molecular dynamics simulations human formula see text role modified bases mrna recognition',\n",
       " 'novel endonuclease iv postpcr genotyping system',\n",
       " 'pandemic influenza preparedness ethical framework guide decisionmaking',\n",
       " 'open lung biopsy earlystage acute respiratory distress syndrome',\n",
       " 'association host selectivity multihost pathogens',\n",
       " 'effectiveness contact tracing emerging epidemics',\n",
       " 'waiting time intercountry spread pandemic influenza',\n",
       " 'neutralizing antibody fails impact course ebola virus infection monkeys',\n",
       " 'public health preparedness alberta systemslevel study',\n",
       " 'immunoregulatory allergyassociated cytokines aetiology otitis media effusion',\n",
       " 'benchtobedside review critical illness-associated cognitive dysfunction mechanisms markers emerging therapeutics',\n",
       " 'procat data analysis approach protein microarrays',\n",
       " 'positional clustering improves computational binding site detection identifies novel cisregulatory sites mammalian gabaa receptor subunit genes',\n",
       " 'transmissibility highly pathogenic avian influenza commercial poultry industrialised countries',\n",
       " 'influenza pandemic preparedness planning tool influsim',\n",
       " 'immune pathways defence mechanisms honey bees apis mellifera',\n",
       " 'elad deubiquitinating protease expressed coli',\n",
       " 'mutational analysis human ceacam1 potential receptor polymorphism increasing host susceptibility bacterial infection',\n",
       " 'immune reconstitution inflammatory syndrome iris review common infectious manifestations treatment options',\n",
       " 'global surveillance emerging influenza virus genotypes mass spectrometry',\n",
       " 'transmission parameters foot mouth epidemic great britain',\n",
       " 'efficient replication pneumonia virus mice pvm mouse macrophage cell line',\n",
       " 'designing conducting tabletop exercises assess public health preparedness manmade naturally occurring biological threats',\n",
       " 'transcriptlevel annotation affymetrix probesets improves interpretation gene expression data',\n",
       " 'selective redox regulation cytokine receptor signaling extracellular thioredoxin1',\n",
       " 'screen isg15crossreactive deubiquitinases',\n",
       " 'srtmelt rapid mutation scanning using enzymatic selection real time dna-melting new potential multiplex genetic analysis',\n",
       " 'rapid identification malaria vaccine candidates based -helical coiled coil protein motif',\n",
       " 'flugenome web tool genotyping influenza virus',\n",
       " 'influenza pandemic intervention planning using influsim pharmaceutical non pharmaceutical interventions',\n",
       " 'dna vaccines protozoan parasites advances challenges',\n",
       " 'estimating individual household reproduction numbers emerging epidemic',\n",
       " 'natural killer cells promote early cd8 cell responses cytomegalovirus',\n",
       " 'trojan chicken study minnesota',\n",
       " 'restriction zoonotic perv transmission human apobec3g',\n",
       " 'experimental infection h5n1 hpai balbc mice',\n",
       " 'prediction rna pseudoknots using heuristic modeling mapping sequential folding',\n",
       " 'cellpenetrating peptides transporters morpholino oligomers effects amino acid composition intracellular delivery cytotoxicity',\n",
       " 'lost world functional genomics systems biology translational research life milstein award',\n",
       " 'electrospray ionisationcleavable tandem nucleic acid mass tag peptide nucleic acid conjugates synthesis applications quantitative genomic analysis using electrospray ionisation-ms/ms',\n",
       " 'hairpin structure within',\n",
       " 'global public goods global health agenda problems priorities potential',\n",
       " 'outcome paediatric intensive care survivors',\n",
       " 'evaluation comparative genome sequencing cgs comparing two previously-sequenced bacterial genomes',\n",
       " 'antibodybased hiv1 vaccines recent developments future directions summary report global hiv vaccine enterprise working group',\n",
       " 'host gene expression profiling dengue virus infection cell lines patients',\n",
       " 'speciesspecific evolution immune receptor tyrosine based activation motifcontaining ceacam1-related immune receptors dog',\n",
       " 'nucleolus fascinating nuclear body',\n",
       " 'antidiabetes antiobesity activity lagerstroemia speciosa',\n",
       " 'transmissibility influenza virus pandemic',\n",
       " 'surfactant therapy acute respiratory failure children systematic review metaanalysis',\n",
       " 'clinical review update avian influenza infections humans',\n",
       " 'clinical review mass casualty triage pandemic influenza critical care',\n",
       " 'avian influenza outbreak turkey health personnels views qualitative study',\n",
       " 'influenza activity europe eight seasons evaluation indicators used measure activity assessment timing length course peak activity spread across europe',\n",
       " 'diagnosis treatment severe sepsis',\n",
       " 'simian virus vectors pulmonary gene therapy',\n",
       " 'role receptor polymorphism glycosylation syncytium induction host range variation ecotropic mouse gammaretroviruses',\n",
       " 'presence tar rna structure alters programmed ribosomal frameshift efficiency human immunodeficiency virus type hiv- modifying rate translation initiation',\n",
       " 'establishing nationwide emergency departmentbased syndromic surveillance system better public health responses taiwan',\n",
       " 'amino acid similarity accounts cell crossreactivity holes cell repertoire',\n",
       " 'distinguishing molecular features clinical characteristics putative new rhinovirus species human rhinovirus hrv',\n",
       " 'epithelial cell apoptosis neutrophil recruitment acute lung injury unifying hypothesis learned small interfering rnas',\n",
       " 'cucumovirus',\n",
       " 'epigrass tool study disease spread complex networks',\n",
       " 'autoimmune cholangitis sjlj mouse antigen nonspecific',\n",
       " 'la crosse virus infectivity pathogenesis immunogenicity mice monkeys',\n",
       " 'intrinsically disordered terminal domain measles virus nucleoprotein interacts c terminal domain phosphoprotein via two distinct sites remains predominantly unfolded',\n",
       " 'survey knowledge attitudes practices towards avian influenza adult population italy',\n",
       " 'evolution human influenza viruses complete genome study',\n",
       " 'presumed consent justify duty treat infectious diseases analysis',\n",
       " 'improved production human type ii procollagen yeast pichia pastoris shake flasks wirelesscontrolled fedbatch system',\n",
       " 'hmgb1 endogenous danger signaling',\n",
       " 'quantitative measurement thyroglobulin mrna peripheral blood patients total thyroidectomy',\n",
       " 'functional analysis',\n",
       " 'preliminary findings randomized trial nonpharmaceutical interventions prevent influenza transmission households',\n",
       " 'real time bayesian estimation epidemic potential emerging infectious diseases',\n",
       " 'detectiv visualization normalization significance testing pathogen-detection microarray data',\n",
       " 'expression footandmouth disease virus capsid proteins silkworm-baculovirus expression system utilization subunit vaccine',\n",
       " 'effect network mixing patterns epidemic dynamics efficacy disease contact tracing',\n",
       " 'general practice pandemic influenza framework planning comparison plans five countries',\n",
       " 'apoptotic signals induce specific degradation ribosomal rna yeast',\n",
       " 'virus adaptation manipulation hosts gene expression',\n",
       " 'deletion human metapneumovirus increases mutation frequency attenuates growth hamsters',\n",
       " 'longer innocent bystander epithelial tolllike receptor signaling development mucosal inflammation',\n",
       " 'ubiquitination required effective replication coxsackievirus',\n",
       " 'professional homemade face masks reduce exposure respiratory infections among general population',\n",
       " 'oct4 expression maintained cancer stemlike properties lung cancer-derived cd133-positive cells',\n",
       " 'early transcriptional response jejunum germfree piglets oral infection virulent rotavirus',\n",
       " 'gatekeepers health qualitative assessment child care centre staffs perspectives practices challenges enteric illness prevention management child care centres',\n",
       " 'dating time viral subtype divergence',\n",
       " 'discovery development tolllike receptor tlr4 antagonists new paradigm treating sepsis diseases',\n",
       " 'multiplex cytokine profile dengue patients mip1beta ifn-gamma predictive factors severity',\n",
       " 'temporal trends discovery human viruses',\n",
       " 'investigating selection viruses statistical alignment approach',\n",
       " 'seasonality influenza ah3n2 virus hong kong perspective',\n",
       " 'h5n1 pandemic influenza virus infection results early excessive infiltration macrophages neutrophils lungs mice',\n",
       " 'patterns positive selection six mammalian genomes',\n",
       " 'mathematical analysis copy number variation dna sample using digital pcr nanofluidic device',\n",
       " 'geosimulation west nile virus propagation multiagent climate sensitive tool risk management public health',\n",
       " 'alternative medicines aids resourcepoor settings insights exploratory anthropological studies asia africa',\n",
       " 'evolutionary transmission dynamics reassortant h5n1 influenza virus indonesia',\n",
       " 'endothelial cells support persistent gammaherpesvirus infection',\n",
       " 'analysis synonymous codon usage evolution begomoviruses',\n",
       " 'animal models acute lung injury',\n",
       " 'intrapulmonary administration recombinant activated factor vii diffuse alveolar haemorrhage report two case stories',\n",
       " 'activation unfolded protein response required defenses bacterial poreforming toxin vivo',\n",
       " 'composition function haemolymphatic tissues european common shrew',\n",
       " 'prevention cytotoxic cell escape using heteroclitic subdominant viral cell determinant',\n",
       " 'hivspecific tcells accumulate liver hcv/hiv co-infection',\n",
       " 'multiorgan failure due hemophagocytic syndrome case report',\n",
       " 'studying copy number variations using nanofluidic platform',\n",
       " 'analysis hospital preparedness capacity public health emergency four regions china beijing shandong guangxi hainan',\n",
       " 'molecular evidence evolution ichnoviruses ascoviruses symbiogenesis',\n",
       " 'nasal delivery adenovirusbased vaccine bypasses preexisting immunity vaccine carrier improves immune response mice',\n",
       " 'screening pneumonia patients mimivirus',\n",
       " 'resource allocation influenza pandemic',\n",
       " 'wu polyomavirus infection children germany',\n",
       " 'factors influencing psychological distress disease epidemic data australias first outbreak equine influenza',\n",
       " 'influenza virus inhibits type ifn signaling via nf b-dependent induction socs- expression',\n",
       " 'biodefense versus bioterrorism',\n",
       " 'key role splenic myeloid dcs ifn response adenoviruses vivo',\n",
       " 'hemorrhagic shock encephalopathy syndrome markers early hses diagnosis',\n",
       " 'unifying evolutionary thermodynamic information rna folding multiple alignments',\n",
       " 'sensitive arraybased assay identifying multiple tmprss2erg fusion gene variants',\n",
       " 'delivery steric block morpholino oligomers rx- peptides structure activity studies',\n",
       " 'immune mechanisms responsible vaccination clearance mucosal lymphatic norovirus infection',\n",
       " 'selfinterest versus groupinterest antiviral control',\n",
       " 'crosssubtype immunity avian influenza persons recently vaccinated influenza',\n",
       " 'human bocavirus infections hospitalized children adults',\n",
       " 'pandemic influenza planning united states health disparities perspective',\n",
       " 'conflict emerging infectious diseases',\n",
       " 'global distribution novel rhinovirus genotype',\n",
       " 'cost effective strategies completing interactome',\n",
       " 'augmented lung inflammation protects influenza pneumonia',\n",
       " 'novel peptide enhances therapeutic efficacy liposomal anticancer drugs mice models human lung cancer',\n",
       " 'il1 il- rantes biomarkers chikungunya severity',\n",
       " 'avian influenza china alarmed',\n",
       " 'rift valley fever virus nss protein promotes posttranscriptional downregulation protein kinase pkr inhibits eif2 phosphorylation',\n",
       " 'influenza virus h5n1 live bird markets food markets thailand',\n",
       " 'antimicrobial antioxidant activities cortex magnoliae officinalis medicinal plants commonly used southeast asia',\n",
       " 'results hypothesis generating casecontrol study herpes family viruses schizophrenia among military personnel',\n",
       " 'sarscov lessons global health',\n",
       " 'science policy preparing pandemic influenza',\n",
       " 'smallpox season reanalysis historical data',\n",
       " 'chinese journals guide epidemiologists',\n",
       " 'complete genome proteome laribacter hongkongensis reveal potential mechanisms adaptations different temperatures habitats',\n",
       " 'malignant mesothelioma',\n",
       " 'antiviral resistance pandemic influenza implications stockpiling drug use',\n",
       " 'transmission dynamics prospects elimination canine rabies',\n",
       " 'detection genetically modified organisms gmos using isothermal amplification target dna sequences',\n",
       " 'multivalent ha dna vaccination protects highly pathogenic h5n1 avian influenza infection chickens mice',\n",
       " 'virusspecific readthrough codon preference affects infectivity chimeric cucumber green mottle mosaic viruses displaying dengue virus epitope',\n",
       " 'enhanced hygiene measures norovirus transmission outbreak',\n",
       " 'polyomaviruses ki wu immunocompromised patients respiratory disease',\n",
       " 'significance surfactant proteina within human lungs',\n",
       " 'proteolytic processing precursor protein growthpromoting peptide subtilisin serine protease arabidopsis',\n",
       " 'protein domain boundary predictions structural biology perspective',\n",
       " 'scientific abstracts',\n",
       " 'international course emerging viruses amazon region',\n",
       " 'enhancing timeseries detection algorithms automated biosurveillance',\n",
       " 'molecular mechanisms recombination restriction envelope gene human immunodeficiency virus',\n",
       " 'avian influenza virus glycoproteins restrict virus replication spread human airway epithelium temperatures proximal airways',\n",
       " 'multidimensional classification public health activity australia',\n",
       " 'small interfering rna targeting gene induces effective long term inhibition influenza virus replication',\n",
       " 'increased expression levels pvcrto pvmdr1 genes patient severe plasmodium vivax malaria',\n",
       " 'health workers views quality prevention motherto-child transmission postnatal care hiv-infected women children',\n",
       " 'inhibition lassa virus glycoprotein cleavage multicycle replication site proteaseadapted -antitrypsin variants',\n",
       " 'virhostnet knowledge base management analysis proteomewide virus host interaction networks',\n",
       " 'rfam updates rna families database',\n",
       " 'new respiratory enterovirus recombinant rhinoviruses among circulating picornaviruses',\n",
       " 'lowcost hiv1 diagnosis quantification dried blood spots real time pcr',\n",
       " 'statistical framework adaptive management epidemiological interventions',\n",
       " 'benchtobedside review angiopoietin signalling critical illness future target',\n",
       " 'mapping sequence mutations h1n1 influenza virus neuraminidase relative drug antibody binding sites',\n",
       " 'development taqman mgb fluorescent real-time pcr assay detection anatid herpesvirus',\n",
       " 'role nitric oxide management acute respiratory distress syndrome',\n",
       " 'avian influenza tip iceberg',\n",
       " 'amino acids reverse transcriptase human immunodeficiency virus1 critical protein stability',\n",
       " 'cvtree update newly designed phylogenetic study platform using composition vectors whole genomes',\n",
       " 'remission invasive cancer stemlike glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy',\n",
       " 'microarray based approach identification common foodborne viruses',\n",
       " 'risk multiple sclerosis related biography immune system',\n",
       " 'evidence recombination genetic diversity human rhinoviruses children acute respiratory infection',\n",
       " 'poster exhibition',\n",
       " 'reading chest radiographs critically ill part ii radiography lung pathologies common icu patient',\n",
       " 'cytomegalovirus infection critically ill patients systematic review',\n",
       " 'heliox reduces respiratory system resistance respiratory syncytial virus induced respiratory failure',\n",
       " 'regulation apoptosisinducing kinase drak2 cyclooxygenase2 colorectal cancer',\n",
       " 'rooting human parechovirus evolution time',\n",
       " 'hivaids prevention china challenge new millennium',\n",
       " 'emerging zoonotic diseases opportunity apply concepts nidality onemedicine',\n",
       " 'disease ecology global emergence zoonotic pathogens',\n",
       " 'globalization emerging governance modalities',\n",
       " 'generation characterization novel human iras monoclonal antibodies',\n",
       " 'molecular physiologic basis quinoline drug resistance plasmodium falciparum malaria',\n",
       " 'interaction humans poultry rural cambodia',\n",
       " 'bird migration routes risk pathogen dispersion western mediterranean wetlands',\n",
       " 'prolonged extracorporeal membrane oxygenation therapy severe acute respiratory distress syndrome child affected rituximabresistant autoimmune hemolytic anemia case report',\n",
       " 'regulated ire1dependent decay messenger rnas mammalian cells',\n",
       " 'empirical relationship intrapurine intrapyrimidine differences conserved gene sequences',\n",
       " 'willingness hong kong healthcare workers accept prepandemic influenza vaccination different alert levels two questionnaire surveys',\n",
       " 'evolutionarily conserved herpesviral protein interaction networks',\n",
       " 'insertiondeletion polymorphism angiotensin converting enzyme gene kawasaki disease',\n",
       " 'differential regulation type interferon epidermal growth factor pathways human respirovirus virulence factor',\n",
       " 'host type interferon response induced cytosolic sensing bacterial second messenger cyclicdigmp',\n",
       " 'gene expression profiling cells enhanced -secretase activity',\n",
       " 'bayesian phylogeography finds roots',\n",
       " 'model repository models infectious disease agent study',\n",
       " 'escape autologous neutralizing antibodies acuteearly subtype hiv1 infection requires multiple pathways',\n",
       " 'crystal structure nacetylmannosamine kinase domain gne',\n",
       " 'increased host species diversity decreased prevalence sin nombre virus',\n",
       " 'chineselike strain porcine epidemic diarrhea virus thailand',\n",
       " 'optimismpessimism healthrelated quality life pregnancy across three continents matched cohort study china ghana united states',\n",
       " 'emerging technologies detection rabies virus challenges hopes',\n",
       " 'ducks trojan horses h5n1 influenza',\n",
       " 'nonhemagglutinating flaviviruses molecular mechanisms emergence new strains via adaptation european ticks',\n",
       " 'diagnosis management drugassociated interstitial lung disease',\n",
       " 'primary biliary cirrhosis',\n",
       " 'orma tool identification speciesspecific variations',\n",
       " 'initial psychological responses influenza h1n1 swine flu',\n",
       " 'managing complex adaptive systems motivated biosystems application infections',\n",
       " 'prevalence human herpesvirus antibodies dna allogeneic stem cell transplant patients twoyear single centre experience',\n",
       " 'infection primary avian tracheal epithelial cells infectious bronchitis virus',\n",
       " 'using dynamic stochastic modelling estimate population risk factors infectious disease example fiv cat populations',\n",
       " 'multiplex primer prediction software divergent targets',\n",
       " 'shorthairpin rnas delivered lentiviral vector transduction trigger rigi-mediated ifn activation',\n",
       " 'early diversification influenza ah1n1pdm',\n",
       " 'immunoglobulin superfamily virus receptors evolution adaptive immunity',\n",
       " 'peptidemediated cellular delivery oligonucleotidebased therapeutics vitro quantitative evaluation overall efficacy employing easy handle reporter systems',\n",
       " 'human pregnancyassociated malariaspecific cells target polymorphic conformational epitopes var2csa',\n",
       " 'optaids project towards global halting hivaids',\n",
       " 'early assessment anxiety behavioral response novel swineorigin influenza ah1n1',\n",
       " 'accurate noise projection reduced stochastic epidemic models',\n",
       " 'comparison distance measures spatial analytical modeling health service planning',\n",
       " 'evaluation five decontamination methods filtering facepiece respirators',\n",
       " 'antiviral activity plants used nepalese traditional medicine',\n",
       " 'predicting intention treat hivinfected patients among tanzanian sudanese medical dental students using theory planned behaviour cross sectional study',\n",
       " 'pattern recognition receptor dependent mechanisms acute lung injury',\n",
       " 'exposure cats low doses felv seroconversion sole parameter infection',\n",
       " 'large accurate collection peptidase cleavages merops database',\n",
       " 'efficient assembly secretion recombinant subviral particles four dengue serotypes using native prm proteins',\n",
       " 'breaking waves modelling potential impact public health measures defer epidemic peak novel influenza ah1n1',\n",
       " 'european hedgehogs hosts borrelia spp germany',\n",
       " 'expression vp2 protein murine norovirus translation terminationreinitiation strategy',\n",
       " 'interaction hiv1 frameshift signal ribosome',\n",
       " 'outdoor environments human pathogens air',\n",
       " 'combination strategies pandemic influenza response systematic review mathematical modeling studies',\n",
       " 'let sun shine effects ultraviolet radiation invasive pneumococcal disease risk philadelphia pennsylvania',\n",
       " 'listeriolysin necessary sufficient induce autophagy listeria monocytogenes infection',\n",
       " 'definition mafaa haplotypes pedigreed cynomolgus macaques macaca fascicularis',\n",
       " 'vitro viability cytotoxicity testing samewell multiparametric combinations high throughput screening',\n",
       " 'relapsing macrophage activating syndrome',\n",
       " 'multiple lung abscesses due acinetobacter infection case report',\n",
       " 'novel antimycobacterial function mitogenactivated protein kinase phosphatase-',\n",
       " 'localization lowdensity detergentresistant membrane proteins intact acrosome-reacted mouse sperm',\n",
       " 'global expression profiling epileptogenesis add confusion',\n",
       " 'fluorescence competition assay measurements free energy changes rna pseudoknots',\n",
       " 'proteomics analysis nucleolus adenovirusinfected cells',\n",
       " 'analysis memory cell responses isolation novel monoclonal antibodies neutralizing breadth hiv1infected individuals',\n",
       " 'recode2 new design new search tools many genes',\n",
       " 'viralorfeome integrated database generate versatile collection viral orfs',\n",
       " 'clinical review primary influenza viral pneumonia',\n",
       " 'calculating potential withinflight transmission influenza h1n1',\n",
       " 'abstracts',\n",
       " 'ips1 essential control west nile virus infection immunity',\n",
       " 'severe malaria case fatal plasmodium knowlesi infection postmortem findings case report',\n",
       " 'mathematical modeling effectiveness facemasks reducing spread novel influenza h1n1',\n",
       " 'correcting actual reproduction number simple method estimate early epidemic growth data',\n",
       " 'using satellite images environmental changes predict infectious disease outbreaks',\n",
       " 'clinical assessment improved diagnosis bocavirusinduced wheezing children finland',\n",
       " 'evidence gag facilitates hiv1 envelope association gpienriched plasma membrane detergent resistant membranes facilitates envelope incorporation onto virions primary cd4 cells',\n",
       " 'two novel hlaa0201 -cell epitopes avian h5n1 viral nucleoprotein induced specific immune responses hhd mice',\n",
       " 'anthropogenic factors risk highly pathogenic avian influenza h5n1 prospects spatialbased model',\n",
       " 'systematic analysis comparison integration disease based human genetic association data mouse genetic phenotypic information',\n",
       " 'pneumonitis consequence peginterferon-ribavirin combination therapy hepatitis review literature',\n",
       " 'hivrelated restrictions entry residence stay european region survey',\n",
       " 'triple combination amantadine ribavirin oseltamivir highly active synergistic drug resistant influenza virus strains vitro',\n",
       " 'successful treatment hivassociated multicentric castlemans disease multiple organ failure rituximab supportive care case report',\n",
       " 'attenuated salmonella choleraesuismediated rnai targeted conserved regions footand-mouth disease virus guinea pigs swine',\n",
       " 'community acquired methicillinresistant staphylococcus aureus pneumonia leading rhabdomyolysis case report',\n",
       " 'binding herpes simplex virus type1 virions leads induction intracellular signalling absence virus entry',\n",
       " 'seasonal influenza risk hospital healthcare workers strongly associated household occupational exposures results prospective cohort study berlin germany',\n",
       " 'predicting drugtarget interaction networks based functional groups biological features',\n",
       " 'intermolecular rna triplex provides insight structural determinants pseudoknot stimulator ribosomal frameshifting',\n",
       " 'early days food environmental virology',\n",
       " 'mitigation approaches combat flu pandemic',\n",
       " 'nss encoded groundnut bud necrosis virus bifunctional enzyme',\n",
       " 'mortality among patients tuberculosis requiring intensive care retrospective cohort study',\n",
       " 'comparative efficacy hemagglutinin nucleoprotein matrix protein gene-based vaccination h5n1 influenza mouse ferret',\n",
       " 'impact contact tracing clustered populations',\n",
       " 'serological profiling candida albicans protein microarray reveals permanent hostpathogen interplay stagespecific responses candidemia',\n",
       " 'dna vaccines developing new strategies cancer',\n",
       " 'tlr agonist stat3 sirna conjugates cell-specific gene silencing enhanced antitumor immune responses',\n",
       " 'rapid accumulation virulent rift valley fever virus mice attenuated virus carrying single nucleotide substitution rna',\n",
       " 'confronting potential influenza h5n1 pandemic better vaccines',\n",
       " 'global public health security',\n",
       " 'dynamics control diseases networks community structure',\n",
       " 'generation human ceacam1 transgenic mice binding neisseria opa protein neutrophils',\n",
       " 'tuberculous sarcoidosis exist',\n",
       " 'dotknot pseudoknot prediction using probability dot plot refined energy model',\n",
       " 'risk importing zoonotic diseases wildlife trade united states',\n",
       " 'effect vaccination evolution population dynamics avian paramyxovirus1',\n",
       " 'chinas engagement global health diplomacy sars watershed',\n",
       " 'electron tomography reveals steps filovirus budding',\n",
       " 'peptidemediated liposomal drug delivery system targeting tumor blood vessels anticancer therapy',\n",
       " 'elevation intact proteolytic fragments acute phase proteins constitutes earliest systemic antiviral response hiv1 infection',\n",
       " 'synthesis pharmacological evaluation schiff bases -aminophenyl -morpholines',\n",
       " 'proper distance metrics phylogenetic analysis using complete genomes without sequence alignment',\n",
       " 'single immunization soluble recombinant trimeric hemagglutinin protects chickens highly pathogenic avian influenza virus h5n1',\n",
       " 'hospital triage system adult patients using influenzalike illness scoring system pandemic mexico',\n",
       " 'acute encephalopathy associated influenza infection adults',\n",
       " 'largescale evolutionary surveillance h1n1 influenza virus using resequencing arrays',\n",
       " 'journals academics pandemics',\n",
       " 'age groups spread influenza implications vaccination strategy',\n",
       " 'extracorporeal life support management refractory cardiac respiratory failure initial experience tertiary centre',\n",
       " 'necessary fast testkit mitigation pandemic flu',\n",
       " 'rotavirus structural proteins dsrna required human primary plasmacytoid dendritic cell ifn response',\n",
       " 'role cd14 lung inflammation infection',\n",
       " 'noninvasive ventilation critically ill patients pandemic h1n1 influenza virus infection',\n",
       " 'immune response lactobacillus plantarum expressing borrelia burgdorferi ospa modulated lipid modification antigen',\n",
       " 'neutralization r5tropic hiv- nl4- variants hocl-modified serum albumins',\n",
       " 'human pregnancy specific beta1glycoprotein psg1 potential role placental vascular morphogenesis',\n",
       " 'structural optimization de novo design dengue virus entry inhibitory peptides',\n",
       " 'caveolin1 influences human influenza virus h1n1 multiplication cell culture',\n",
       " 'class ii transactivator ciita enhances cytoplasmic processing hiv- pr55gag',\n",
       " 'computational approaches sizeandshape distributions sedimentation velocity analytical ultracentrifugation',\n",
       " 'extrapulmonary tissue responses cynomolgus macaques macaca fascicularis infected highly pathogenic avian influenza h5n1 virus',\n",
       " 'using complementary alternative medicines target host response severe influenza',\n",
       " 'pandemic h1n1 influenza community transmission established one australian state virus first identified north america',\n",
       " 'radiological clinical characteristics military outbreak pandemic h1n1 influenza virus infection',\n",
       " 'clathrin independent macropinocytosislike entry mechanism used bluetongue virus1 infection bhk cells',\n",
       " 'assessing human immune system blood transcriptomics',\n",
       " 'bid regulates pathogenesis neurotropic reovirus',\n",
       " 'effects pulsed electromagnetic fields human osteoblastlike cells mg63 pilot study',\n",
       " 'virology experts boundary zone science policy public biographical analysis',\n",
       " 'human bocaviruses highly diverse dispersed recombination prone prevalent enteric infections',\n",
       " 'battle virus host modulation tolllike receptor signaling pathways virus infection',\n",
       " 'pneumonia incidence mortality mainland china systematic review chinese english literature',\n",
       " 'possible role robustness evolution infectious diseases',\n",
       " 'isolation characterization microparticles sputum cystic fibrosis patients',\n",
       " 'hiv antigen incorporation within adenovirus hexon hypervariable novel hiv vaccine approach',\n",
       " 'model end stage liver disease meld score greater predicts length stay icu mortality liver transplant recipients',\n",
       " 'angiotensinconverting enzyme autoantibodies evidence role renin-angiotensin system inflammation',\n",
       " 'role chemokines viral infection cns',\n",
       " 'crosssectional survey evaluate knowledge attitudes practices kap regarding seasonal influenza vaccination among european travellers resource-limited destinations',\n",
       " 'serodiagnosis echinococcus spp infection explorative selection diagnostic antigens peptide microarray',\n",
       " 'protective efficacy crossreactive cd8+ cells recognising mutant viral epitopes depends peptide-mhc- structural interactions cell activation threshold',\n",
       " 'development symptom score clinical studies identify children documented viral upper respiratory tract infection',\n",
       " 'cancer biomarker discovery entropic hallmark',\n",
       " 'sysgenet meeting report new european network systems genetics',\n",
       " 'adaptive contact networks change effective disease infectiousness dynamics',\n",
       " 'role infections pathogenesis course multiple sclerosis',\n",
       " 'calciomics prediction analysis efhand calcium binding proteins protein engineering',\n",
       " 'proteomics comparison cerebrospinal fluid relapsing remitting primary progressive multiple sclerosis',\n",
       " 'interstitial lung diseases children',\n",
       " 'predictive power air travel socioeconomic data early pandemic spread',\n",
       " 'evolutionary entropy determines invasion success emergent epidemics',\n",
       " 'nature protein domain evolution shaping interaction network',\n",
       " 'quantitative phosphoproteomics proteasome inhibition multiple myeloma cells',\n",
       " 'insights evolution emergence novel infectious disease',\n",
       " 'role host immune response viral load differential outcome pandemic h1n1 influenza virus infection indian patients',\n",
       " 'generation human antigenspecific monoclonal igm antibodies using vaccinated human immune system mice',\n",
       " 'reflections pandemic h1n1 international response',\n",
       " 'development largescale isolation chamber system safe humane care mediumsized laboratory animals harboring infectious diseases',\n",
       " 'proteomics challenges techniques possibilities overcome biological sample complexity',\n",
       " 'systematic molecular pathology study laboratory confirmed h5n1 human case',\n",
       " 'situational awareness health protective responses pandemic influenza h1n1 hong kong cross-sectional study',\n",
       " 'human antiplague monoclonal antibodies protect mice yersinia pestis bubonic plague model',\n",
       " 'diagnostic value triggering receptor expressed myeloid cells1 creactive protein patients lung infiltrates observational study',\n",
       " 'nodeomics pathogen detection vertebrate lymph nodes using metatranscriptomics',\n",
       " 'vitro vivo studies identify important features dengue virus pre protein interactions',\n",
       " 'alternative splicing cd200 regulated exonic splicing enhancer sf2asf',\n",
       " 'efficacy oseltamivirzanamivir combination compared monotherapy seasonal influenza randomized placebo-controlled trial',\n",
       " 'comparison methods purification concentration norovirus gii4 capsid viruslike particles',\n",
       " 'urine peptidomic targeted plasma protein analyses diagnosis monitoring systemic juvenile idiopathic arthritis',\n",
       " 'segmented helical structure neck region glycanbinding receptor dcsignr',\n",
       " 'translation elongation factor',\n",
       " 'calculation information organismal complexity',\n",
       " 'environmental factors preceding illness onset differ phenotypes juvenile idiopathic inflammatory myopathies',\n",
       " 'network analysis global influenza spread',\n",
       " 'willingness accept h1n1 pandemic influenza vaccine crosssectional study hong kong community nurses',\n",
       " 'development optimized rnabased murine norovirus reverse genetics system',\n",
       " 'epidemic modeling real time application novel h1n1 influenza outbreak canada',\n",
       " 'antiviral neuroprotective role octaguanidinium dendrimerconjugated morpholino oligomers japanese encephalitis',\n",
       " 'severe novel influenza h1n1 infection cancer patients',\n",
       " 'tennessee childrens respiratory initiative objectives design recruitment results prospective cohort study investigating infant viral respiratory illness development asthma allergic diseases',\n",
       " 'eosinophilic infiltrate patient severe legionella pneumonia levofloxacinrelated complication case report',\n",
       " 'functional analysis srv1 rna frameshifting pseudoknot',\n",
       " 'molecular clamp ensures allosteric coordination peptidyltransfer ligand binding ribosomal asite',\n",
       " 'hybridization properties long nucleic acid probes detection variable target sequences development hybridization prediction algorithm',\n",
       " 'asymmetry presence migration stabilizes multistrain disease outbreaks',\n",
       " 'clinical factors associated severity hospitalized children infected avian influenza h5n1',\n",
       " 'human monoclonal igg selection plasmodium falciparum expression placental malariaspecific variant surface antigens',\n",
       " 'stimulation ribosomal frameshifting antisense lna',\n",
       " 'flexible loop yeast ribosomal protein coordinates psite trna binding',\n",
       " 'involvement micrornas physiological pathological processes lung',\n",
       " 'rapid detection pandemic influenza presence seasonal influenza',\n",
       " 'responses human endothelial cells pathogenic nonpathogenic leptospira species',\n",
       " 'porcine adenovirus low human seroprevalence promising alternative vaccine vector human adenovirus h5n1 virus disease model',\n",
       " 'liposomecoupled antigens internalized antigenpresenting cells via pinocytosis cross-presented cd8 cells',\n",
       " 'therapeutic vaccination chronic hepatitis preclinical studies woodchuck',\n",
       " 'human immunome bioinformatic analyses using hla supermotifs parasite genome binding assays studies human cell responses immunization hla- * transgenic mice including novel adjuvants provide foundation hla- restricted cd8 cell epitope based adjuvanted vaccine protective toxoplasma gondii',\n",
       " 'conserved epitopes influenza virus inducing protective immunity prospects universal vaccine development',\n",
       " 'intracellular dynamic protein palmitoylation',\n",
       " 'impact sex gender pregnancy h1n1 disease',\n",
       " 'phever database global exploration virus host evolutionary relationships',\n",
       " 'reporting errors infectious disease outbreaks application pandemic influenza ah1n1',\n",
       " 'pathological ultrastructural analysis surgical lung biopsies patients swine origin influenza type /h1n1 acute respiratory failure',\n",
       " 'ventilatory ecmo treatment h1n1induced severe respiratory failure results italian referral ecmo center',\n",
       " 'broadly crossreactive antibodies dominate human cell response pandemic h1n1 influenza virus infection',\n",
       " 'annual symposium society study inborn errors metabolism',\n",
       " 'assessment virally vectored autoimmunity biocontrol strategy cane toads',\n",
       " 'analysing eosinophil cationic protein clue function eosinophil granulocyte',\n",
       " 'excess healthcare burden influenza pandemic taiwan implications post-pandemic preparedness',\n",
       " 'multifunctional nanoparticles simulants gravimetric immunoassay',\n",
       " 'hepatitis virus associated aplastic anemia recent case pakistan',\n",
       " 'travel patterns china',\n",
       " 'spatial dynamics influenza pandemic england wales united states',\n",
       " 'chargesurrounded pockets electrostatic interactions small ions modulate activity retroviral fusion proteins',\n",
       " 'tracheostomy mechanical ventilation weaning children affected respiratory virus according weaning protocol pediatric intensive care unit argentina observational restrospective trial',\n",
       " 'activity hiv1 ires stimulated oxidative stress controlled negative regulatory element',\n",
       " 'characterisation translational terminationreinitiation signal influenza virus segment rna',\n",
       " 'rna dna bacteriophages molecular diagnosis controls clinical virology comprehensive study routine pcr tests',\n",
       " 'pandemic h1n1 influenza virus h275y oseltamivir resistance neuraminidase mutation shows small compromise enzyme activity viral fitness',\n",
       " 'ketamine inhibits tumor necrosis factor secretion raw2647 murine macrophages stimulated antibioticexposed strains community-associated methicillin-resistant staphylococcus aureus',\n",
       " 'avipoxviruses infection biology use vaccine vectors',\n",
       " 'apolipoprotein gene apom polymorphism modifies metabolic disease traits type diabetes',\n",
       " 'noninvasive microstructure morphology investigation mouse lung qualitative description quantitative measurement',\n",
       " 'evolution size pattern social amoebas',\n",
       " 'plant plastid engineering',\n",
       " 'role glutathione immunity inflammation lung',\n",
       " 'complacent populationbased public health response first influenza pandemic',\n",
       " 'gleamviz computational tool publicly available software explore realistic epidemic spreading scenarios global scale',\n",
       " 'nursing heroism',\n",
       " 'implications copy number variation people chromosomal abnormalities potential greater variation copy number state may contribute variability phenotype',\n",
       " 'hepatitis associated aplastic anemia review',\n",
       " 'factors affecting intention receive selfreported receipt pandemic h1n1 vaccine hong kong longitudinal study',\n",
       " 'dengue virus virulence transmission determinants',\n",
       " 'tylosema esculentum marama tuber bean extracts strong antiviral agents rotavirus infection',\n",
       " 'sphaeranthus indicus linn phytopharmacological review',\n",
       " 'autonomous targeting infectious superspreaders using engineered transmissible therapies',\n",
       " 'screening random peptide library hemagglutinin pandemic ah1n1 influenza virus reveals unexpected antigenically important regions',\n",
       " 'new insights old defense system structure function clinical relevance complement system',\n",
       " 'targeting vaccination novel infections risk age spatial structure pandemic influenza great britain',\n",
       " 'networks epidemiology infectious disease',\n",
       " 'viral encephalomyelitis',\n",
       " 'assessing vitro fitness oseltamivirresistant seasonal ah1n1 influenza strain using mathematical model',\n",
       " 'genomic signatures strain selection enhancement bacillus atrophaeus var globigii historical biowarfare simulant',\n",
       " 'differential induction functional igg using plasmodium falciparum placental malaria vaccine candidate var2csa',\n",
       " 'severe pneumococcal pneumonia impact new quinolones prognosis',\n",
       " 'generalized maternal optimism pessimism pregnancy associated unplanned cesarean section deliveries china',\n",
       " 'vitro gene delivery mediated asialofetuinappended cationic liposomes associated -cyclodextrin hepatocytes',\n",
       " 'participation cell polarity protein pals1 tcell receptormediated nf- b activation',\n",
       " 'canadian critical care trials group project collaboration international forum acute care trialists collaborative h1n1 adjuvant treatment pilot trial chat study protocol design randomized controlled trial',\n",
       " 'dissection influenza virus endocytic routes reveals macropinocytosis alternative entry pathway',\n",
       " 'alphacopi coatomer protein required rough endoplasmic reticulum whorl formation mosquito midgut epithelial cells',\n",
       " 'interaction specific population human embryonic stem cell derived progenitor cells cd11b+ cells ameliorates sepsis-induced lung inflammatory injury',\n",
       " 'wide prevalence heterosubtypic broadly neutralizing human antiinfluenza antibodies',\n",
       " 'peptide model helices lipid membranes insertion positioning lipid response aggregation studied -ray scattering',\n",
       " 'vaccine potential nipah viruslike particles',\n",
       " 'antibodymediated universal osteoclast targeting platform using calcitonin model drug',\n",
       " 'insights modeling',\n",
       " 'production ifn listeria monocytogenes infection restricted monocyte/macrophage lineage',\n",
       " 'endogenous ribosomal frameshift signals operate mrna destabilizing elements least two molecular pathways yeast',\n",
       " 'time revise paradigm hantavirus syndromes hantavirus pulmonary syndrome caused european hantavirus',\n",
       " 'antigenspecific monoclonal antibodies isolated cells expressing constitutively active stat5',\n",
       " 'genomic characterization high prevalence bocaviruses swine',\n",
       " 'analysis codon usage nucleotide composition bias polioviruses',\n",
       " 'novel divergent simian hemorrhagic fever viruses wild ugandan red colobus monkey discovered using direct pyrosequencing',\n",
       " 'live bird markets bangladesh h9n2 viruses near absence highly pathogenic h5n1 influenza',\n",
       " 'monitoring influenza activity united states comparison traditional surveillance systems google flu trends',\n",
       " 'monitoring systemic human memory cell compartment melanoma patients antitumor igg antibodies',\n",
       " 'multifaceted poliovirus',\n",
       " 'transmission potential chikungunya virus control measures case italy',\n",
       " 'clustering heart rate dynamics associated -adrenergic receptor polymorphisms analysis information-based similarity index',\n",
       " 'infection chicken tracheal epithelial cells h6n1 avian influenza virus',\n",
       " 'classification viral zoonosis receptor pattern analysis',\n",
       " 'simple inexpensive device nucleic acid amplification without electricity toward instrument-free molecular diagnostics low-resource settings',\n",
       " 'quantitative subcellular proteome secretome profiling influenza virusinfected human primary macrophages',\n",
       " 'angiotensinconverting enzyme central regulator cardiovascular function',\n",
       " 'potent hostdirected smallmolecule inhibitors myxovirus rna-dependent rna-polymerases',\n",
       " 'insight interaction metal ions troa streptococcus suis',\n",
       " 'complement system',\n",
       " 'chest imaging features patients afflicted influenza h1n1 malaysian tertiary referral centre',\n",
       " 'noninvasive ventilation acute respiratory failure due h1n1 influenza',\n",
       " 'temporal anomalies immunological gene expression time series wild mice signature epidemic',\n",
       " 'spliced leader rnas mitochondrial gene frameshifts multiprotein phylogeny expand support genus perkinsus unique group alveolates',\n",
       " 'oneyear molecular survey astrovirus infection turkeys poland',\n",
       " 'new approach monitoring dengue activity',\n",
       " 'dynamic variations peripheral blood lymphocyte subgroups patients pandemic h1n1 swineorigin influenza virus infection',\n",
       " 'maternal influenza immunization reduced likelihood prematurity small gestational age births retrospective cohort study',\n",
       " 'role nonformal education combating hiv epidemic philippines taiwan',\n",
       " 'standardization methods early diagnosis onsite treatment highaltitude pulmonary edema',\n",
       " 'noninvasive ventilation acute respiratory failure due h1n1 influenza word caution',\n",
       " 'temporal analysis honey bee microbiome reveals four novel viruses seasonal prevalence known viruses nosema crithidia',\n",
       " 'evaluation coseasonality influenza invasive pneumococcal disease results prospective surveillance',\n",
       " 'macrophagemediated optic neuritis induced retrograde axonal transport spike gene recombinant mouse hepatitis virus',\n",
       " 'nonapical membrane antigen ama1 iggs malian children interfere functional activity ama1 iggs judged growth inhibition assay',\n",
       " 'hepatitis virus genotype forms corelike particles unique structural properties',\n",
       " 'indepth analysis antibody response individuals exposed primary dengue virus infection',\n",
       " 'spatial temporal characteristics ah1n1 influenza pandemic peru',\n",
       " 'rhinovirus genome variation chronic upper lower respiratory tract infections',\n",
       " 'gene expression profile chondrogenesis human bone marrow derived mesenchymal stem cells using cdna microarray',\n",
       " 'identification cd8 cytotoxic lymphocyte epitopes porcine reproductive respiratory syndrome virus matrix protein balb/ mice',\n",
       " 'network clustering revealed systemic alterations mitochondrial protein expression',\n",
       " 'claudins lung diseases',\n",
       " 'human bocavirus patients respiratory tract infection',\n",
       " 'seasonal distribution active systemic lupus erythematosus correlation meteorological factors',\n",
       " 'ceacam1 separates graftversushost-disease graft-versus-tumor activity experimental allogeneic bone marrow transplantation',\n",
       " 'programmed death pd deficient mice extremely sensitive murine hepatitis virus strain- mhv- infection',\n",
       " 'machupo virus glycoprotein determinants human transferrin receptor binding cell entry',\n",
       " 'advent ecmo pumpless extracorporeal lung assist ards',\n",
       " 'gitype t4ssmediated horizontal transfer',\n",
       " 'conformationsensitive monoclonal antibody domain von willebrand factor reduces proteolysis adamts13',\n",
       " 'brief review diagnosis footandmouth disease livestock conventional molecular tools',\n",
       " 'renewed global partnerships redesigned roadmaps rabies prevention control',\n",
       " 'interplay sin3a stat3 mediates chromatin conformational changes gfap expression cellular differentiation',\n",
       " 'fertility quality life fertiqol tool development general psychometric properties',\n",
       " 'longterm respiratory followup h1n1 infection',\n",
       " 'milk lacking -casein leads permanent reduction body size mice',\n",
       " 'geometry adhesion extracellular domains dcsignr neck length variants analyzed force distance measurements',\n",
       " 'global mrna degradation lytic gammaherpesvirus infection contributes establishment viral latency',\n",
       " 'modified ms2 bacteriophage plaque reduction assay rapid screening antiviral plant extracts',\n",
       " 'equal graph partitioning estimated infection network effective epidemic mitigation measure',\n",
       " 'strengthening systems communicable disease surveillance creating laboratory network rwanda',\n",
       " 'immunity traits pigs substantial genetic variation limited covariation',\n",
       " 'demographic etiological histological pulmonary analysis patients acute respiratory failure study years autopsies',\n",
       " 'type interferon induction natural killer cell gamma interferon production defense lymphocytic choriomeningitis virus infection',\n",
       " 'interaction lfa1 mononuclear cells icam1 tubular epithelial cells accelerates tgf- 1-induced renal epithelial-mesenchymal transition',\n",
       " 'histological study biodynamics iron oxide nanoparticles different diameters',\n",
       " 'microbial detection array combined random phi29amplification used diagnostic tool virus detection clinical samples',\n",
       " 'cell repertoire analysis identifies new antigenic domains glycoprotein human cytomegalovirus target neutralizing antibodies',\n",
       " 'inflammatory cytokine expression associated chikungunya virus resolution symptom severity',\n",
       " 'failure',\n",
       " 'identification highly conserved subtypespecific epitope diagnostic potential hemagglutinin protein influenza virus',\n",
       " 'stimulation stop codon readthrough frequent presence extended rna structural element',\n",
       " 'antigenexpressing immunostimulatory liposomes genetically programmable synthetic vaccine',\n",
       " 'chinese herbal formula xiao yao san treatment depression systematic review randomized controlled trials',\n",
       " 'preventing next sars european healthcare workers attitudes towards monitoring health surveillance newly emerging infections qualitative study',\n",
       " 'informational needs assessment non hodgkin lymphoma survivors physicians',\n",
       " 'prediction peptide reactivity human ivig knowledgebased approach',\n",
       " 'description two measles outbreaks lazio region italy importance pockets low vaccine coverage sustaining infection',\n",
       " 'systematic identification novel essential host genes affecting bromovirus rna replication',\n",
       " 'unusual association stt abnormalities myocarditis cardiomyopathy influenza pregnancy two case reports review literature',\n",
       " 'dominating biological networks',\n",
       " 'neglected disease african sleeping sickness recent synthetic modeling advances',\n",
       " 'nod nucleolar localization sequence detector eukaryotic viral proteins',\n",
       " 'avian influenza risk perception preventive behavior among traditional market workers shoppers taiwan practical implications prevention',\n",
       " 'name greater good',\n",
       " 'emerging viral threats gabon health capacities response risk emerging zoonotic diseases central africa',\n",
       " 'poverty global health infectious disease lessons haiti rwanda',\n",
       " 'forecasting incidence hemorrhagic fever renal syndrome china using arima model',\n",
       " 'delivery systems intradermal vaccination',\n",
       " 'recurrent recruitment manoeuvres improve lung mechanics minimize lung injury mechanical ventilation healthy mice',\n",
       " 'virtual highthroughput screening identifies mycophenolic acid novel rna capping inhibitor',\n",
       " 'longterm followup treatment congenital alveolar proteinosis',\n",
       " 'severe influenza cases paediatric intensive care units germany prepandemic seasons',\n",
       " 'epidemiological clinical characteristics childhood pandemic h1n1 virus infection observational cohort study',\n",
       " 'immunodetection occult eosinophils lung tissue biopsies may help predict survival acute lung injury',\n",
       " 'overlapping signals translational regulation packaging influenza virus segment',\n",
       " 'leukocyte plateletderived microvesicle interactions following vitro vivo activation toll-like receptor lipopolysaccharide',\n",
       " 'nkg2d contributes efficient clearance picornavirus acutely infected murine brain',\n",
       " 'discovery genomic characterization novel ovine partetravirus new genotype bovine partetravirus',\n",
       " 'reconstructing disease outbreaks genetic data graph approach',\n",
       " 'human bocavirus insights newly identified respiratory virus',\n",
       " 'plasmacytoid dendritic cells control herpesvirus infections',\n",
       " 'communicable diseases prioritized surveillance epidemiological research results standardized prioritization procedure germany',\n",
       " 'vesicular stomatitis virus repliconbased bioassay rapid sensitive determination multispecies type interferon',\n",
       " 'characterization neutralizing profiles hiv1 infected patients hj16 hgn194 hk20 mabs obtained',\n",
       " 'ebvgp350 confers bcell tropism tailored exosomes neo-antigen normal malignant cells new option treatment -cll',\n",
       " 'ebola virus glycoprotein hiv1 vpu employ different strategies counteract antiviral factor tetherin',\n",
       " 'detection fourth orbivirus nonstructural protein',\n",
       " 'geographic distribution risk factors initial adult hospitalized cases pandemic influenza h1n1 virus infection mainland china',\n",
       " 'inferring viral quasispecies spectra pyrosequencing reads',\n",
       " 'ebola virion attachment entry human macrophages profoundly effects early cellular gene expression',\n",
       " 'casebased reported mortality associated laboratoryconfirmed influenza h1n1 virus infection netherlands pandemic season versus influenza season',\n",
       " 'chinese herbal formula improve general psychological status posttraumatic stress disorder randomized placebocontrolled trial sichuan earthquake survivors',\n",
       " 'quercetin',\n",
       " 'use recombinant adenovirus vectored consensus ifn avert severe arenavirus infection',\n",
       " 'protein disulfide isomerase hostpathogen interaction',\n",
       " 'improved immunological tolerance following combination therapy ctla4ig aav-mediated pd-/ muscle gene transfer',\n",
       " 'comparison humoral immune responses epsteinbarr virus kaposi sarcoma associated herpesvirus using viral proteome microarray',\n",
       " 'stem loop structures effectively substitute rna pseudoknot ribosomal frameshifting',\n",
       " 'usefulness published pcr primers detecting human rhinovirus infection',\n",
       " 'nnalign webbased prediction method allowing non-expert end-user discovery sequence motifs quantitative peptide data',\n",
       " 'red blood cell transfusion critically ill patient',\n",
       " 'respiratory support neurally adjusted ventilatory assist nava severe rsv-related bronchiolitis case series report',\n",
       " 'evaluation approaches identify targets cellular immunity proteomewide scale',\n",
       " 'porcine major histocompatibility complex mhc class molecules analysis peptide-binding specificities',\n",
       " 'immunogenetic factors associated severe respiratory illness caused zoonotic h1n1 h5n1 influenza viruses',\n",
       " 'china students crowded dormitories low ventilation rate common colds evidence airborne transmission',\n",
       " 'epidemiology clinical characteristics hospitalized patients pandemic influenza h1n1 infections effects bacterial coinfection',\n",
       " 'clinical review genebased therapies ali/ards',\n",
       " 'critical care services h1n1 influenza epidemic australia new zealand impact second winter epidemic',\n",
       " 'early corticosteroid treatment severe pneumonia caused h1n1 influenza virus',\n",
       " 'multinational observational study procalcitonin icu patients pneumonia requiring mechanical ventilation multicenter observational study',\n",
       " 'role receptor advanced glycation endproducts rage infection',\n",
       " 'metagenomic analysis fever thrombocytopenia leukopenia syndrome ftls henan province china discovery new bunyavirus',\n",
       " 'clinical aspects cytokine response severe h1n1 influenza virus infection',\n",
       " 'clinical review idiopathic pulmonary fibrosis acute exacerbations unravelling ariadnes thread',\n",
       " 'influence genetic variability surfactant proteins communityacquired pneumonia prospective observational genetic study',\n",
       " 'survival influenza ah1n1 materials found households implications infection control',\n",
       " 'respiratory failure presenting h1n1 influenza legionnaires disease two case reports',\n",
       " 'agricultural intensification priming persistence emergence nipah virus lethal bat-borne zoonosis',\n",
       " 'expert assessments converge exploratory case study evaluating managing blood supply risk',\n",
       " 'noninvasive positive pressure ventilation acute respiratory failure children concise review',\n",
       " 'pandemic ah1n1v influenza hospitalized children multicenter belgian survey',\n",
       " 'quantitative method specific assessment caspase6 activity cell culture',\n",
       " 'quantifying social distancing arising pandemic influenza',\n",
       " 'novel inhibitor design hemagglutinin h1n1 influenza virus core hopping method',\n",
       " 'tamifluresistant hamediated cell-to-cell transmission apical membranes cell-associated influenza viruses',\n",
       " 'persistent expression hepatitis virus nonstructural proteins leads increased autophagy mitochondrial injury human hepatoma cells',\n",
       " 'neighborhood properties important determinants temperature sensitive mutations',\n",
       " 'missing accounted gaps areas wealth public health review literature',\n",
       " 'inhibition interferon induction action nairovirus nairobi sheep disease virusganjam virus',\n",
       " 'human monoclonal antibody neutralizing activity highly divergent influenza subtypes',\n",
       " 'tissue tropism target cells nssdeleted rift valley fever virus live immunodeficient mice',\n",
       " 'evaluation internal reference genes quantitative expression analysis realtime pcr ovine whole blood',\n",
       " 'normal variation thermal radiated temperature cattle implications footand-mouth disease detection',\n",
       " 'cochrane systematic reviews chinese herbal medicines overview',\n",
       " 'current status immunomodulation immunomediated therapeutic strategies multiple sclerosis',\n",
       " 'towards crosslingual alerting bursty epidemic events',\n",
       " 'reducing mortality sepsis new directions',\n",
       " 'synergistic roles eukaryotic translation elongation factors',\n",
       " 'mannosebinding lectin contributes deleterious inflammatory response pandemic h1n1 avian h9n2 infection',\n",
       " 'essential epidemiological mechanisms underpinning transmission dynamics seasonal influenza',\n",
       " 'amiodarone exposure modest inflammation induces idiosyncrasylike liver injury rats role tumor necrosis factor-alpha',\n",
       " 'polyvalent dna vaccines expressing ha antigens h5n1 influenza viruses optimized leader sequence elicit crossprotective antibody responses',\n",
       " 'elm database eukaryotic linear motifs',\n",
       " 'epithelial cells derived swine bone marrow express stem cell markers support influenza virus replication vitro',\n",
       " 'two birds one stone possible dualtargeting h1n1 inhibitors traditional chinese medicine',\n",
       " 'synthesis antiviral drug precursor chitin using saprophyte wholecell catalyst',\n",
       " 'mrna pseudoknot structures act ribosomal roadblocks',\n",
       " 'secretory phospholipase pathway various types lung injury neonates infants multicentre translational study',\n",
       " 'transmissibility temporal changes ph1n1 pandemic summer fallwinter waves',\n",
       " 'molecular mechanisms inflammation tissue injury major traumais complement bad guy',\n",
       " 'predicting biological functions compounds based chemicalchemical interactions',\n",
       " 'identification characterization novel nonstructural protein bluetongue virus',\n",
       " 'interference hbonding substituent effects nitro hydroxy-substituted salicylaldehydes',\n",
       " 'acute respiratory distress syndrome induced swine h1n1 variant mice',\n",
       " 'true versus false parasite interactions robust method take risk factors account application feline viruses',\n",
       " 'transmembrane domain ceacam14s determinant anchorage independent growth tumorigenicity',\n",
       " 'human subtilase ski1s1p master regulator hcv lifecycle potential host cell target developing indirect-acting antiviral agents',\n",
       " 'hmgb1 alarmin promoting hiv dissemination latency dendritic cells',\n",
       " 'evaluation seeplex meningitis ace detection kit detection common bacterial viral pathogens acute meningitis',\n",
       " 'colorphylo color code accurately display taxonomic classifications',\n",
       " 'deconstructing hostpathogen interactions drosophila',\n",
       " 'organisation ebola virus reveals capacity extensive modular polyploidy',\n",
       " '',\n",
       " 'perspectives immunoglobulins colostrum milk',\n",
       " 'crazypaving pattern radiological-pathological correlation',\n",
       " 'comparison percutaneous radiofrequency thermal ablation surgical resection small hepatocellular carcinoma',\n",
       " 'making sense perceptions risk diseases vaccinations qualitative study combining models health beliefs decision-making risk perception',\n",
       " 'development applications vsv vectors based cell tropism',\n",
       " 'distinct regulation host responses erk jnk map kinases swine macrophages infected pandemic h1n1 influenza virus',\n",
       " 'international society disease surveillance conference building future public health surveillance building future public health surveillance',\n",
       " 'rnaseq based transcriptional map bovine respiratory disease pathogen histophilus somni',\n",
       " 'review chemical biological properties cayratia trifolia linn vitaceae',\n",
       " 'molecular mechanism subunit stoichiometry rod cyclic nucleotidegated ion channels',\n",
       " 'retrovirology prize winner masao matsuoka forward looking antisense',\n",
       " 'effect modification environmental factors influenzaassociated mortality time-series study two chinese cities',\n",
       " 'influenza ah1n1 septic shock patient systemic lupus erythematosus case report',\n",
       " 'timeliness contact tracing among flight passengers influenza ah1n1',\n",
       " 'validation selfswab virologic confirmation influenza virus infections community setting',\n",
       " 'molecular mimicry mechanism autoimmune disease',\n",
       " 'low usage government healthcare facilities acute respiratory infections guatemala implications influenza surveillance',\n",
       " 'understanding clinical spectrum complicated plasmodium vivax malaria systematic review contributions brazilian literature',\n",
       " 'protective role ace2ang',\n",
       " 'viral proteins acquired host converge simplified domain architectures',\n",
       " 'treatment neuroterrorism',\n",
       " 'new cardiovascular pulmonary therapeutic strategies based angiotensinconverting enzyme',\n",
       " 'unraveling structural complexity singlestranded rna tail implications efficient ligand binding prequeuosine riboswitch',\n",
       " 'soluble rage severity marker community acquired pneumonia associated sepsis',\n",
       " 'virus identification unknown tropical febrile illness cases using deep sequencing',\n",
       " 'effects nonconservative sequence properties -glucuronidase aspergillus terreus li-',\n",
       " 'protein sequence analysis based hydropathy profile amino acids',\n",
       " 'filovirus tropism cellular molecules viral entry',\n",
       " 'replicationcompetent recombinant porcine reproductive respiratory syndrome prrs viruses expressing indicator proteins antiviral cytokines',\n",
       " 'coopted deadbox rna helicase enhances tombusvirus plus-strand synthesis',\n",
       " 'transmission infectious diseases en route habitat hotspots',\n",
       " 'dispanins novel gene family ancient origin contains human members',\n",
       " 'health system resource gaps associated mortality pandemic influenza across six asian territories',\n",
       " 'epidemiology viral etiologies severe acute respiratory infections sari northern vietnam',\n",
       " 'impact different influenza cultivation conditions ha nglycosylation',\n",
       " 'isolation active peptides plant hydrolysates promote vero cells growth stirred cultures',\n",
       " 'first dating recombination event mammalian tickborne flaviviruses',\n",
       " 'isothermal amplification using chemical heating device pointofcare detection hiv-',\n",
       " 'design management orthopaedic bone bank netherlands',\n",
       " 'dectin1 dcsign polymorphisms associated invasive pulmonary aspergillosis infection',\n",
       " 'lethal nipah virus infection induces rapid overexpression cxcl10',\n",
       " 'influenza virus respiratory infection transmission following ocular inoculation ferrets',\n",
       " 'placement leucine zipper motifs carboxyl terminus hiv1 protease significantly reduces virion production',\n",
       " 'year review intensive care medicine nephrology epidemiology nutrition therapeutics neurology ethical legal issues experimentals',\n",
       " 'using support vector machine evolutionary profiles predict antifreeze protein sequences',\n",
       " 'reliability external validity amstar assessing quality tcm systematic reviews',\n",
       " 'innate immune response human alveolar macrophages influenza infection',\n",
       " 'successful treatment chlamydophila pneumoniae acute respiratory distress syndrome extracorporeal membrane oxygenator case report diagnostic review',\n",
       " 'environmental sampling avian influenza virus h5n1 live-bird markets indonesia',\n",
       " 'manifesting ecologic microbial connections',\n",
       " 'influenza refugees thailand myanmar border may october',\n",
       " 'early clinical features dengue virus infection nicaraguan children longitudinal analysis',\n",
       " 'influenza h1n1 swine flu pregnancy',\n",
       " 'use evaluation molecular diagnostics pneumonia etiology studies',\n",
       " 'resveratrol inhibits kshv reactivation lowering levels cellular egr1',\n",
       " 'common variants cdkn2bas1 associated opticnerve vulnerability glaucoma identified genome-wide association studies japanese',\n",
       " 'interleukin18 expression response treatment patients psoriasis',\n",
       " 'replication enhancer elements within open reading frame tickborne encephalitis virus evolution within flavivirus genus',\n",
       " 'tlr2 trif contribute interferon production listeria infection',\n",
       " 'protein reporter bioassay systems phenotypic screening candidate drugs mouse platform antiaging drug screening',\n",
       " 'suppression adenosineactivated chloride transport ethanol airway epithelia',\n",
       " 'high fidelity processing activation human -defensin hnp1 precursor neutrophil elastase proteinase',\n",
       " 'foxp3 regulatory cells control persistence viral cns infection',\n",
       " 'superimposed highfrequency jet ventilation combined continuous positive airway pressureassisted spontaneous breathing improves oxygenation patients h1n1-associated ards',\n",
       " 'serious invasive saffold virus infections children',\n",
       " 'pandemic h1n1 among quarantined close contacts beijing people republic china',\n",
       " 'dengue virus infection perturbs lipid homeostasis infected mosquito cells',\n",
       " 'human cardioviruses meningitis sudden infant death syndrome children',\n",
       " 'knowledge avian influenza h5n1 among poultry workers hong kong china',\n",
       " 'pilot study host genetic variants associated influenzaassociated deaths among children young adults',\n",
       " 'clinical features risk factors severe critical pregnant women pandemic h1n1 influenza infection china',\n",
       " 'scientometric analysis indian research output medicine',\n",
       " 'membrane fusion cell entry xmrv phindependent modulated envelope glycoproteins cytoplasmic tail',\n",
       " 'impact weather influenza pneumonia mortality new york city retrospective study',\n",
       " 'finding removing highly connected individuals using suboptimal vaccines',\n",
       " 'impact media coverage transmission dynamics human influenza',\n",
       " 'detection mycobacterium ulcerans loop mediated isothermal amplification method',\n",
       " 'human prm antibody recognizes novel cryptic epitope dengue glycoprotein',\n",
       " 'lack association clec5a gene singlenucleotide polymorphisms kawasaki disease taiwanese children',\n",
       " 'nonvh169 heterosubtypic neutralizing human monoclonal antibody protects mice h1n1 h5n1 viruses',\n",
       " 'webbased investigation multistate salmonellosis outbreak',\n",
       " 'dengue fever hawaii',\n",
       " 'estimating sars incubation period',\n",
       " 'syndromic surveillance',\n",
       " 'human metapneumovirus severity respiratory syncytial virus disease',\n",
       " 'community responses communication campaigns influenza h1n1 focus group study',\n",
       " 'quantifying typespecific reproduction numbers nosocomial pathogens evidence heightened transmission asian sequence type mrsa clone',\n",
       " 'discovery genomic characterization novel bat sapovirus unusual genomic features phylogenetic position',\n",
       " 'angiotensin converting enzyme ace ace2 bind integrins ace2 regulates integrin signalling',\n",
       " 'altered thymic function interferon therapy hcvinfected patients',\n",
       " 'baculovirusbased vaccine displaying respiratory syncytial virus glycoprotein induces protective immunity rsv infection without vaccineenhanced disease',\n",
       " \"divergent lineage novel hantavirus banana pipistrelle neoromicia nanus c te 'ivoire\",\n",
       " 'protective immunity listeria monocytogenes infection mediated recombinant listeria innocua harboring vgc locus',\n",
       " 'transcriptomics vitro immunestimulated hemocytes manila clam ruditapes philippinarum using highthroughput sequencing',\n",
       " 'distribution risk factors pandemic influenza h1n1 mainland china',\n",
       " 'replication neurotropism pathogenicity avian paramyxovirus serotypes',\n",
       " 'patterns influencing factor synonymous codon usage porcine circovirus',\n",
       " 'development humanized antibody high therapeutic potential dengue virus type',\n",
       " 'cd8 cells leishmania infections friends foes',\n",
       " 'macroevolutionary immunology role immunity diversification animal life',\n",
       " 'recent advances diagnosis treatment influenza pneumonia',\n",
       " '',\n",
       " 'ceacd3bispecific antibody medi- mt111 binds nonlinear epitope full-length short splice variant cea',\n",
       " 'high throughput screening small molecule enhancers interferon signaling pathway drive nextgeneration antiviral drug discovery',\n",
       " 'feline immunodeficiency virus south america',\n",
       " 'chinese medicine shenfu injection heart failure systematic review metaanalysis',\n",
       " 'genome stability pandemic influenza h1n1 based analysis hemagglutinin neuraminidase genes',\n",
       " 'severe imported malaria intensive care unit review cases',\n",
       " 'use controlled low dose gamma irradiation sterilize allograft tendons acl reconstruction biomechanical clinical perspective',\n",
       " 'distinct immunoregulatory cytokine pattern egyptian patients occult hepatitis infection unexplained persistently elevated liver transaminases',\n",
       " 'dcsign cd209 promoter rs4804803 polymorphism associated susceptibility kawasaki disease',\n",
       " 'interferoninduced ifit2isg54 protects mice lethal vsv neuropathogenesis',\n",
       " 'immunogenetic mechanisms driving norovirus gii4 antigenic variation',\n",
       " 'induction gadd34 necessary dsrnadependent interferon production participates control chikungunya virus infection',\n",
       " 'targets intracellular signaling mechanisms deoxynivalenolinduced ribosomal rna cleavage',\n",
       " 'pilot evaluation rtpcrelectrospray ionization mass spectrometry plex-id/flu assay influenza-positive specimens',\n",
       " 'evaluation atherosclerotic lesions using dextran mannan dextran-coated uspio mri analysis pathological findings',\n",
       " 'il15 participates respiratory innate immune response influenza virus infection',\n",
       " 'enterovirus infection adult japan',\n",
       " 'screening influenza ah1n1pdm09 auckland international airport new zealand',\n",
       " 'immunologic changes pandemic h1n1 china',\n",
       " 'pandemic h1n1 risk frontline health care workers',\n",
       " 'coronavirus hku1 children brazil',\n",
       " 'increased urinary angiotensinconverting enzyme renal transplant patients diabetes',\n",
       " 'pepmapper collaborative web tool mapping epitopes affinityselected peptides',\n",
       " 'autophagy nonselective pathway',\n",
       " 'sigma class glutathione transferase liver fluke fasciola hepatica',\n",
       " 'discriminating active latent tuberculosis patients presenting community clinics',\n",
       " 'novel evidence hbv recombination family cluster infections western china',\n",
       " 'identifying live bird markets potential act reservoirs avian influenza h5n1 virus survey northern viet nam cambodia',\n",
       " 'porcine noroviruses related human noroviruses',\n",
       " 'clinical relevance discriminatory value elevated liver aminotransferase levels dengue severity',\n",
       " 'directed fusion mesenchymal stem cells cardiomyocytes via vsvg facilitates stem cell programming',\n",
       " 'design novel dual agonists treating type2 diabetes targeting peroxisome proliferatoractivated receptors core hopping approach',\n",
       " 'prognosis hospitalized patients h1n1 influenza spain influence neuraminidase inhibitors',\n",
       " 'veillonella montpellierensis endocarditis',\n",
       " 'primatetohuman retroviral transmission asia',\n",
       " 'application consensus scoring principal component analysis virtual screening -secretase bace-',\n",
       " '',\n",
       " 'human bocavirus children',\n",
       " 'acute environment rather cell subset precommitment regulates expression human cell cytokine amphiregulin',\n",
       " 'allosct multiple myeloma review outcomes single transplant center',\n",
       " 'sequence analysis feline coronaviruses circulating virulentavirulent theory',\n",
       " 'unc93b1 mediates innate inflammation antiviral defense liver acute murine cytomegalovirus infection',\n",
       " 'bioinformatics analysis rabbit haemorrhagic disease virus genome',\n",
       " 'oligonucleotide based magnetic bead capture onchocerca volvulus dna pcr pool screening vector black flies',\n",
       " 'prediction identification cell epitopes h5n1 influenza virus nucleoprotein chicken',\n",
       " 'novel paramyxoviruses freeranging european bats',\n",
       " 'lipid rafts alzheimer disease protein-lipid interactions perturbation signaling',\n",
       " 'west nile virus infection killer whale texas usa',\n",
       " 'outbreak porcine epidemic diarrhea suckling piglets china',\n",
       " 'differential seroprevalence human bocavirus species beijing china',\n",
       " 'clarithromycin suppresses human respiratory syncytial virus infectioninduced streptococcus pneumoniae adhesion cytokine production pulmonary epithelial cell line',\n",
       " 'posttranscriptional control type interferon induction porcine reproductive respiratory syndrome virus natural host cells',\n",
       " 'clinical review special populations critical illness pregnancy',\n",
       " 'paco2 alveolar dead space relevant pao /fio ratio monitoring respiratory response prone position ards patients physiological study',\n",
       " 'lung function organ dysfunctions patients requiring mechanical ventilation influenza h1n1 pandemic',\n",
       " 'comparative analysis mycobacterium related actinomycetes yields insight evolution mycobacterium tuberculosis pathogenesis',\n",
       " 'proteasomedependent disruption ubiquitin ligase anaphasepromoting complex hcmv protein pul21a',\n",
       " 'deciphering novel host herpesvirus interactions virion proteomics',\n",
       " 'naturallyoccurring genetic variants human dcsign increase hiv- capture cell-transfer risk mother-to-child transmission',\n",
       " 'new model hendra virus encephalitis mouse',\n",
       " 'ipomoelin jacalinrelated lectin compact tetrameric association versatile carbohydrate binding properties regulated terminus',\n",
       " 'retroviral env glycoprotein trafficking incorporation virions',\n",
       " 'production characterization applications toxoplasma gondiispecific polyclonal chicken egg yolk immunoglobulins',\n",
       " 'preparation antitumor antivirus agent chemical modification -mmc map30 momordica charantia covalent conjugation polyethyelene glycol',\n",
       " 'evaluation four different systems extraction rna stool suspensions using ms2 coliphage exogenous control rtpcr inhibition',\n",
       " 'analysis pathogenesis symptomatic pulmonary embolism human genomics',\n",
       " 'diversity roles trna ligases',\n",
       " 'esp abstracts',\n",
       " 'molecular imaging reveals progressive pulmonary inflammation lower airways ferrets infected h1n1 pandemic influenza virus',\n",
       " 'dynamics causes possible prevention hepatitis outbreaks',\n",
       " 'human bocaviruses significantly associated gastroenteritis results retesting archive dna case control study uk',\n",
       " 'structural origins loss catalytic activities bifunctional human lta4h revealed molecular dynamics simulations',\n",
       " 'molecular microscopic analysis bacteria viruses exhaled breath collected using simple impaction condensing method',\n",
       " 'seasonal influenza vaccination knowledge risk perception health beliefs vaccination behaviours nurses',\n",
       " 'ifn signaling astrocytes protects autoimmune mediated neurological disability',\n",
       " 'influence mabs prpsc formation using vitro cell-free systems',\n",
       " 'predictors outcome patients acute respiratory distress syndrome caused miliary tuberculosis retrospective study chongqing china',\n",
       " 'symptomatic venous thromboembolism disease related infection immune dysfunction',\n",
       " 'cedar virus novel henipavirus isolated australian bats',\n",
       " 'host modulators h1n1 cytopathogenicity',\n",
       " 'association fc receptor iib polymorphism cryptococcal meningitis hiv-uninfected chinese patients',\n",
       " 'infectious disease transmission organ tissue transplantation',\n",
       " 'nonhiv pneumocystis pneumonia conventional community-acquired pneumonia guidelines estimate severity',\n",
       " 'proteomic investigation falciparum vivax malaria identification surrogate protein markers',\n",
       " 'novel method isolation murine clara cell secretory proteinexpressing cells traces stemness',\n",
       " 'development realtime pcr array simultaneous detection eight human bloodborne viral pathogens',\n",
       " 'tcdc significantly repress toxin expression clostridium difficile',\n",
       " 'childhood tuberculosis presenting haemophagocytic syndrome',\n",
       " 'activation canonical bone morphogenetic protein bmp pathway lung morphogenesis adult lung tissue repair',\n",
       " 'pulmonary sequelae patient recovered swine flu',\n",
       " 'dengue virus serotype blocks extracellular signalregulated kinase nuclear factor b activation downregulate cytokine production',\n",
       " 'high influenza virus infection rates mallards bred hunting camargue south france',\n",
       " 'establishment reverse genetics system studying human bocavirus human airway epithelia',\n",
       " 'personal occupational public health perspectives dealing first case influenza h1n1 united arab emirates',\n",
       " 'human anticcr4 minibody gene transfer treatment cutaneous tcell lymphoma',\n",
       " 'vntr polymorphism dcsignr gene susceptibility hiv1 infection meta-analysis',\n",
       " 'tolllike receptors critical clearance brucella play different roles development adaptive immunity following aerosol challenge mice',\n",
       " 'diagnostic devices isothermal nucleic acid amplification',\n",
       " 'clinical characteristics pediatric hospitalizations associated pandemic influenza h1n1 northern bavaria germany',\n",
       " 'pip6pmo new generation peptide-oligonucleotide conjugates improved cardiac exon skipping activity dmd treatment',\n",
       " 'clinical characteristics outcome penicillium marneffei infection among hivinfected patients northern vietnam',\n",
       " 'prospective application clinicianperformed lung ultrasonography h1n1 influenza pandemic distinguishing viral bacterial pneumonia',\n",
       " 'serum levels gelatinase associated lipocalin indicator inflammatory status coronary artery disease',\n",
       " 'activity based protein profiling detect serine hydrolase alterations virus infected cells',\n",
       " 'murphys law anything go wrong problems phage electron microscopy',\n",
       " 'herbal products benefits limits applications chronic liver disease',\n",
       " 'identification pneumonia influenza deaths using death certificate pipeline',\n",
       " 'functional analysis rift valley fever virus nss encoding partial truncation',\n",
       " 'predictive reactive distribution vaccines antivirals crossregional pandemic outbreaks',\n",
       " 'novel vaccine using nanoparticle platform present immunogenic m2e avian influenza infection',\n",
       " 'factors associated increased risk perception pandemic influenza australia',\n",
       " 'blow flies one possible candidates transmission highly pathogenic h5n1 avian influenza virus outbreaks japan',\n",
       " 'examining knowledge attitudes practices domestic international university students towards seasonal pandemic influenza',\n",
       " 'use functional gene arrays elucidating situ biodegradation',\n",
       " 'functional studies ssdna binding ability marr family protein tcar staphylococcus epidermidis',\n",
       " 'marine organism cell biology regulatory sequence discoveryin comparative functional genomics',\n",
       " 'regulated multicistronic expression technology mammalian metabolic engineering',\n",
       " 'production high titre disabled infectious single cycle disc hsv microcarrier culture',\n",
       " 'diagnosis influenza viruses special reference novel h1n1 influenza virus',\n",
       " 'influenza highly pathogenic h5n1 pandemic h1n1 epidemiology clinical features',\n",
       " 'lessons learned influenza pandemic',\n",
       " 'differential effects il12 tregs nontreg cells roles ifn- il- il-',\n",
       " 'genetic variation tnf gene associated susceptibility severe sepsis mortality',\n",
       " 'identification characterization application gquadruplex structured dna aptamer cancer biomarker protein anterior gradient homolog',\n",
       " 'flt3l combined rapamycin promotes cardiac allograft tolerance inducing regulatory dendritic cells allograft autophagy mice',\n",
       " 'renalases expression distribution renal tissue cells',\n",
       " 'virus contaminations cell cultures biotechnological view',\n",
       " 'denv inhibits type ifn production infected cells cleaving human sting',\n",
       " 'acute reactogenicity intramuscular immunization recombinant vesicular stomatitis virus linked production il1',\n",
       " 'competition influenza virus genome segments',\n",
       " 'oral health china trends challenges',\n",
       " 'national intensive care unit bed capacity icu patient characteristics low income country',\n",
       " 'influenza virus infection nonhuman primates',\n",
       " 'labelfree electrochemical diagnosis viral antigens genetically engineered fusion protein',\n",
       " 'development plasticbased microfluidic immunosensor chip detection h1n1 influenza',\n",
       " 'hepatitis vlps delivered dendritic cells tlr2 targeting lipopeptide results enhanced antibody cellmediated responses',\n",
       " 'viral metagenomic analysis bushpigs potamochoerus larvatus uganda identifies novel variants porcine parvovirus torque teno sus virus',\n",
       " 'threedimensional comparison tickborne flavivirus infection mammalian tick cell lines',\n",
       " 'seed servers highperformance access seed genomes annotations metabolic models',\n",
       " 'ecr book abstracts postergraduate educational programme',\n",
       " 'discovery targeted lcmsms purified polerovirus reveals differences virus-host interactome associated altered aphid transmission',\n",
       " 'mortality severe acute respiratory infection influenza-like illness associated influenza h1n1 pdm09 argentina',\n",
       " 'difficile erm spo0a regulates sporulation contribute toxin production direct high-affinity binding target dna',\n",
       " 'sodium taurocholate cotransporting polypeptide functional receptor human hepatitis virus',\n",
       " 'evolutionary pattern glycosylation sites influenza virus h5n1 hemagglutinin neuraminidase',\n",
       " 'niclosamide proton carrier targets acidic endosomes broad antiviral effects',\n",
       " 'single native ganglioside gm1-binding site sufficient cholera toxin bind cells complete intoxication pathway',\n",
       " 'single residue substitution receptorbinding domain h5n1 hemagglutinin critical packaging pseudotyped lentiviral particles',\n",
       " 'particulate matter air pollution disrupts endothelial cell barrier via calpainmediated tight junction protein degradation',\n",
       " 'expression nicotinic receptor alpha7 cochlear development',\n",
       " 'identification serum proteomic biomarkers early porcine reproductive respiratory syndrome prrs infection',\n",
       " 'production characterization human antiv3 monoclonal antibodies cells hiv1 infected indian donors',\n",
       " 'toxicology biodistribution shedding profile recombinant measles vaccine vector expressing hiv1 antigens cynomolgus macaques',\n",
       " 'fortyfive years marburg virus research',\n",
       " 'human cytomegalovirus dna polymerase processivity factor ul44 modified sumo dnadependent manner',\n",
       " 'fasdeficient mice impaired alveolar neutrophil recruitment decreased expression antikc autoantibody kc complexes model acute lung injury',\n",
       " 'evolutionary dynamics interferoninduced transmembrane gene family vertebrates',\n",
       " 'filovirus research gabon equatorial africa experience research center heart africa',\n",
       " 'reproductive number serial interval first wave influenza ah1n1pdm09 virus south africa',\n",
       " 'measuring healthcare preparedness allhazards approach',\n",
       " 'presentation hemophagocytic lymphohistiocytosis due novel munc mutation masked partial therapeutic immunosuppression',\n",
       " 'relative cost outcomes intensive care unit acute lung injury ali due pandemic influenza compared etiologies single-center study',\n",
       " 'identification conserved bcell epitope reticuloendotheliosis virus envelope protein screening phagedisplayed random peptide library',\n",
       " 'lower respiratory tract infection renal transplant recipient forget metapneumovirus',\n",
       " 'primary mode smallpox transmission implications biodefense',\n",
       " 'chitinase dependent control protozoan cyst burden brain',\n",
       " 'automatic detection quantification treeinbud tib opacities ct scans',\n",
       " 'mannosebinding lectin deficiency acute exacerbations chronic obstructive pulmonary disease',\n",
       " 'changing phenotype microglia homeostasis disease',\n",
       " 'diversity salmonella spp serovars isolated intestines water buffalo calves gastroenteritis',\n",
       " 'severe childhood malaria syndromes defined plasma proteome profiles',\n",
       " 'predicting pseudoknotted structures across two rna sequences',\n",
       " ...]"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "clean_text"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Perform Vectorization"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Q1b).\tFor each title text, convert it into corresponding TF-IDF vector. [1 pt]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['a0201restricted', 'a1166c', 'a2a', 'a59induced', 'aacr', 'aan', 'aav', 'aav8mediated', 'ab', 'abbreviated', 'abbreviations', 'abc', 'abcb1', 'abcd', 'abcgefahrenlagen', 'abdominal', 'abdulaziz', 'aberrant', 'abgabensystem', 'abgebrochenen', 'abgesagt', 'abilities', 'ability', 'abkl', 'ablation', 'ablative', 'abnormal', 'abnormalities', 'aboincompatible', 'abordaje', 'aboriginal', 'abortion', 'abortive', 'abortus', 'abortusovis', 'abroad', 'abrogates', 'abrogating', 'abruzzo', 'abscess', 'abscesses', 'abseits', 'absence', 'absetzen', 'absolute', 'absolutely', 'absorption', 'absorptive', 'abstract', 'abstracts', 'abundance', 'abundant', 'abuse', 'abusers', 'acacetin', 'academia', 'academic', 'academics', 'academy', 'acanthamoeba', 'acari', 'acat1', 'acbd3', 'accelerate', 'accelerates', 'accelerating', 'acceleration', 'accept', 'acceptability', 'acceptance', 'accepted', 'accepting', 'access', 'accessibility', 'accessible', 'accident', 'accidental', 'accidents', 'acciones', 'acclimation', 'accommodating', 'accompanied', 'accompanying', 'according', 'account', 'accountability', 'accountants', 'accounted', 'accounting', 'accounts', 'accueil', 'accumbens', 'accumulate', 'accumulated', 'accumulating', 'accumulation', 'accuracy', 'accurate', 'accurately', 'ace', 'ace2', 'ace2ang', 'ace2p', 'acellular', 'acetonide', 'aceturate', 'acetyl', 'acetylated', 'acetylation', 'acetylcholine', 'acetylcholinesterase', 'acetylesterase', 'acetylneuraminic', 'ach', 'achieve', 'achievements', 'achieving', 'acid', 'acidbased', 'acidbuffered', 'acidcoated', 'aciddependent', 'acidic', 'acidification', 'acidindependent', 'acidinduced', 'acidmediated', 'acidosis', 'acids', 'acidsensitive', 'acidsuppressant', 'acinar', 'acinetobacter', 'acini', 'acinonyx', 'acl', 'acmt', 'aconitine', 'acquired', 'acquisition', 'acral', 'acronym', 'acronyms', 'acrosome', 'across', 'act', 'acta', 'acting', 'actinidia', 'actinidiae', 'actinobacillus', 'actinomycetes', 'action', 'actions', 'activate', 'activated', 'activates', 'activating', 'activation', 'activationdependent', 'activationlike', 'activator', 'activators', 'active', 'activin', 'activities', 'activity', 'activityrelated', 'acts', 'actuacin', 'actual', 'actualits', 'actuaries', 'actuated', 'acuity', 'acupoint', 'acute', 'acuteearly', 'acutely', 'acuteonchronic', 'acvim', 'acyclic', 'acyclovir', 'acyl', 'acylated', 'acylates', 'acylation', 'ad', 'ad53', 'adalimumab', 'adam17dependent', 'adam17mediated', 'adamts13', 'adap2', 'adaptability', 'adaptation', 'adaptations', 'adapted', 'adaptin', 'adaption', 'adaptive', 'add', 'added', 'addicted', 'addition', 'additional', 'address', 'addressed', 'addressing', 'adenine', 'adenoassociated', 'adenocarcinoma', 'adenosine', 'adenosineactivated', 'adenoviral', 'adenoviromics', 'adenovirus', 'adenovirusbased', 'adenoviruses', 'adenovirushost', 'adenovirusinfected', 'adenovirusvectored', 'adh', 'adherence', 'adherent', 'adhesinlike', 'adhesins', 'adhesion', 'adiponectin', 'adipose', 'adiposederived', 'adjudication', 'adjunct', 'adjunctive', 'adjusted', 'adjuvant', 'adjuvanted', 'adjuvants', 'administered', 'administration', 'admission', 'admissions', 'admitted', 'adolesc', 'adolescent', 'adolescents', 'adopted', 'adoptees', 'adopting', 'adoption', 'adoptive', 'adp', 'adpribosyl', 'adpribosylation', 'adqi', 'adrenal', 'adrenaline', 'adrenergic', 'adsorption', 'adult', 'adulte', 'adulthood', 'adulto', 'adultonset', 'adultos', 'adults', 'advance', 'advanced', 'advancements', 'advances', 'advancing', 'advantage', 'advantages', 'advax', 'advent', 'adventures', 'adversary', 'adverse', 'advisories', 'advisory', 'advocacy', 'aecopd', 'aedes', 'aedestransmitted', 'aegypti', 'aengland', 'aep', 'aeration', 'aeroallergen', 'aeromonas', 'aeropyrum', 'aerosol', 'aerosolbased', 'aerosolization', 'aerosolized', 'aerosols', 'aerospace', 'aeruginosa', 'aetiological', 'aetiology', 'af', 'af2240', 'afebrile', 'aff', 'affair', 'affairs', 'affect', 'affected', 'affecting', 'affects', 'affektiver', 'affinity', 'affinityselected', 'afflicted', 'afford', 'afforded', 'affymetrix', 'afi', 'aflatoxin', 'africa', 'african', 'afrotropics', 'after', 'aftereffects', 'aftermath', 'ag', 'ag22', 'againstbabesia', 'agalactiae', 'agamospecies', 'agar', 'agarose', 'agate', 'age', 'aged', 'agedependent', 'ageing', 'ageism', 'agencies', 'agency', 'agenda', 'agent', 'agentbased', 'agents', 'ageold', 'agerelated', 'ages', 'agesensitive', 'agespecific', 'agespecificity', 'agglomerative', 'agglutination', 'aggravate', 'aggravates', 'aggravating', 'aggregates', 'aggregation', 'aggression', 'agiho', 'aging', 'agingrelated', 'ago', 'agonist', 'agonists', 'agricultural', 'agrobacterium', 'aguda', 'agudizaciones', 'agudo', 'ah1n1', 'ah1n12009', 'ah1n1pdm', 'ah1n1pdm09', 'ah1n1v', 'ah3n2', 'ah5', 'ah5n1', 'ah5nx', 'ah7h9', 'ah7n9', 'ahaw', 'ahead', 'ahelical', 'ahora', 'aid', 'aids', 'aidscausing', 'aidsmyelopathy', 'aidspatienten', 'aigu', 'aikkarantai', 'ailuropoda', 'aimed', 'aims', 'aing', 'air', 'airborne', 'airbornetransmission', 'aircraft', 'aire', 'airflow', 'airflows', 'airline', 'airliquid', 'airlung', 'airplane', 'airport', 'airway', 'airwayresident', 'airways', 'ais', 'aise', 'aises', 'aj', 'akademie', 'akademievorlesung', 'akap7', 'aki', 'akt', 'aktivit', 'aktmtor', 'aktuell', 'aktuelle', 'aktuellen', 'aktueller', 'akutaufchronische', 'akutaufchronischen', 'akute', 'akutem', 'akuten', 'akuter', 'akutes', 'alage', 'alamos', 'alanine', 'alaninetovaline', 'alanyl', 'alarm', 'alarmed', 'alarmin', 'alaska', 'albacares', 'alberta', 'albicans', 'albopictus', 'album', 'albumin', 'albumins', 'albuterol', 'alcl', 'alcohol', 'alcoholbased', 'aldosteron', 'aldosteroneinduced', 'alecto', 'alert', 'alerting', 'alexandrium', 'alfa', 'alfaxolone', 'algae', 'algal', 'alginate', 'alginic', 'algorithm', 'algorithmidentified', 'algorithms', 'ali', 'alice', 'alices', 'alien', 'alignment', 'alignments', 'alimentary', 'alkaloid', 'alkaloids', 'alkb', 'alkhurma', 'allcause', 'alleges', 'allele', 'alleles', 'allelespecific', 'allelic', 'allergen', 'allergic', 'allergie', 'allergies', 'allergology', 'allergy', 'allergyassociated', 'alleviate', 'alleviates', 'alleviation', 'allgemeine', 'allhazards', 'allies', 'allocation', 'allocationscheduling', 'allogeneic', 'allograft', 'allografts', 'allometry', 'allopurinol', 'allosct', 'allosteric', 'allotransplantation', 'allotypes', 'allowing', 'allows', 'alloy', 'allozyme', 'allozymes', 'alltag', 'almost', 'alnus', 'alone', 'along', 'alp', 'alpacas', 'alpha', 'alpha7', 'alphabaculovirus', 'alphabet', 'alphabtique', 'alphacopi', 'alphahelical', 'alphahybrid', 'alphavirus', 'alphaviruses', 'alpine', 'alprostadil', 'als', 'alte', 'alten', 'alter', 'alteration', 'alterations', 'altered', 'altering', 'alternate', 'alternation', 'alternative', 'alternatives', 'alters', 'althoff', 'alto', 'alum', 'alumanyl', 'aluminium', 'aluminum', 'alvarezii', 'alveolar', 'alveolarcapillary', 'alveolates', 'alveolitiden', 'alveolitis', 'alveolocapillary', 'alvj', 'always', 'alzheimer', 'alzheimers', 'ama1', 'amalgam', 'amantadine', 'amaryllidaceae', 'amastigotes', 'amazon', 'amber', 'ambient', 'ambiguity', 'ambra1', 'ambrosino', 'ambulance', 'ambulant', 'ambulanten', 'ambulatorio', 'ambulatory', 'amd', 'amebiasis', 'ameliorate', 'ameliorates', 'america', 'american', 'americas', 'amidoximotriterpenoids', 'amidst', 'amiloride', 'amine', 'amino', 'aminoacyl', 'aminoacyltrna', 'aminoglycosides', 'aminoguanidine', 'aminopeptidase', 'aminophenyl', 'aminoquinolines', 'aminoterminal', 'aminotransferase', 'amiodarone', 'amiodaroneinduced', 'aml', 'ammonia', 'amniotic', 'amodiaquine', 'amoebae', 'amoebas', 'amoebic', 'amoebozoan', 'among', 'amotosalen', 'amounts', 'amp', 'amphetamineregulated', 'amphibians', 'amphiphilic', 'amphipoda', 'amphiregulin', 'amphotericin', 'ampk', 'amplicon', 'ampliconbased', 'amplification', 'amplified', 'amplifies', 'amplifying', 'amstar', 'amtilche', 'amylase', 'amyloid', 'amyloidogenic', 'amyotrophic', 'anabolic', 'anaemia', 'anaerobes', 'anaerobic', 'anaesthesia', 'anaesthesie', 'anaesthesiologist', 'anakinra', 'anales', 'analgesia', 'analgosedation', 'analog', 'analogies', 'analogous', 'analogs', 'analogue', 'analogues', 'analyse', 'analyses', 'analysing', 'analysis', 'analytical', 'analytics', 'analyzable', 'analyze', 'analyzed', 'anambra', 'anaphasepromoting', 'anaphylaxis', 'anaplasmataceae', 'anaplasmosis', 'anaplastic', 'anatid', 'anatomopathological', 'anatomy', 'anbessa', 'anca', 'ancaassociated', 'anchorage', 'anchored', 'ancient', 'ancylostoma', 'and', 'andalusia', 'andarterivirus', 'andcampylobacter', 'andere', 'anderen', 'andersen', 'anderson', 'andin', 'andor', 'andrew', 'androgenic', 'anemia', 'anesthesia', 'anesthetic', 'anesthetics', 'aneurysm', 'aneurysms', 'anforderungen', 'ang', 'ang1', 'angeborenen', 'angewandte', 'angina', 'angiogenesis', 'angiopeptin', 'angiopoietin', 'angiopoietin2', 'angiotensin', 'angiotensin1', 'angiotensinconverting', 'angiotensinogen', 'angle', 'anglo', 'angst', 'anguilla', 'anguillarum', 'anhydrideinduced', 'anhydridemodified', 'animal', 'animales', 'animals', 'animation', 'anion', 'anionic', 'anions', 'anisodamine', 'ankara', 'ankylosis', 'anlisis', 'anmbr', 'anmie', 'anmietoleranz', 'annales', 'annealing', 'annexin', 'anniversary', 'annonc', 'annotating', 'annotation', 'annotations', 'announcements', 'annual', 'annulling', 'anomalies', 'anopheles', 'another', 'ans', 'ansthesie', 'anstze', 'answer', 'answers', 'antagonism', 'antagonist', 'antagonisten', 'antagonistic', 'antagonists', 'antagonized', 'antagonizes', 'antarctic', 'ante', 'antenatal', 'anterior', 'anterooms', 'anthracis', 'anthraquinone', 'anthrax', 'anthropocene', 'anthropocne', 'anthropogenic', 'anthropological', 'anthroponotic', 'anti', 'antiacth', 'antiaging', 'antiaids', 'antiallergic', 'antiangiogenic', 'antiasthmatic', 'antiavian', 'antibacterial', 'antibiofilm', 'antibiothrapie', 'antibiotic', 'antibioticexposed', 'antibiotics', 'antibiotikatherapie', 'antibodies', 'antibody', 'antibodyantigen', 'antibodybased', 'antibodyconjugated', 'antibodydependent', 'antibodyenhanced', 'antibodymediated', 'antibodysecreting', 'antibodyvalidated', 'antic5a', 'anticaix', 'anticancer', 'anticaries', 'anticcr4', 'anticd19', 'anticipating', 'anticoagulation', 'anticorps', 'anticytokine', 'antideath', 'antidengue', 'antidiabetes', 'antidiarrheal', 'antidotes', 'antiebola', 'antiendotoxin', 'antifibrinolytic', 'antifibrotic', 'antifolates', 'antifootand', 'antifreeze', 'antifungal', 'antiganglioside', 'antigen', 'antigendefined', 'antigenexpressing', 'antigenic', 'antigenically', 'antigenicity', 'antigeninduced', 'antigenome', 'antigenomic', 'antigenpresenting', 'antigenrelated', 'antigens', 'antigensparing', 'antigenspecific', 'antih5n1', 'antihcv', 'antihemagglutinin', 'antiherpetic', 'antihistamines', 'antihiv', 'antihiv1', 'antiidiotypicantibodies', 'antiinfective', 'antiinfektive', 'antiinflammatory', 'antiinfluenza', 'antiinvasion', 'antik', 'antikc', 'antileishmanial', 'antilymphocyte', 'antimalaria', 'antimalarial', 'antimalarials', 'antimda', 'antimda5', 'antimeasles', 'antimicrobial', 'antimicrobialassociated', 'antimicrobialresistant', 'antimicrobiano', 'antimycobacterial', 'antineoplastic', 'antineuroinflammatory', 'antiobesity', 'antioxidant', 'antioxidants', 'antioxidative', 'antipa', 'antiparasitic', 'antipeptide', 'antiphospholipid', 'antiphospholipidantikrpersyndrom', 'antiplague', 'antiplasmodial', 'antiplasmodials', 'antiproliferative', 'antiprostate', 'antiproteinase', 'antirabies', 'antiradiation', 'antirespiratory', 'antiretroviral', 'antirhinovirus', 'antirotaviral', 'antisense', 'antisenseinduced', 'antiserum', 'antishiv', 'antistreptolysin', 'antisynthetase', 'antitgev', 'antitherapeutics', 'antithrombin', 'antithymocyte', 'antitoxoplasmosis', 'antitrypsin', 'antituberculosis', 'antitumor', 'antitussive', 'antiv3', 'antiviral', 'antiviraler', 'antivirals', 'antivirus', 'antizika', 'ants', 'anual', 'anwendbarkeit', 'anwendung', 'anwendungsm', 'anxieties', 'anxiety', 'anxious', 'anything', 'anyway', 'aortic', 'ap', 'ap1', 'ap2', 'ap3', 'apache', 'apacheii', 'apandemic', 'aparato', 'apart', 'apasl', 'apelin12', 'apelin13', 'apes', 'apgar', 'aphid', 'api', 'apical', 'apilimod', 'apis', 'aplastic', 'aplastischer', 'apmv', 'apn', 'apneic', 'apnoea', 'apnoeas', 'apobec3', 'apobec3g', 'apoc1', 'apocalypse', 'apolipoprotein', 'apom', 'apoptosis', 'apoptosisinducing', 'apoptotic', 'apparatus', 'apparent', 'apparently', 'appeal', 'appearance', 'appears', 'appended', 'apple', 'applicability', 'applicants', 'application', 'applications', 'applied', 'apply', 'applying', 'apport', 'appraisal', 'approach', 'approaches', 'approche', 'appropriate', 'approve', 'approved', 'approves', 'approximate', 'approximating', 'approximationaccuracy', 'apr', 'apreimplantation', 'apricot', 'april', 'aprotinin', 'aprv', 'aptamer', 'aptamers', 'aptenodytes', 'aqp2', 'aquaporins', 'aquatic', 'aqueous', 'aquifers', 'arab', 'arabia', 'arabian', 'arabidopsis', 'arabinoside', 'arachidonic', 'aragn', 'araneae', 'arbaeenia', 'arbeiten', 'arbeitsgemeinschaft', 'arbeitskreises', 'arbeitssoziologie', 'arbeitstagung', 'arbidol', 'arboviral', 'arboviren', 'arbovirus', 'arboviruses', 'archaeal', 'archaeosome', 'archaism', 'archazolid', 'architecture', 'architectures', 'archive', 'archived', 'arctic', 'arctigenin', 'ards', 'area', 'areal', 'areas', 'arenavirus', 'arenaviruses', 'arenes', 'aresistant', 'arex', 'argasidae', 'argentina', 'argentine', 'arginase', 'argininerich', 'argl', 'argon', 'argonautes', 'argumentaire', 'arguments', 'ariadnes', 'arima', 'arising', 'arizona', 'arkhangelsk', 'arm', 'armenia07', 'armored', 'arms', 'army', 'arnold', 'around', 'array', 'arraybased', 'arrays', 'arrest', 'arrestin', 'arrival', 'arrive', 'arrives', 'arsenicinduced', 'arsenicum', 'art', 'artemether', 'artemisinin', 'arterial', 'arteriosclerosis', 'arteritis', 'arterivirus', 'artery', 'artesunate', 'arthralgias', 'arthritic', 'arthritis', 'arthroplasty', 'arthropod', 'arthropoden', 'artibeus', 'article', 'articles', 'articular', 'artificial', 'artificially', 'ary', 'aryabhattai', 'arzneimittelinduzierte', 'as03', 'as03adjuvanted', 'as03b', 'asarum', 'ascendancy', 'ascites', 'ascomycetes', 'ascorbate', 'ascorbic', 'ascoviruses', 'asecomethylenamino', 'aseer', 'aseptic', 'asfv', 'asi', 'asia', 'asialofetuinappended', 'asian', 'asians', 'asiatica', 'asite', 'ask', 'asm', 'asmase', 'asn', 'asnglyarg', 'asp268del', 'aspbased', 'aspect', 'aspects', 'aspekte', 'aspergillosis', 'aspergillus', 'aspirate', 'aspiration', 'assam', 'assay', 'assays', 'assemblages', 'assemble', 'assembled', 'assemblies', 'assembling', 'assembly', 'assemblydisassembly', 'assess', 'assessed', 'assessing', 'assessment', 'assessments', 'assigned', 'assignment', 'assimilation', 'assist', 'assistance', 'assistant', 'assisted', 'associate', 'associated', 'associates', 'association', 'associations', 'assorted', 'assumptions', 'assurance', 'asteraceae', 'asthma', 'asthmatic', 'asthme', 'astragali', 'astrocyte', 'astrocytes', 'astrocytic', 'astroglia', 'astroviridae', 'astrovirus', 'astroviruses', 'asylum', 'asymmetric', 'asymmetry', 'asymptomatic', 'asynchrony', 'at', 'at1', 'at2', 'at527', 'ataxia', 'ateminsuffizienz', 'atemnotsyndroms', 'atemsystemfiltern', 'atemwegserkrankungen', 'atemwegssyndrom', 'atenci', 'atencin', 'atg', 'atg5', 'atg512', 'atg5atg12', 'atg7', 'atg8', 'atherosclerosis', 'atherosclerotic', 'athletes', 'atina', 'atlantic', 'atlas', 'atmospheric', 'atmosphericpressure', 'atomic', 'atomistic', 'atopic', 'atopy', 'atorvastatin', 'atpase', 'atpdependent', 'atrainduced', 'atraumatic', 'atresia', 'atrh2', 'atrh5', 'atrial', 'atrich', 'atrophaeus', 'atrophy', 'attachment', 'attack', 'attainment', 'atteinte', 'attempts', 'attended', 'attendees', 'attending', 'attends', 'attention', 'attenuata', 'attenuate', 'attenuated', 'attenuates', 'attenuating', 'attenuation', 'attenuationderived', 'atti', 'attitude', 'attitudes', 'attributable', 'attribute', 'attributes', 'atypical', 'atypiques', 'atypisch', 'au', 'auassociated', 'auckland', 'audit', 'auf', 'aufbereitung', 'aufgaben', 'aufrechterhaltung', 'auftreten', 'augen', 'augmentations', 'augmented', 'augments', 'august', 'aujeszkys', 'aura', 'aurata', 'auratus', 'aureus', 'aureusnecrotizing', 'auris', 'aurka', 'aurkb', 'aus', 'ausbildungsprogramme', 'ausbr', 'ausbruch', 'ausbruchsgeschehen', 'ausgebrannt', 'ausgestellt', 'ausl', 'auslandsreisen', 'auslser', 'ausnahmesituationen', 'australasian', 'australia', 'australian', 'australians', 'australias', 'australis', 'austria', 'austrian', 'auswirkungen', 'auteurs', 'author', 'authorised', 'authorization', 'authorizations', 'authors', 'autoantibodies', 'autoantibody', 'autoantigen', 'autochthonous', 'autocrine', 'autografted', 'autographa', 'autoimmune', 'autoimmunemediated', 'autoimmunity', 'autologous', 'automated', 'automatic', 'automatisierter', 'autonomous', 'autonomy', 'autopeep', 'autophagic', 'autophagy', 'autophagyassociated', 'autophagylike', 'autopsie', 'autopsies', 'autopsy', 'autopsyconfirmed', 'autoreactive', 'autoreactivity', 'autoregulation', 'autorenindex', 'autorenregister', 'autosomal', 'autotransplantation', 'autotransporter', 'autumn', 'auxiliary', 'availability', 'available', 'avec', 'avenae', 'average', 'avert', 'averting', 'aviaire', 'avian', 'avianorigin', 'aviantype', 'aviar', 'aviation', 'avidity', 'avipoxviruses', 'avirulent', 'avium', 'avoid', 'avoidable', 'avoiding', 'avp', 'avulavirus', 'awaiting', 'awake', 'awaken', 'awakening', 'award', 'aware', 'awareness', 'awmf', 'axial', 'axis', 'axon', 'axonal', 'axons', 'ayant', 'azathioprine', 'azithromycin', 'azoospermia', 'azt', 'azyklovir', 'b1a', 'b38cap', 'b3infected', 'babesiosis', 'bac', 'baccalaureate', 'bace', 'bacilli', 'bacillus', 'bacitracin', 'back', 'background', 'backgrounds', 'backyard', 'bacteraemia', 'bacteraemias', 'bacteremia', 'bacteria', 'bacteriaderived', 'bacterial', 'bactericidal', 'bacterin', 'bacteriocins', 'bacteriological', 'bacteriophage', 'bacteriophages', 'bacterium', 'bacteriumlike', 'bactrienne', 'baculoviral', 'baculovirus', 'baculovirusbased', 'bad', 'badger', 'bafilomycin', 'bagaza', 'baicalein', 'baidu', 'bakterielle', 'bal', 'balance', 'balanced', 'balancing', 'balb', 'balbc', 'balf', 'balkan', 'ball', 'baltimore', 'baltistan', 'bamboo', 'ban', 'banana', 'band', 'bane', 'bangladesh', 'bank', 'banna', 'bap31', 'bar', 'barcelona', 'barcodes', 'bariatric', 'baricitinib', 'bark', 'barlow', 'barnavirus', 'barr', 'barrel', 'barrier', 'barriere', 'barrierreared', 'barriers', 'bartonella', 'basal', 'base', 'based', 'basederived', 'baseline', 'basement', 'baseplate', 'bases', 'basic', 'basics', 'basin', 'basis', 'basismanahmen', 'basses', 'bat', 'bats', 'battle', 'baumannii', 'bavaria', 'bayes', 'bayesian', 'bcell', 'bcg', 'bcl', 'bcl11a', 'bcl2associated', 'bclass', 'bcs', 'beach', 'beachten', 'beacon', 'bead', 'beaked', 'bean', 'bearing', 'bears', 'beast', 'beat', 'beating', 'beatmung', 'beatmungsassoziierte', 'bec', 'become', 'bed', 'bedarf', 'bedeutung', 'bedside', 'bee', 'beech', 'beef', 'beer', 'bees', 'befindlichkeit', 'before', 'befunde', 'beginner', 'begomoviruses', 'behandeling', 'behandlung', 'behandlungseinrichtungen', 'behandlungsstrategien', 'behandlungszentren', 'behaving', 'behavior', 'behavioral', 'behaviors', 'behaviour', 'behavioural', 'behaviourchange', 'behaviours', 'behind', 'beholder', 'bei', 'beijing', 'beim', 'beings', 'beispiel', 'bek', 'bekd', 'bekkum', 'belfast', 'belgian', 'belgium', 'beliefs', 'bell', 'belonging', 'belongs', 'belt', 'beluga', 'bem', 'bench', 'benchmark', 'benchtobedside', 'beneficial', 'benefit', 'benefits', 'benign', 'benjamin', 'benzavir2', 'benzimidazoles', 'benzotriazole', 'benzyl', 'beperkt', 'ber', 'berberine', 'berblick', 'bereich', 'bergmann', 'bericht', 'beringeii', 'berlegungen', 'berlin', 'berliner', 'berne', 'beroepsgroep', 'berraschung', 'bersicht', 'bertragbare', 'berufsausbungsgemeinschaft', 'berufsverbandes', 'beschermingsmaatregelen', 'besnoiti', 'besnoitia', 'besondere', 'besonderer', 'best', 'bestmatch', 'bet', 'beta', 'beta1', 'beta1glycoprotein', 'beta2', 'betablockers', 'betaketothiolase', 'betalactam', 'betanodavirus', 'betathalassemia', 'betreuung', 'betroffenen', 'better', 'betulina', 'betulinus', 'between', 'betweenhost', 'betweenstrain', 'beware', 'bewertung', 'bexsero', 'beyond', 'bfa', 'bh', 'bhk', 'bhk21', 'bhutanese', 'bhv1', 'bi', 'bias', 'biased', 'biases', 'bibliographies', 'bibliogrficas', 'bibliometric', 'bicarbonate', 'bicolored', 'bid', 'biddeficient', 'bidentate', 'bidirectional', 'bien', 'bifida', 'bifidobacterium', 'bifunctional', 'big', 'biggest', 'biguanide', 'bilateral', 'bildgebende', 'bildgebung', 'bile', 'bilharzioses', 'biliary', 'bilineata', 'bimetallic', 'bimmediated', 'bimmobilized', 'bimode', 'bind', 'binding', 'binds', 'binomial', 'bio', 'bioactivation', 'bioactive', 'bioactivities', 'bioactivity', 'bioaerosol', 'bioaerosols', 'bioanalysis', 'bioanalyzer', 'bioassay', 'bioattack', 'bioavailability', 'biobank', 'biobanking', 'biocatalysts', 'biochanin', 'biochemical', 'biochemist', 'biochemistry', 'biocides', 'bioconductor', 'bioconjugation', 'biocontainment', 'biocontrol', 'biodefence', 'biodefense', 'biodegradable', 'biodegradation', 'biodistribution', 'biodiversity', 'biodynamics', 'bioenergetics', 'bioethical', 'biofilms', 'biofire', 'biofluids', 'biogenesis', 'biogeochemical', 'biogeographic', 'biogeography', 'biographical', 'biography', 'biohazard', 'biohazards', 'bioinformatic', 'bioinformatics', 'biokil', 'biologic', 'biological', 'biologically', 'biologicals', 'biologics', 'biologique', 'biologischen', 'biologischer', 'biologists', 'biology', 'bioluminescence', 'biomarker', 'biomarkers', 'biomaterials', 'biome', 'biomechanical', 'biomedical', 'biomedicine', 'biomimetics', 'biomolecules', 'bioorthogonal', 'biopharmaceutical', 'biophotonic', 'biophysical', 'biopolis', 'biopolitical', 'biopolitics', 'biopolymer', 'bioprocess', 'bioprocessing', 'biopsies', 'biopsy', 'bioreactor', 'bioreactors', 'biosafety', 'bioscience', 'biosciences', 'biosecurity', 'biosense', 'biosensor', 'biosensors', 'biosignatures', 'biosurveillance', 'biosynthesis', 'biosynthesized', 'biosynthetic', 'biosystems', 'biotech', 'biotechnological', 'biotechnologies', 'biotechnology', 'biotechnoloy', 'bioterror', 'bioterrorism', 'bioterrorismo', 'biotin', 'biotinavidin', 'biotinylated', 'biowarfare', 'bioweapon', 'bipap', 'bipgrp78', 'biphenyls', 'biran', 'bird', 'birdflu', 'birds', 'birdzilla', 'birth', 'births', 'bis', 'bischofberger', 'bisher', 'bismuth', 'bispecific', 'bisphosphatase', 'bisphosphonaterelated', 'bite', 'bites', 'biting', 'bitter', 'bivalent', 'biventricular', 'bk', 'bla', 'black', 'bladder', 'bladders', 'blame', 'blandm', 'blanquet', 'blastogenesis', 'blastogenic', 'blastomycosis', 'blastomycosisrelated', 'blastomycotic', 'bleeding', 'bleiben', 'blends', 'bleomycininduced', 'blepharoptosis', 'bletilla', 'blica', 'blick', 'blind', 'blinded', 'blines', 'bloc', 'block', 'blockade', 'blockage', 'blocked', 'blocker', 'blockers', 'blocking', 'blocks', 'bloeddruk', 'blood', 'bloodborne', 'bloodretinal', 'bloodstage', 'bloodstream', 'bloody', 'blooms', 'blot', 'blotting', 'blow', 'blueprint', 'bluetongue', 'blunt', 'blut', 'blutdruckvariabilitt', 'blutprodukten', 'bmesir', 'bmnpv', 'bmp', 'bmt', 'bmvbased', 'boar', 'board', 'boarding', 'boardinvited', 'boars', 'boas', 'bocavirus', 'bocaviruses', 'bocavirusinduced', 'bodied', 'bodies', 'body', 'bodyderived', 'boeris', 'bohv4based', 'boiling', 'bola', 'boltzmann', 'bombyx', 'bondedcommunities', 'bonds', 'bondtethered', 'bone', 'bonemarrow', 'bongetta', 'bonnes', 'bonobo', 'bonobos', 'book', 'boophilus', 'boost', 'boosting', 'boosts', 'bootstrap', 'bopta', 'borane', 'border', 'borders', 'bordetella', 'boreal', 'boredom', 'born', 'borna', 'bornavirus', 'bornaviruses', 'borne', 'borrelia', 'borreliose', 'bortezomib', 'bosentan', 'boss', 'botswana', 'bottlenecked', 'bottlenecks', 'botulinum', 'boulardii', 'bound', 'boundary', 'bovine', 'bovinemurine', 'bovis', 'bowel', 'box', 'boy', 'boydii', 'bozen', 'bpd', 'brace', 'bracing', 'bradykinin', 'brain', 'braindead', 'braininfiltrating', 'brainspecific', 'brainstem', 'branches', 'branching', 'brandenburgischen', 'brands', 'braun', 'braunschweig', 'brazil', 'brazilian', 'braziliensis', 'brd4', 'breadth', 'breakdown', 'breaking', 'breaks', 'breast', 'breath', 'breathing', 'breaths', 'bred', 'breda', 'breeders', 'breeding', 'breeds', 'brefeldin', 'breiten', 'bremen', 'brentuximab', 'brevinin', 'bridge', 'brief', 'bright', 'brilifitm5', 'brindled', 'bringing', 'brink', 'britain', 'british', 'broad', 'broaden', 'broadly', 'broadrange', 'broadscale', 'broadspectrum', 'broiler', 'brome', 'bromide', 'bromovirus', 'bronchial', 'bronchiale', 'bronchiectasis', 'bronchiolite', 'bronchiolitis', 'bronchiseptica', 'bronchitis', 'bronchoalveolar', 'bronchoconstriction', 'bronchokonstriktorische', 'bronchology', 'bronchopneumopathie', 'bronchopulmonale', 'bronchopulmonary', 'bronchoscopy', 'bronchoscopyassociated', 'bronichiloitis', 'bronquiolitis', 'brotes', 'broth', 'brought', 'broussonetia', 'brown', 'browning', 'brucei', 'brucella', 'brucellosis', 'brundtland', 'brunt', 'brush', 'brushborder', 'bryophytes', 'bsa', 'bsl', 'bsl3', 'bspc', 'bst2', 'btv', 'bubalis', 'bubalus', 'bubonic', 'buch', 'bucyrus', 'bud', 'budapest', 'budding', 'budget', 'budgeting', 'buffalo', 'buffaloes', 'bug', 'bugs', 'buho', 'build', 'building', 'buildings', 'built', 'bulb', 'bulbs', 'bulgaria', 'buliisa', 'bulk', 'bulletin', 'bumps', 'bund', 'bundesministeriums', 'bundesrztekammer', 'bundl', 'bundle', 'buntain', 'bunyamwera', 'bunyavirus', 'burden', 'burgdorferi', 'burgdorferispecific', 'burkholderia', 'burkitt', 'burn', 'burnout', 'burqa', 'bursa', 'bursal', 'bursectomy', 'bursty', 'bus', 'bush', 'bushpigs', 'business', 'butte', 'butterfly', 'butyrolactone', 'buying', 'buzz', 'buzzed', 'bvd', 'bvdu', 'byersi', 'bypasses', 'bystander', 'bzip', 'c3p3g1', 'c57bl', 'c57bl6', 'c58nt', 'ca', 'ca2', 'cabased', 'cabin', 'caco2', 'cadets', 'cadherin', 'cadmium', 'caeca', 'cag', 'cage', 'cageside', 'caging', 'calcarifer', 'calcification', 'calcifications', 'calciomics', 'calcitonin', 'calcium', 'calciumactivated', 'calciumdependent', 'calciumsensing', 'calculated', 'calculating', 'calculation', 'calculations', 'calculus', 'calf', 'calfhood', 'calgary', 'calibration', 'caliciviren', 'calicivirus', 'calicivirusassociated', 'caliciviruses', 'california', 'californica', 'call', 'caller', 'calling', 'callithrix', 'calls', 'callus', 'calmettegu', 'calpainmediated', 'calreticulin', 'calves', 'cam', 'camargue', 'cambio', 'cambodia', 'cambridge', 'camel', 'camelids', 'camellia', 'camels', 'camelus', 'camp', 'campaign', 'campaigns', 'campdependent', 'campestris', 'camphecin', 'campus', 'campylobacter', 'cams', 'canada', 'canadian', 'canadians', 'canal', 'canalicular', 'canaliculata', 'cancelled', 'cancels', 'cancer', 'cancerassociated', 'cancerinduced', 'cancers', 'candida', 'candidate', 'candidates', 'candidatm', 'candidatus', 'candidemia', 'cane', 'canids', 'canine', 'caninum', 'canis', 'canker', 'cannula', 'cannulation', 'canonical', 'cap', 'capabilities', 'capability', 'capable', 'capacitated', 'capacities', 'capacity', 'capdependent', 'cape', 'capecitabine', 'capillary', 'capillaryleak', 'capital', 'capping', 'caprine', 'capsaicin', 'capsid', 'capsidcleaved', 'capsiddeficient', 'capsids', 'capstone', 'captive', 'capture', 'captured', 'captures', 'car', 'carabid', 'carbapenem', 'carbapenemaseproducing', 'carbapenemresistant', 'carbene', 'carbohydrate', 'carbohydratebased', 'carbon', 'carbonization', 'carbosil', 'carbowhite', 'carboxy', 'carboxyl', 'carboxylate', 'carboxypeptidase', 'carboxyprotected', 'carboxyterminal', 'carcass', 'carcinoembryonic', 'carcinogenesis', 'carcinoma', 'carcinomas', 'carcinomatous', 'card', 'card9mediated', 'cardiac', 'cardio', 'cardiology', 'cardiomyocyte', 'cardiomyocytes', 'cardiomyopathy', 'cardiopulmonary', 'cardiorenal', 'cardiothoracic', 'cardiotoxicity', 'cardiovascular', 'cardioversion', 'cardioviruses', 'carditis', 'care', 'career', 'caregivers', 'cares', 'cargo', 'caribbean', 'caricom', 'caring', 'carinii', 'carnivores', 'carnosine', 'carollia', 'carota', 'carp', 'carrageenophyta', 'carriage', 'carrier', 'carriers', 'carries', 'carroll', 'carrot', 'carrying', 'cars', 'cart', 'cartilage', 'cartilaginous', 'carto', 'cartpt', 'cas', 'cas12abased', 'cascade', 'cascades', 'case', 'casebased', 'casecontrol', 'casei', 'caseidisplayed', 'casein', 'casemix', 'cases', 'cash', 'cashew', 'caso', 'casos', 'caspase', 'caspase11', 'caspase3', 'caspase6', 'caspasedependent', 'caspaseindependent', 'caspases', 'cassette', 'cassiae', 'cassociated', 'castanospermine', 'castlemans', 'castration', 'casualty', 'cat', 'catalase', 'cataloging', 'catalysis', 'catalyst', 'catalytic', 'catalytically', 'catalyzed', 'catarro', 'catastrophe', 'catastrophic', 'catches', 'catching', 'catchphrase', 'categorical', 'categories', 'category', 'catenin', 'cathelicidin', 'cathelicidins', 'cathepsin', 'cathepsins', 'catheterrelated', 'cation', 'cationconducting', 'cationic', 'catopsilia', 'cats', 'cattle', 'caucasus', 'caudatum', 'caudigerum', 'causal', 'causation', 'causative', 'cause', 'caused', 'causes', 'causing', 'caution', 'cautionary', 'cava', 'cavalier', 'cave', 'caveolaemediated', 'caveolin1', 'cavernous', 'cavities', 'cavity', 'cayratia', 'cbf1csl', 'cbrn', 'cbyj', 'cc', 'cc1', 'cccdna', 'cccf', 'cchf', 'ccl', 'ccl2', 'ccl22', 'ccl4', 'ccl5', 'ccmv', 'ccr', 'ccr2', 'ccr5', 'ccr532', 'cd', 'cd10', 'cd11b', 'cd11chi', 'cd13', 'cd133', 'cd134', 'cd13aminopeptidase', 'cd13specific', 'cd14', 'cd147', 'cd163', 'cd19', 'cd1d', 'cd20', 'cd200', 'cd204', 'cd206', 'cd209', 'cd209b', 'cd25', 'cd28', 'cd30', 'cd30positive', 'cd34', 'cd4', 'cd40ligand', 'cd40ligation', 'cd44', 'cd45highcd11b', 'cd49b', 'cd4binding', 'cd4cd56', 'cd4positive', 'cd55', 'cd56', 'cd63containing', 'cd8', 'cd81', 'cd95', 'cdc', 'cdcgrandrounds', 'cdcs', 'cdk46', 'cdk9', 'cdkn2bas1', 'cdna', 'cdnas', 'cdrh2', 'cds', 'cdvinfected', 'ce', 'cea', 'ceacam1', 'ceacam10', 'ceacam14s', 'ceacampsg', 'ceacams', 'ceacd3bispecific', 'cebp', 'cec', 'cect', 'cedar', 'cefotaxime', 'cela1', 'celebrating', 'celebration', 'celiac', 'cell', 'cellassociated', 'cellbased', 'cellcell', 'cellconditioned', 'cellculturederived', 'celldeficient', 'cellderived', 'cellfree', 'cellhitchhiking', 'cellinducer', 'cellintrinsic', 'cellmediated', 'cellpenetrating', 'cellphone', 'cellprotective', 'cells', 'cells1', 'cellsderived', 'cellspecific', 'celltargeting', 'celltocell', 'cellular', 'cellulase', 'center', 'centers', 'centertbi', 'central', 'centralization', 'centrally', 'centralplace', 'centre', 'centres', 'centrolepidaceae', 'centrosome', 'century', 'cenzato', 'cephalopod', 'cepi', 'ceramidase', 'ceramide', 'cerebellar', 'cerebral', 'cerebrospinal', 'cerebrovascular', 'cereus', 'cerevisiae', 'certain', 'certificate', 'ceruleininduced', 'cervical', 'ces', 'cesa', 'cesarean', 'cessation', 'cest', 'cestoda', 'cf', 'cfsebased', 'cftr', 'cg3303', 'cgas', 'cgasindependent', 'cgassting', 'cgmp', 'cgs', 'chadox1', 'chadox2', 'chain', 'chains', 'challenge', 'challenged', 'challengeexposure', 'challenges', 'challenging', 'chamber', 'chambers', 'chance', 'chandipura', 'change', 'changed', 'changers', 'changes', 'changing', 'channe', 'channel', 'channels', 'chaos', 'chaotropic', 'chaperone', 'chaperonelike', 'chapter', 'characterisation', 'characteristic', 'characteristics', 'characterization', 'characterizations', 'characterize', 'characterizing', 'charantia', 'charcoal', 'charge', 'charged', 'chargesurrounded', 'charity', 'charles', 'chart', 'charybdis', 'chasing', 'chat', 'checking', 'checkpoint', 'checkpoints', 'cheetah', 'cheetahs', 'chelator', 'chelonae', 'chemical', 'chemicalbiologicalradio', 'chemicalchemical', 'chemically', 'chemiluminescence', 'cheminformatics', 'chemistry', 'chemoattractant', 'chemoinformatics', 'chemokine', 'chemokineadjuvanted', 'chemokines', 'chemometrics', 'chemophrophylaxis', 'chemoprevention', 'chemopreventive', 'chemoprophylaxis', 'chemoselective', 'chemotherapeutic', 'chemotherapie', 'chemotherapy', 'chemotherapyand', 'chemotherapyinduced', 'chemotype', 'chemotypes', 'chen', 'chest', 'chez', 'chhnyf2014', 'chiari', 'chiasma', 'chicago', 'chick', 'chicken', 'chickenpox', 'chickens', 'chicks', 'chief', 'chikungunya', 'chikv', 'child', 'childcare', 'childhood', 'children', 'childrens', 'childturcottepugh', 'chile', 'chimera', 'chimeric', 'chimerism', 'chimpanzee', 'china', 'chinaafrica', 'chinac', 'chinas', 'chinense', 'chinese', 'chineselike', 'chinesetype', 'chinju99', 'chip', 'chip28', 'chiral', 'chiroptera', 'chirurgie', 'chitin', 'chitinase', 'chitinbinding', 'chitosan', 'chitosandna', 'chittagong', 'chlamydia', 'chlamydiae', 'chlamydophila', 'chloral', 'chloride', 'chlorophyll', 'chloroplast', 'chloroquine', 'chloroquinecontaining', 'chloroquineprimaquine', 'chloroquineresistance', 'choindroitinase', 'choix', 'cholangiocarcinoma', 'cholangiocyte', 'cholangitis', 'cholecystokinin', 'cholera', 'choleraesuismediated', 'cholestasis', 'cholestatic', 'cholesterol', 'cholesteroldependent', 'cholinergic', 'cholinetreated', 'chondrocytic', 'chondrogenesis', 'chondroitin', 'chongqing', 'choosing', 'chop', 'chorioallantoic', 'choriomeningitis', 'choroideremia', 'chosen', 'christian', 'chromatin', 'chromatographic', 'chromatography', 'chromogenic', 'chromogranins', 'chromosomal', 'chromosomalscaffolding', 'chromosome', 'chromosomes', 'chronic', 'chronicle', 'chronique', 'chronisch', 'chronologically', 'chronotype', 'chs', 'chymotrypsin', 'ci', 'cidr', 'cigarette', 'ciita', 'ciliary', 'ciliocytophthoria', 'cimetidine', 'ciprofloxacin', 'circadian', 'circle', 'circovirus', 'circoviruses', 'circuit', 'circuitry', 'circuits', 'circular', 'circulating', 'circulation', 'circulatory', 'circumcision', 'circumstances', 'cirp', 'cirrhosis', 'cirrhotic', 'cirse', 'cis', 'cisacting', 'cisactivity', 'cisatracurium', 'cisgender', 'cisplatin', 'cisregulatory', 'cistanche', 'citation', 'cities', 'citrate', 'citrobacter', 'citrus', 'city', 'civilian', 'cjun', 'ck', 'ck1e', 'cke', 'cken', 'cksichtigung', 'cl', 'clade', 'clades', 'cladistic', 'cladoceran', 'clam', 'clamp', 'clan', 'clandestine', 'clans', 'clara', 'clarithromycin', 'clasificacin', 'class', 'classes', 'classic', 'classical', 'classification', 'classifications', 'classifier', 'classifiers', 'classifying', 'classroom', 'classspecific', 'clathrin', 'claudins', 'cldn1', 'cle', 'clean', 'cleaning', 'clear', 'clearance', 'cleavage', 'cleavages', 'cleave', 'cleaves', 'cleaving', 'clec5a', 'clerkship', 'clerodendrum', 'clickseq', 'client', 'clientowned', 'climate', 'climatesensitive', 'climatic', 'clindamycin', 'clinic', 'clinical', 'clinically', 'clinicalstage', 'clinician', 'clinicianperformed', 'clinicians', 'clinicopathological', 'clinics', 'clinique', 'cliniques', 'clinmicronet', 'clinton', 'clip', 'clipping', 'cll', 'clock', 'clomiphene', 'clonal', 'clone', 'cloned', 'clones', 'cloning', 'close', 'closecontact', 'closedchest', 'closedloop', 'closedtube', 'closely', 'closer', 'closing', 'clostridium', 'closure', 'closures', 'clouds', 'clover', 'cloxacillin', 'clp', 'clpp', 'clpx', 'club', 'clue', 'clues', 'clumping', 'cluster', 'clustered', 'clustering', 'clusters', 'cmaj', 'cmap', 'cmv', 'cngof', 'cnica', 'cnn', 'cns', 'co', 'co2', 'coa', 'coacervate', 'coactivator', 'coagents', 'coagulation', 'coagulationfibrinolysis', 'coagulopathie', 'coagulopathy', 'coalitions', 'coast', 'coastal', 'coat', 'coated', 'coating', 'coatomer', 'cobatest', 'cocaine', 'cocaines', 'coccidia', 'coccidioidomycosis', 'coccidiosis', 'coccolithovirus', 'cochi', 'cochlea', 'cochlear', 'cochrane', 'cocirculating', 'cockroach', 'cocksfoot', 'cocktail', 'coculture', 'code', 'codec', 'codelivery', 'codes', 'codetection', 'codetections', 'codierung', 'coding', 'codiverged', 'codivergence', 'codon', 'coe', 'coeliotomy', 'coevolution', 'coevolving', 'coexistence', 'coexisting', 'coexpressing', 'coexpression', 'cognitive', 'coherence', 'cohort', 'cohorts', 'cohortstudy', 'coil', 'coilassisted', 'coiled', 'coiledcoil', 'coils', 'coin', 'coincidence', 'coinfecciones', 'coinfection', 'coinfections', 'coke', 'col1a1', 'colchicine', 'cold', 'coldinducible', 'colds', 'coli', 'colibacillosis', 'coliinduced', 'coliphage', 'colisepticemia', 'colistin', 'colistinresistant', 'colitis', 'coll', 'collaboration', 'collaborations', 'collaborative', 'collagen', 'collageninduced', 'collapse', 'collateral', 'collected', 'collection', 'collections', 'collective', 'college', 'collegebased', 'colloidal', 'colobanthus', 'colobus', 'colocalized', 'colocasia', 'cologues', 'colombia', 'colombian', 'colon', 'colonic', 'colonisation', 'colonisations', 'colonization', 'colony', 'colonystimulating', 'color', 'colorado', 'colorectal', 'colorimetric', 'colorphylo', 'colorstock', 'coloscopie', 'colostrum', 'colostrumacquired', 'colour', 'coloured', 'colt', 'coltivirus', 'colubraria', 'colubrids', 'columbia', 'column', 'coma', 'combat', 'combating', 'combination', 'combinations', 'combinatorial', 'combined', 'combining', 'come', 'comes', 'comfort', 'coming', 'commemorating', 'commensal', 'comment', 'commentaires', 'commentary', 'comments', 'commercial', 'commercially', 'commission', 'commissioned', 'commissioner', 'commitment', 'committee', 'committees', 'common', 'commonly', 'communautaire', 'communicable', 'communication', 'communications', 'communities', 'community', 'communityacquired', 'communitybased', 'communitysubmitted', 'comn', 'como', 'comorbid', 'comorbidities', 'comorbidity', 'comp', 'compact', 'compaction', 'compactness', 'companion', 'companions', 'comparacin', 'comparative', 'compared', 'comparing', 'comparison', 'comparisons', 'compartment', 'compartmental', 'compartmentalization', 'compartments', 'compassion', 'compendium', 'compensation', 'compete', 'competence', 'competency', 'competing', 'competition', 'competitive', 'complacent', 'complement', 'complementary', 'complementdependent', 'complemented', 'complementrelated', 'complementspecific', 'complet', 'complete', 'completely', 'completeness', 'completing', 'complex', 'complexantigens', 'complexes', 'complexities', 'complexity', 'compliance', 'compliant', 'complicance', 'complicated', 'complicates', 'complicating', 'complication', 'complications', 'compliqu', 'component', 'components', 'composed', 'composite', 'composition', 'compositional', 'compound', 'compounds', 'comprehending', 'comprehensive', 'compressed', 'comprising', 'compromise', 'compromising', 'compulsory', 'computation', 'computational', 'computed', 'computer', 'computeraided', 'computertomographie', 'computing', 'comunes', 'con', 'concentrated', 'concentrates', 'concentration', 'concentrations', 'concept', 'conceptions', 'concepts', 'conceptual', 'concern', 'concerned', 'concerns', 'concerted', 'concise', 'conclusion', 'conclusiones', 'conclusions', 'concolor', 'concomitant', 'concurrency', 'concurrent', 'concurs', 'condensing', 'condition', 'conditioning', 'conditions', 'condom', 'conduct', 'conductance', 'conducting', 'conduction', 'conduite', 'condylurus', 'confer', 'conference', 'conferred', 'conferring', 'confers', 'configurations', 'confined', 'confinement', 'confirmation', 'confirmed', 'conflict', 'conflicting', 'conformation', 'conformational', 'conformations', 'conformationsensitive', 'confounders', 'confounding', 'confront', 'confronting', 'confusing', 'confusion', 'congenital', 'congo', 'congr', 'congress', 'congresso', 'conidia', 'conjoint', 'conjugate', 'conjugated', 'conjugates', 'conjugation', 'conjugationdeconjugation', 'conjunctivitis', 'connatal', 'connatre', 'connected', 'connections', 'connective', 'connectivity', 'cons', 'conscious', 'consecutive', 'consenso', 'consensus', 'consent', 'consequence', 'consequences', 'conservation', 'conservative', 'conserved', 'consideration', 'considerations', 'considering', 'consistency', 'consistent', 'consolidation', 'consommer', 'consortium', 'conspiracist', 'conspirators', 'constant', 'constituents', 'constitutes', 'constitutive', 'constitutively', 'constrained', 'constraints', 'construct', 'constructing', 'construction', 'constructs', 'consultation', 'consumer', 'consumption', 'cont', 'contact', 'contacts', 'contagion', 'contagiosum', 'contagious', 'contagiousness', 'contain', 'containing', 'containment', 'contains', 'contaminant', 'contaminantes', 'contaminants', 'contaminated', 'contamination', 'contaminations', 'contemplates', 'contemporary', 'content', 'contentious', 'contents', 'contest', 'context', 'contexto', 'contexts', 'continents', 'contingency', 'continued', 'continuing', 'continuous', 'continuousflow', 'continuum', 'contortus', 'contour', 'contr', 'contraceptives', 'contractile', 'contractility', 'contraction', 'contrast', 'contrastenhanced', 'contrasting', 'contre', 'contribute', 'contributes', 'contributing', 'contribution', 'contributions', 'contributors', 'control', 'controlled', 'controlling', 'controls', 'controversial', 'controversias', 'controversies', 'controversy', 'conundrum', 'convalescent', 'convection', 'conventional', 'conventionallyreared', 'converge', 'convergence', 'convergent', 'converging', 'conversations', 'conversion', 'convertases', 'converting', 'conveying', 'conviction', 'convolutional', 'cooperaci', 'cooperacin', 'cooperate', 'cooperation', 'cooperative', 'coopted', 'coopts', 'coordinated', 'coordinates', 'coordination', 'cop9', 'copd', 'copper', 'coptidis', 'copy', 'copyback', 'coral', 'cord', 'cordoba', 'core', 'corelike', 'cores', 'coreshell', 'corneal', 'cornell', 'corona', 'coronakrise', 'coronary', 'coronasteps', 'coronavimses', 'coronavirus', 'coronavirus2', 'coronaviruses', 'coronaviruslike', 'corporeal', 'corps', 'correct', 'correcting', 'correction', 'corrections', 'correctly', 'correlate', 'correlated', 'correlates', 'correlation', 'correlational', 'correlations', 'correspond', 'correspondence', 'corresponds', 'corrigendum', 'corsica', 'corta', 'cortex', 'cortical', 'corticosteroid', 'corticosteroids', 'cortisol', 'coryi', 'coseasonality', 'cosmopolitanism', 'cost', 'costeffective', 'costeffectiveness', 'costimulation', 'costimulatory', 'costs', 'coterminal', 'cotranslational', 'cotransporting', 'cotton', 'coucang', 'cough', 'coughgenerated', 'coughs', 'could', 'coumermycin', 'council', 'counselling', 'counselors', 'count', 'counted', 'counter', 'counteract', 'counteraction', 'counteracts', 'counterfeit', 'countermeasure', 'countermeasures', 'counterpart', 'counterparts', 'counting', 'countries', 'country', 'countrywide', 'counts', 'county', 'coupled', 'coupling', 'courage', 'courante', 'cours', 'course', 'courses', 'cov', 'covalent', 'covariation', 'covary', 'coverage', 'covered', 'covert', 'coverup', 'covid', 'covid19', 'covid2019', 'cow', 'cowpox', 'cows', 'coxsackie', 'coxsackievirus', 'coxsackieviruscell', 'coxsakievirus', 'cpap', 'cpdna', 'cpg', 'cpgc41', 'cpgcontaining', 'cppmediated', 'cproperties', 'cptcgmp', 'cr', 'cr1', 'crandell', 'crandellrees', 'cranial', 'cras', 'crassirhizoma', 'crazypaving', 'crdiothoracic', 'cre', 'creactive', 'created', 'creatine', 'creating', 'creatinine', 'creativity', 'credibility', 'crelox', 'crenarchaeota', 'crescentic', 'crestderived', 'crested', 'crfk', 'cricothyrotomy', 'crimean', 'crimeancongo', 'criminal', 'criminalizing', 'crise', 'crises', 'crisis', 'crisprassociated', 'crisprcas9', 'criteria', 'criterios', 'crithidia', 'critical', 'criticalillnessmyopathie', 'criticality', 'critically', 'critics', 'crnica', 'crocin', 'crohn', 'crohns', 'cromoglyeate', 'cronic', 'crop', 'croquet', 'crosante', 'cross', 'crossborder', 'crossbridge', 'crosscirculation', 'crossclade', 'crosse', 'crosses', 'crossgroup', 'crossing', 'crosslingual', 'crosslinking', 'crossneutralizing', 'crossover', 'crossprotection', 'crossprotective', 'crossreactive', 'crossreactivity', 'crossregional', 'crossroads', 'crosssectional', 'crossspecies', 'crosssubtype', 'crosst', 'crosstalk', 'croup', 'crow', 'crowded', 'crowding', 'crownof', 'crtc1', 'crucial', 'crude', 'cruise', 'cruz', 'cruzi', 'cry', 'cryo', 'cryoablation', 'cryoelectron', 'cryoem', 'cryofibrinogenemia', 'cryoprecipitate', 'cryopreserved', 'cryptic', 'cryptococcal', 'cryptococcosis', 'cryptococcus', 'cryptodex', 'cryptosporidia', 'cryptosporidiosis', 'cryptosporidium', 'cryptosporidiuminfected', 'crystal', 'crystallin', 'crystallization', 'crystallography', 'csf', 'csf1', 'csra', 'cst5', 'ct', 'cta1conjugated', 'cte', 'cterminal', 'cterminus', 'ctg', 'ctica', 'ctl', 'ctla4ig', 'cts1', 'ctype', 'cuadros', 'cucumber', 'cucumovirus', 'cues', 'cuff', 'culex', 'culicidae', 'culicoides', 'culls', 'cultivated', 'cultivation', 'cultural', 'culture', 'cultureadapted', 'cultured', 'cultureproven', 'cultures', 'cumulative', 'cuprizoneinduced', 'curative', 'curcumin', 'cure', 'cures', 'curious', 'current', 'currently', 'curriculum', 'curtailing', 'curvaceous', 'curves', 'cushing', 'cusp', 'customfit', 'customize', 'customized', 'custommade', 'cut', 'cutaneous', 'cvtree', 'cvtree3', 'cwh', 'cx', 'cxc', 'cxcl1', 'cxcl10', 'cxcl10ip', 'cxcl5', 'cxcl56', 'cxcl8', 'cxcl9', 'cxcr1', 'cxcr2', 'cxcr6', 'cyberbiosecurity', 'cyberplagiarism', 'cycle', 'cycleregulated', 'cyclic', 'cyclicdigmp', 'cyclin', 'cyclind1', 'cycling', 'cyclization', 'cyclodextrin', 'cyclodextrins', 'cyclohexapeptide', 'cyclooxygenase2', 'cyclophilin', 'cyclophosphamide', 'cyclophosphamidetotal', 'cyclopium', 'cyclosporin', 'cyclosporine', 'cymbidium', 'cynomolgus', 'cyp2c19', 'cyp2c8', 'cyp450', 'cyperaceae', 'cypr', 'cyrpa', 'cyst', 'cystatin', 'cysteine', 'cysteinyl', 'cysteinyltrna', 'cystic', 'cystine', 'cystinuria', 'cystitis', 'cystoisospora', 'cystometry', 'cytarabine', 'cytobact', 'cytochemical', 'cytochemistry', 'cytochrome', 'cytokine', 'cytokines', 'cytologische', 'cytolysis', 'cytolytic', 'cytomegalovirus', 'cytomegalovirusassociated', 'cytometry', 'cytopathic', 'cytopathogenic', 'cytopathogenicity', 'cytopathology', 'cytophotometric', 'cytoplasm', 'cytoplasmic', 'cytoprotection', 'cytosine', 'cytoskeleton', 'cytosolic', 'cytotoxic', 'cytotoxicity', 'cytotoxin', 'czech', 'd1a', 'da', 'dacapo', 'daig', 'daily', 'dairy', 'dakota', 'dalian', 'dam', 'damage', 'damagedependent', 'damageinduced', 'damageresponse', 'damn', 'dampens', 'dampness', 'dams', 'danger', 'dangerous', 'dangerously', 'dangers', 'danhong', 'danio', 'danish', 'dans', 'dap12coupled', 'dapsone', 'daptomycin', 'daratumumab', 'darmstaedter', 'darmstaedterpreises', 'dars', 'das', 'dasatinibinduced', 'dash', 'dasthme', 'data', 'database', 'databases', 'datadriven', 'dataset', 'datasets', 'date', 'dating', 'daubentonii', 'daucus', 'dawley', 'dawn', 'day', 'daycare', 'days', 'daytoday', 'dba1', 'dbdb', 'dc', 'dca', 'dcir', 'dcr3', 'dcs', 'dcsign', 'dcsignr', 'ddrug', 'ddx19', 'ddx5', 'de', 'de205b', 'deacetylases', 'deacetylation', 'deactivation', 'dead', 'deadbox', 'deadenylation', 'deadly', 'deadspace', 'deal', 'dealing', 'death', 'deaths', 'debate', 'debates', 'debris', 'debunking', 'dec', 'decade', 'decades', 'decay', 'december', 'decentralized', 'decidua', 'deciphering', 'decision', 'decisionmakers', 'decisionmaking', 'decisions', 'decisionsupport', 'decitabine', 'decitabineinduced', 'declares', 'decline', 'declines', 'decompensated', 'decomposition', 'decompression', 'decongestant', 'deconstructing', 'decontamination', 'decoy', 'decrease', 'decreased', 'decreases', 'decreasing', 'dectin1', 'deduced', 'deemed', 'deep', 'deepens', 'deer', 'deescalation', 'defeating', 'defective', 'defectiveinterfering', 'defects', 'defence', 'defendants', 'defending', 'defense', 'defenses', 'defensin', 'defensins', 'defer', 'defibrillatoren', 'deficiencies', 'deficiency', 'deficiencymediated', 'deficient', 'deficits', 'defined', 'defines', 'defining', 'definition', 'definitionen', 'definitions', 'defy', 'degeneracy', 'degenerate', 'degeneration', 'degenerative', 'degradation', 'degree', 'degrees', 'degro', 'dehydration', 'dehydrocoupling', 'dehydrogenase', 'dehydrogenaseelevating', 'deklaration', 'del', 'delay', 'delayed', 'delayedtype', 'delays', 'deleterious', 'deletion', 'deletions', 'deliciosa', 'delirium', 'deliver', 'delivered', 'deliveries', 'delivery', 'delphi', 'delta', 'dem', 'demand', 'demanding', 'demands', 'dementia', 'democratic', 'demographic', 'demography', 'demokratischen', 'demonstrate', 'demonstrates', 'demonstrating', 'demonstration', 'demyelinating', 'demyelination', 'den', 'denaturing', 'dendrimerconjugated', 'dendritic', 'dengue', 'dengueexperienced', 'denguefieber', 'denguespecific', 'denmark', 'denning', 'dense', 'density', 'densovirus', 'dental', 'dentistry', 'denv', 'denve', 'deoxynivalenolinduced', 'deoxyzebularine', 'department', 'departmentbased', 'departments', 'departures', 'dependence', 'dependency', 'dependent', 'depending', 'depends', 'depleted', 'depletion', 'deployable', 'deployed', 'deployment', 'deportista', 'deposited', 'deposition', 'depressed', 'depression', 'depressions', 'depressive', 'deprivation', 'depth', 'der', 'derangement', 'deregulated', 'dereplication', 'deresuscitation', 'derivative', 'derivativeinduced', 'derivatives', 'derived', 'deriving', 'dermatitis', 'dermato', 'dermatologists', 'dermatology', 'dermatomyositis', 'dermoscopy', 'derzeitigen', 'des', 'desaturase', 'described', 'describing', 'description', 'descriptive', 'desempe', 'desenmascarada', 'desert', 'deserticola', 'desialylation', 'design', 'designation', 'designed', 'designer', 'designing', 'desinfektionsmittelkommission', 'desinfektionsmitteln', 'desirable', 'desires', 'despite', 'destabilizing', 'destination', 'destinations', 'destroyed', 'destroys', 'destructans', 'destruction', 'detachment', 'detail', 'detailed', 'details', 'detect', 'detectable', 'detectadas', 'detected', 'detecting', 'detection', 'detectiv', 'detective', 'detector', 'detects', 'detergent', 'detergentresistant', 'detergenttreated', 'deterioration', 'determinant', 'determinants', 'determination', 'determine', 'determined', 'determines', 'determining', 'deterministic', 'deubiquitinase', 'deubiquitinases', 'deubiquitinating', 'deubiquitylating', 'deutsche', 'deutschen', 'deutscher', 'deutschland', 'devascularization', 'develop', 'developed', 'developers', 'developing', 'development', 'developmental', 'developments', 'deviation', 'device', 'devices', 'devicesrelated', 'dewevrei', 'deworming', 'dexamethasone', 'dexamethasoneimmunosuppressed', 'dexamethasoneinduced', 'dexmedetomidine', 'dextran', 'df1', 'dgai', 'dgfl', 'dghm', 'dgho', 'dgiin', 'dgim', 'dgkch', 'dgkh', 'dgkj', 'dgpi', 'dgrh', 'dgrhkongress', 'dgspj', 'dgu', 'dgv', 'dhaka', 'dhi', 'dhnmelanin', 'dhumba', 'di', 'diabetes', 'diabetic', 'diagn', 'diagnose', 'diagnosed', 'diagnoses', 'diagnosis', 'diagnostic', 'diagnostics', 'diagnostik', 'diagnostique', 'diagnostische', 'diagnstico', 'diagonal', 'dialysis', 'diameters', 'diamine', 'diapause', 'diaphragm', 'diaphragmatic', 'diaphragmprotective', 'diarrh', 'diarrha', 'diarrhea', 'diarrheal', 'diarrheas', 'diarrheic', 'diarrhoea', 'diarrhoeas', 'diarrhoeic', 'diary', 'diarylquinoline', 'diastolic', 'diatrie', 'diatrique', 'diatrische', 'diatrischen', 'diatrischer', 'diazaspiro', 'diazepaminduced', 'dibromothymoquinone', 'dic', 'dicament', 'dicer', 'dichlorophenylbenzotriazoles', 'dicistronic', 'dicistrovirus', 'dictates', 'dictyostelia', 'dictyostelium', 'dicyclohexylcarbodiimide', 'dids', 'die', 'dieckol', 'died', 'dielectric', 'dielectrophoresis', 'diesen', 'diet', 'dietary', 'diethylaminoethyldextran', 'diethylene', 'dietinduced', 'differ', 'difference', 'differences', 'different', 'differential', 'differentialdiagnostik', 'differentially', 'differentiate', 'differentiated', 'differentiates', 'differentiating', 'differentiation', 'differenzen', 'differenzialdiagnose', 'differenzialdiagnosen', 'differs', 'difficile', 'difficult', 'difficulttoexpress', 'diffraction', 'diffuse', 'diffusion', 'diffusione', 'digest', 'digested', 'digestive', 'digestivo', 'digestivos', 'digital', 'digitally', 'digitizable', 'digoxin', 'dihydroberberine', 'dihydrofolate', 'dihydrorugosaflavonoids', 'dikerogammarus', 'dilated', 'dilemma', 'dilemmas', 'dim', 'dimension', 'dimensional', 'dimensions', 'dimeric', 'dimerization', 'dimers', 'dimethoxyphenyl', 'dimethyloxaloylglycine', 'diminazene', 'diminished', 'dimorphic', 'dinap', 'dinitrotoluene', 'dinoflagellate', 'dinucleotide', 'dinucleotides', 'diodes', 'diols', 'dione', 'dioscorea', 'dioxide', 'dipeptidyl', 'diphosphate', 'diphtheria', 'diploidcell', 'diplomacy', 'diplomatic', 'diptera', 'dipteran', 'dipyrithione', 'direct', 'directacting', 'directed', 'directfromspecimen', 'directing', 'direction', 'directional', 'directions', 'directly', 'director', 'directorgeneral', 'directors', 'directs', 'disability', 'disabled', 'disaccharides', 'disappearing', 'disassembly', 'disassortative', 'disaster', 'disasters', 'disasterspecific', 'disc', 'discharge', 'discharged', 'discipline', 'discoideum', 'discomforts', 'discontinuation', 'discontinued', 'discontinuing', 'discontinuous', 'discordant', 'discourse', 'discovered', 'discoveries', 'discovering', 'discovery', 'discoveryin', 'discrepancy', 'discrete', 'discretetime', 'discriminating', 'discrimination', 'discriminative', 'discriminatory', 'discs', 'discussion', 'discvr', 'disease', 'diseaseassociated', 'diseasecontrol', 'diseased', 'diseaseinduced', 'diseaselike', 'diseaserelated', 'diseaserisk', 'diseases', 'diseasespecific', 'diseasome', 'disentangle', 'dish', 'disinfectants', 'disinfection', 'disintegrin', 'diskurs', 'diskussionsbeitrag', 'dislocation', 'dismutase', 'disorder', 'disordered', 'disorders', 'dispanins', 'dispar', 'disparities', 'dispatch', 'dispensability', 'dispensable', 'dispersal', 'disperse', 'dispersed', 'dispersible', 'dispersion', 'displaced', 'display', 'displayed', 'displaying', 'displays', 'disposable', 'disposition', 'dispositional', 'disregarded', 'disrupted', 'disrupting', 'disruption', 'disruptions', 'disrupts', 'dissecting', 'dissection', 'dissektion', 'disseminated', 'dissemination', 'disseminators', 'dissociated', 'dissociation', 'dissolved', 'dissolving', 'distal', 'distance', 'distancing', 'distemper', 'distinct', 'distinctions', 'distinguish', 'distinguishing', 'distr', 'distraction', 'distress', 'distributed', 'distribution', 'distributions', 'district', 'districtlevel', 'districts', 'disturbance', 'disturbances', 'disturbs', 'disulfide', 'disulphide', 'diterpenes', 'ditorial', 'diubiquitin', 'diuresis', 'diva', 'divergence', 'divergent', 'diverse', 'diversification', 'diversity', 'divided', 'division', 'dkk1', 'dl1520', 'dlactate', 'dmab', 'dmd', 'dna', 'dnaa', 'dnaaided', 'dnabased', 'dnabinding', 'dnadependent', 'dnaencoded', 'dnag', 'dnahydrolyzing', 'dnak', 'dnarna', 'dnascaffolded', 'dob', 'dobran', 'dobravabelgrade', 'docetaxel', 'dock2', 'dock6', 'docking', 'doctor', 'doctors', 'documentary', 'documented', 'documenting', 'documento', 'doffing', 'dog', 'dogma', 'dogs', 'doi', 'dologie', 'dolphin', 'domain', 'domains', 'domainspecific', 'domainswapping', 'domestic', 'domestication', 'dominant', 'dominate', 'dominated', 'dominating', 'donation', 'done', 'donepezil', 'donna', 'donor', 'donors', 'donovani', 'doom', 'door', 'doorways', 'dopamine', 'dopaminergic', 'doped', 'dormancy', 'dormitories', 'dornase', 'dorsal', 'dosage', 'dose', 'dosedependent', 'doses', 'dosierter', 'dosing', 'dot', 'dot1l', 'dotblot', 'dotknot', 'dots', 'double', 'doubleblind', 'doubled', 'doubleedged', 'doubleexpression', 'doublemembrane', 'doublestranded', 'down', 'downmodulated', 'downregulate', 'downregulating', 'downregulation', 'downstream', 'downunder', 'doxorubicin', 'doxorubicininduced', 'doxycycline', 'dpb1', 'dq', 'dqb1', 'dqi', 'dr', 'dr4', 'draft', 'drag', 'dragon', 'drak2', 'drastically', 'drawing', 'draws', 'drb1', 'dreams', 'drei', 'dress', 'dried', 'drift', 'drifting', 'drink', 'drinkers', 'drinking', 'drive', 'driven', 'drivers', 'drives', 'driving', 'dromedaries', 'dromedarius', 'dromedary', 'drop', 'droplet', 'dropletbased', 'droplets', 'droplettransmitted', 'droppings', 'drops', 'drosophila', 'drotrecogin', 'drug', 'drugassociated', 'drugresistant', 'drugs', 'drugtarget', 'dry', 'dryopteris', 'dscav1stabilized', 'dsm', 'dsrna', 'dsrnadependent', 'dsrnainduced', 'dtpa', 'dtresse', 'du', 'dual', 'dualagonist', 'dualdegree', 'dualfunctioning', 'dualmode', 'dualpolarized', 'dualsubtype', 'dualtargeting', 'dubos', 'duchenne', 'duck', 'ducks', 'duct', 'due', 'duodenal', 'duplex', 'duplexes', 'duplicated', 'duplication', 'duplicon', 'durable', 'duraci', 'duration', 'durations', 'durch', 'durchbruch', 'dust', 'dutch', 'duty', 'dvv', 'dwelling', 'dxylose', 'dyad', 'dying', 'dynamic', 'dynamics', 'dynamicsderived', 'dysentery', 'dysfonction', 'dysfunction', 'dysfunctions', 'dysfunktion', 'dyskinesia', 'dysphagia', 'dysplasia', 'dysplasie', 'dyspnea', 'dyspnoea', 'dysregulated', 'dysregulation', 'dystrophin', 'dystrophy', 'e145', 'e1a', 'e2d', 'eae', 'eaere', 'eanm', 'eanm17', 'eaorl', 'eap', 'eaps', 'earliest', 'early', 'earlylife', 'earlyonset', 'earlystage', 'earthquake', 'earthquakes', 'east', 'eastern', 'easy', 'eating', 'eav', 'eb66', 'ebmt', 'ebner', 'ebola', 'ebolavirus', 'ebolaviruses', 'ebv', 'ebvgp350', 'ec', 'ecb12', 'ecc4', 'ecdc', 'ecdcs', 'echidnas', 'echinococcus', 'echocardiography', 'echoes', 'echovirus', 'eckhard', 'ecklonia', 'ecls', 'ecmo', 'ecmobased', 'ecmonet', 'ecocultural', 'ecoepidemiology', 'ecohealth', 'ecohydrogeochemical', 'ecologic', 'ecological', 'ecologies', 'ecology', 'economic', 'economically', 'economics', 'economy', 'ecosystem', 'ecosystems', 'ecotoxicity', 'ecotropic', 'ecr', 'ectes', 'ectodomain', 'eculizumab', 'ecv', 'ed', 'edema', 'edge', 'edible', 'edinburgh', 'editing', 'edition', 'editor', 'editores', 'editorial', 'editorialintroduction', 'editors', 'education', 'educational', 'eea', 'eeg', 'eehv', 'eel', 'een', 'effect', 'effective', 'effectively', 'effectiveness', 'effector', 'effects', 'effekt', 'efficacy', 'efficiency', 'efficient', 'efficiently', 'efflux', 'effort', 'efforts', 'effusion', 'effusions', 'efg', 'efhand', 'egcg', 'egf', 'egfr', 'egg', 'eggs', 'eggshell', 'egr1', 'egress', 'egypt', 'egyptian', 'ehealth', 'ehec', 'ehrlich', 'ehrlichia', 'ehrlichiosis', 'eiav', 'eidolon', 'eif2', 'eif4aiii', 'eigene', 'eigener', 'eigenvalue', 'eight', 'eighth', 'ein', 'eine', 'einem', 'einen', 'einer', 'eines', 'einflu', 'einfluss', 'einflussfaktoren', 'einrichtungen', 'einsatz', 'eit', 'either', 'ejecta', 'ejection', 'ejnmmi', 'el', 'elad', 'elane', 'elapsed', 'elastance', 'elastase', 'elastaseinduced', 'elastography', 'elderly', 'elective', 'electret', 'electric', 'electrical', 'electricity', 'electrochemical', 'electrochemiluminescence', 'electrodes', 'electrogenic', 'electrokinetic', 'electrolyte', 'electromagnetic', 'electromyography', 'electron', 'electronic', 'electronics', 'electronmicroscopic', 'electrophilic', 'electrophoresis', 'electroporation', 'electroporationmediated', 'electrospray', 'electrostatic', 'elektronenoptischer', 'element', 'elementary', 'elements', 'elephant', 'elephants', 'elephas', 'eleusis', 'elevated', 'elevating', 'elevation', 'eleven', 'eleventh', 'elicit', 'elicitation', 'elicited', 'eliciting', 'elicits', 'eliminate', 'eliminated', 'elimination', 'elisa', 'elisas', 'elispot', 'elite', 'ellagic', 'ellipsometry', 'elm', 'elongated', 'elongation', 'elr', 'else', 'elsevier', 'elucidates', 'elucidating', 'elusive', 'eluting', 'elution', 'elutriated', 'em', 'email', 'embedded', 'embedding', 'embolism', 'embrace', 'embracing', 'embryo', 'embryoid', 'embryonic', 'embryoniclike', 'embryonicstem', 'embryos', 'emc', 'emergence', 'emergenceand', 'emergencies', 'emergency', 'emergent', 'emergente', 'emergentes', 'emerging', 'emergingreemerging', 'emiliania', 'emirates', 'emissionshandel', 'emitting', 'emla', 'emmprin', 'emodin', 'emotion', 'emotional', 'emotionale', 'emotions', 'empathy', 'empfehlung', 'empfehlungen', 'emphasis', 'emphysema', 'empirical', 'employ', 'employed', 'employee', 'employing', 'emprico', 'empyema', 'ems', 'emulsion', 'en', 'ena', 'enable', 'enabled', 'enables', 'enabling', 'enahcers', 'enation', 'encapsidated', 'encapsidation', 'encapsulated', 'encapsulation', 'encephalitis', 'encephalitisinducing', 'encephalomyelitis', 'encephalomyeloradiculitis', 'encephalomyocarditis', 'encephalopathy', 'encircling', 'enclosure', 'encode', 'encoded', 'encodes', 'encoding', 'encore', 'end', 'endangered', 'enddiastolic', 'endemic', 'endemicity', 'endexpiratory', 'endgame', 'endgames', 'ending', 'endocan', 'endocarditis', 'endocrine', 'endocrinology', 'endocytic', 'endocytosis', 'endoflife', 'endogene', 'endogenous', 'endolysosomal', 'endometrial', 'endometrioid', 'endometriosis', 'endometrium', 'endonuclease', 'endoplasmic', 'endoribonuclease', 'endoscopic', 'endoscopy', 'endoskope', 'endosomal', 'endosomallysosomal', 'endosomelike', 'endosomes', 'endospores', 'endosymbionts', 'endothelial', 'endothelin1', 'endotheliosis', 'endotheliotropic', 'endothelium', 'endotherapy', 'endotoxemia', 'endotoxic', 'endotoxin', 'endotoxininduced', 'endotracheal', 'endplate', 'endproducts', 'ends', 'endstage', 'endtidal', 'endurance', 'enema', 'enemy', 'energy', 'enfant', 'enfermedad', 'enfermedades', 'enfermer', 'enfuvirtide', 'engagement', 'engine', 'engineer', 'engineered', 'engineering', 'england', 'english', 'engraftment', 'enhance', 'enhanced', 'enhancement', 'enhancer', 'enhancers', 'enhances', 'enhancing', 'enigma', 'enjeux', 'enlargement', 'enlightened', 'enlisted', 'enolase', 'enough', 'enqute', 'enrichment', 'enrofloxacin', 'enrolled', 'enrolling', 'enrollment', 'ensemble', 'ensure', 'ensures', 'ensuring', 'entamoeba', 'enter', 'enteral', 'enteric', 'enterica', 'entering', 'enteritidis', 'enteritis', 'enterobacteriaceae', 'enterococcus', 'enterocolitica', 'enterocolitis', 'enterocytes', 'enterokinase', 'enteropathogens', 'enterotoxic', 'enterotoxigenic', 'enterotoxins', 'enterotropic', 'enterovirus', 'enteroviruses', 'enterprise', 'enters', 'entfernung', 'enthaltenen', 'entire', 'entitlements', 'entity', 'entomological', 'entomologie', 'entr', 'entrapment', 'entre', 'entrenched', 'entrocolite', 'entropic', 'entropy', 'entropybased', 'entry', 'entscheiden', 'entscheidend', 'entscheidender', 'entwicklungen', 'entz', 'enumeration', 'env', 'envelope', 'enveloped', 'envelopment', 'environ', 'environment', 'environmental', 'environmentally', 'environmentallymediated', 'environments', 'enzootic', 'enzymatic', 'enzyme', 'enzyme2', 'enzymecatalyzed', 'enzymelinked', 'enzymes', 'eosinophil', 'eosinophiliamyalgia', 'eosinophilic', 'eosinophilie', 'eosinophils', 'eothenomys', 'ependymitis', 'epi', 'epicatechins', 'epichlo', 'epidemia', 'epidemic', 'epidemica', 'epidemics', 'epidemie', 'epidemien', 'epidemiologa', 'epidemiologic', 'epidemiological', 'epidemiologie', 'epidemiologische', 'epidemiologists', 'epidemiology', 'epidemiologyinfections', 'epidermal', 'epidermidis', 'epiflex', 'epigallocatechin', 'epigenetic', 'epigrass', 'epilepsy', 'epileptogenesis', 'epiphyllous', 'episode', 'episodes', 'episodic', 'episodio', 'episomal', 'epistatic', 'episteme', 'epistemic', 'epithelia', 'epithelial', 'epitheliallike', 'epithelium', 'epitope', 'epitopebased', 'epitoperepeat', 'epitopes', 'epitopic', 'epoc', 'epoxide', 'eps', 'epstein', 'epsteinbarr', 'equal', 'equatorial', 'equestris', 'equilibrium', 'equine', 'equipment', 'equity', 'equivalent', 'er', 'era', 'erad', 'eradication', 'erassociated', 'ercc1', 'erectile', 'erfahrungen', 'erfahrungsaustausch', 'erfolgreich', 'erforderlich', 'erfordern', 'erfordernisse', 'ergebnisse', 'ergosterol', 'erh', 'erinyes', 'eriocheiris', 'erithacus', 'erk', 'erk1', 'erk12', 'erk2', 'erkrankungen', 'erks', 'erlangen', 'erm', 'ern', 'ernstig', 'erosion', 'erosive', 'erratum', 'erregerbedingten', 'erregerdiagnostik', 'erreichen', 'error', 'errors', 'erster', 'eruption', 'erwachsene', 'erwachsenen', 'erwachsenenalter', 'erwachsener', 'erweiterte', 'erworbene', 'erysiphe', 'erythematosus', 'erythrocyte', 'erythrocytes', 'es', 'es2', 'esboc', 'escape', 'eschar', 'escherichia', 'escherichla', 'escrt', 'esculenta', 'esculentum', 'esi', 'esicm', 'esicmbarcelona', 'esid', 'esophageal', 'esophagectomy', 'esophagitis', 'esophagology', 'esoteric', 'esp', 'espa', 'especialistas', 'espnic', 'espr', 'essay', 'essen', 'essential', 'essentialsaccharomyces', 'essentielles', 'establish', 'established', 'establishes', 'establishing', 'establishment', 'estacional', 'estados', 'esters', 'estimate', 'estimated', 'estimates', 'estimating', 'estimation', 'estonia', 'estradiol', 'estrogen', 'estuary', 'estudiantes', 'estudio', 'eswi', 'et', 'etch', 'etf1', 'ethanol', 'ethanolinfluorocarbon', 'ethers', 'ethical', 'ethics', 'ethiopia', 'ethische', 'ethnicity', 'ethyl', 'ethylene', 'etiologa', 'etiologic', 'etiological', 'etiologies', 'etiology', 'eu', 'eucariotis', 'eucaryotic', 'eudicotyledonous', 'eukarya', 'eukaryotes', 'eukaryotic', 'eulemur', 'eulerianeulerian', 'eulerianlagrangian', 'eumycetoma', 'eupathdb', 'euphausiids', 'euphorbia', 'eurasian', 'euro', 'euronhid', 'europ', 'europa', 'europe', 'european', 'europeanlike', 'europes', 'europische', 'euthanasia', 'euvae', 'ev21', 'ev71', 'ev71infected', 'evacuation', 'evacuator', 'evade', 'evading', 'evaluate', 'evaluating', 'evaluation', 'evaluations', 'evaluierung', 'evaporating', 'evasion', 'event', 'events', 'ever', 'every', 'evidence', 'evidencebased', 'evidenced', 'evidenceto', 'evidenz', 'evitar', 'evoked', 'evolution', 'evolutionally', 'evolutionarily', 'evolutionary', 'evolve', 'evolved', 'evolving', 'ex', 'exacerbaciones', 'exacerbate', 'exacerbates', 'exacerbation', 'exacerbations', 'exact', 'exaggerates', 'exam', 'examen', 'examination', 'examine', 'examining', 'example', 'examples', 'exantheme', 'excellent', 'exceptional', 'exceptionalism', 'exceptions', 'excess', 'excessive', 'exchange', 'exchanges', 'excitatory', 'exclusion', 'excretion', 'excretory', 'executive', 'exercise', 'exercises', 'exerted', 'exerts', 'exfoliative', 'exhalation', 'exhaled', 'exhaustion', 'exhaustive', 'exhibit', 'exhibition', 'exhibitions', 'exhibits', 'exist', 'existe', 'existence', 'existing', 'exit', 'exocrine', 'exocytotic', 'exogenous', 'exome', 'exon', 'exonic', 'exons', 'exophiala', 'exopolysaccharides', 'exoskeleton', 'exosome', 'exosomeassociated', 'exosomes', 'exotic', 'exoticpet', 'exotique', 'exouinduced', 'exp', 'expand', 'expanded', 'expanding', 'expansion', 'expansions', 'expatriates', 'expect', 'expectancy', 'expectations', 'expectativa', 'expected', 'expectoration', 'expedition', 'expenditure', 'expenditures', 'experience', 'experiences', 'experiencia', 'experiencing', 'experiment', 'experimental', 'experimentally', 'experimentallyinduced', 'experimentals', 'experimentelle', 'experiments', 'expert', 'expertise', 'experts', 'explaining', 'explant', 'explanted', 'explants', 'explicit', 'exploit', 'exploitation', 'exploiting', 'exploits', 'exploration', 'explorations', 'explorative', 'explorativen', 'exploratory', 'explore', 'exploring', 'explosion', 'exponential', 'export', 'exportations', 'exposed', 'exposes', 'exposition', 'exposure', 'exposures', 'express', 'expressed', 'expressing', 'expression', 'expressions', 'extended', 'extending', 'extends', 'extension', 'extensions', 'extensive', 'extensively', 'extent', 'exterior', 'external', 'externer', 'externes', 'extinction', 'extra', 'extracellular', 'extracellularly', 'extracorporeal', 'extracorporelle', 'extract', 'extracted', 'extraction', 'extracts', 'extrakorporale', 'extralymphatic', 'extrapulmonary', 'extravasated', 'extravascular', 'extreme', 'extremely', 'extremities', 'extrinsic', 'extubation', 'exudado', 'exudates', 'exudation', 'exvivo', 'eye', 'eyeassociated', 'eyes', 'ezrin', 'f1r', 'f1v', 'fab', 'fabricius', 'face', 'facebook', 'faced', 'faceless', 'facemask', 'facemasks', 'facepiece', 'faces', 'facets', 'facettes', 'facharztprfung', 'fachausschusses', 'fachgebiet', 'fachgespr', 'facile', 'facilitate', 'facilitated', 'facilitates', 'facilitating', 'facilitation', 'facilitators', 'facilities', 'facility', 'facilitybased', 'facing', 'fact', 'facteurs', 'factor', 'factor1', 'factoralpha', 'factores', 'factorial', 'factories', 'factorless', 'factors', 'factory', 'facts', 'faculty', 'fading', 'faecal', 'faecalis', 'faecium', 'failed', 'fails', 'failure', 'failures', 'fairholmianus', 'fak', 'faktoren', 'falciparum', 'fall', 'fallback', 'fallbeispiele', 'fallbericht', 'falle', 'falls', 'fallwinter', 'false', 'falsely', 'familienzentrierte', 'families', 'famille', 'family', 'famous', 'fan', 'fanconi', 'far', 'faringoamigdalitis', 'farm', 'farmed', 'farmers', 'farming', 'farms', 'farrowtofinish', 'faruvc', 'fascia', 'fascicularis', 'fasciitis', 'fascinating', 'fasciola', 'fascism', 'fasdeficient', 'fashion', 'fast', 'faster', 'fastidious', 'fasttrack', 'fat', 'fat1', 'fatal', 'fatality', 'fatally', 'fatalpasteurella', 'fate', 'father', 'fatigue', 'fatty', 'fautil', 'favipiravir', 'favor', 'favors', 'favours', 'fc', 'fc77', 'fcb2', 'fcdependently', 'fces', 'fcmediated', 'fcov', 'fcrn', 'fda', 'fdaapproved', 'fdg', 'fear', 'fearbola', 'fearrelated', 'fears', 'feasibility', 'feasible', 'feathers', 'feature', 'features', 'featuresinfective', 'featuring', 'feb', 'febril', 'febrile', 'februar', 'february', 'febuxostat', 'fecal', 'feces', 'fed', 'fedbatch', 'federal', 'federation', 'feed', 'feedback', 'feeder', 'feeding', 'feedlot', 'feeds', 'fees', 'fehlgeschlagenen', 'felegehiwot', 'felid', 'felids', 'feline', 'felis', 'felv', 'felvrelated', 'female', 'females', 'feminist', 'femme', 'femoral', 'femoroacetabular', 'fenestrae', 'fenestrated', 'fengcai', 'feni', 'fenofibrate', 'fermentation', 'ferret', 'ferrets', 'ferritin', 'ferroptosis', 'fertility', 'fertilization', 'fertiqol', 'festucae', 'fetal', 'fetoprotein', 'fetus', 'fev', 'fev1', 'fever', 'fevercausing', 'feverishly', 'feverlike', 'fevers', 'ffentlichkeit', 'fgf', 'fgf23', 'fgfr1', 'fgl', 'fi', 'fiat', 'fiber', 'fiberoptic', 'fibers', 'fibrillation', 'fibrindegradation', 'fibrinogen', 'fibrinogenlike', 'fibrinous', 'fibroblast', 'fibroblastic', 'fibroblasts', 'fibromyalgia', 'fibronectin', 'fibrose', 'fibrosis', 'fibrotic', 'fibular', 'fiction', 'fictions', 'fidelity', 'fidelitymodulating', 'fieber', 'field', 'fielddeployable', 'fields', 'fieldsustainable', 'fifth', 'fight', 'fighting', 'figure', 'filamentous', 'filariasis', 'filgrastim', 'filling', 'filmarray', 'filoviral', 'filovirus', 'filovirusexperimentally', 'filter', 'filtering', 'filteringfacepiece', 'filtrate', 'filtration', 'fimbriae', 'fimbrial', 'fin', 'final', 'finally', 'financial', 'financing', 'find', 'finden', 'finding', 'findings', 'finds', 'fine', 'fineneedle', 'finetunes', 'finger', 'fingerprint', 'fingerprinting', 'fingerprints', 'fingers', 'fingolimod', 'finished', 'finishing', 'finite', 'finland', 'finnish', 'fio', 'fio2', 'fip', 'fipv', 'fire', 'firms', 'first', 'fischer', 'fish', 'fisher', 'fishes', 'fission', 'fistula', 'fit', 'fitness', 'fitting', 'fiv', 'five', 'fivemembered', 'fix', 'fixation', 'fixedcell', 'fk23', 'fkbp11', 'fl', 'flab', 'flaccid', 'flag', 'flagellin', 'flares', 'flash', 'flasks', 'flats', 'flavaspidic', 'flavescens', 'flaviviral', 'flaviviridae', 'flavivirus', 'flaviviruses', 'flavonoid', 'flavonoidinduced', 'flavonoidrich', 'flavors', 'flds', 'flexibility', 'flexible', 'flexibler', 'flexneri', 'flies', 'flight', 'flights', 'flj11286', 'fllen', 'floating', 'flock', 'flocks', 'floor', 'flora', 'floribundiquinone', 'florida', 'flos', 'flounder', 'flow', 'flowers', 'flowvolume', 'flt3l', 'flu', 'fluassociated', 'fludarabine', 'flugenome', 'fluid', 'fluidlimiting', 'fluidphase', 'fluke', 'flumazenil', 'fluorescence', 'fluorescent', 'fluoride', 'fluorinated', 'fluorine', 'fluorogenactivating', 'fluoroimmunoassay', 'fluorometric', 'fluoroquinolones', 'fluorosis', 'flux', 'fly', 'flying', 'flyingfox', 'flyingfoxes', 'flyways', 'fmdv', 'fnf', 'foal', 'foals', 'foamy', 'focal', 'focis', 'focus', 'focused', 'focussed', 'foe', 'foes', 'foetal', 'fogarty', 'folate', 'fold', 'foldase', 'folded', 'folding', 'folds', 'folfox', 'follicleassociated', 'follicles', 'follicular', 'follow', 'followed', 'following', 'followup', 'fomite', 'fomitemediated', 'fomites', 'fomitopsis', 'fontanella', 'food', 'foodanimal', 'foodborne', 'foods', 'foot', 'footand', 'footandmouth', 'forager', 'foraging', 'forbidding', 'forbs', 'force', 'forces', 'forcing', 'forecast', 'forecasting', 'forecasts', 'forehead', 'foreign', 'forensic', 'forensics', 'foresee', 'forest', 'forestrelated', 'forests', 'foretold', 'forget', 'forgotten', 'fork', 'form', 'formalin', 'formalizes', 'formation', 'formations', 'formativa', 'formed', 'formerly', 'formes', 'formidable', 'forming', 'forms', 'formula', 'formulated', 'formulation', 'formulations', 'forpneumocystis', 'forschung', 'forskolin', 'forsythia', 'fortbildung', 'forth', 'fortune', 'fortunei', 'fortyfive', 'forum', 'forward', 'fosters', 'fouchier', 'found', 'foundation', 'founder', 'founding', 'four', 'fourth', 'fowl', 'fox', 'foxo1', 'foxo3', 'foxo3a', 'foxp1', 'foxp3', 'fp7', 'fpgnei', 'fr', 'fraction', 'fractional', 'fractionated', 'fractions', 'fractures', 'fragen', 'fragile', 'fragment', 'fragmentation', 'fragmentbased', 'fragments', 'frame', 'frames', 'frameshift', 'frameshifting', 'frameshifts', 'frameshiftstimulating', 'framework', 'frameworks', 'fran', 'france', 'franchises', 'francisco', 'francisella', 'frankfurt', 'fratricide', 'free', 'freegrazing', 'freeliving', 'freely', 'freeranging', 'freezedried', 'fregata', 'freiburg', 'fremdblut', 'french', 'freon113', 'frequencies', 'frequency', 'frequent', 'fresh', 'freshwater', 'frhjahrstagung', 'friday', 'friedreichs', 'friedrich', 'friend', 'friends', 'frigatebirds', 'frog', 'front', 'frontiers', 'frontires', 'frontline', 'frost', 'frozen', 'frster', 'fructose16', 'fructus', 'frugiperda', 'fruit', 'fsme', 'ftls', 'ftlsv', 'fty720', 'fu', 'fucosidase', 'fuerte', 'fugitive', 'fugong', 'fukushima', 'full', 'fuller', 'fullgenome', 'fulllength', 'fullterm', 'fully', 'fulminant', 'fumigatus', 'funcionales', 'function', 'functional', 'functionalised', 'functionality', 'functionalization', 'functionalized', 'functionally', 'functionbased', 'functioning', 'functions', 'fund', 'fundamental', 'funded', 'funder', 'funders', 'funding', 'fungal', 'fungemia', 'fungi', 'fungus', 'funiculus', 'funktion', 'funktionsst', 'furin', 'furindependent', 'furosemide', 'fury', 'fus', 'fused', 'fusing', 'fusion', 'fusions', 'fusobacterium', 'fusogenicity', 'future', 'futuristic', 'futuro', 'fuzzy', 'fwesen', 'fxrbsep', 'g1s', 'g6pd', 'ga', 'gaat', 'gabaa', 'gabon', 'gabriel', 'gabs', 'gadd34', 'gadget', 'gag', 'gaggag', 'gagpol', 'gagpro', 'gain', 'gaining', 'gainof', 'gainoffunction', 'gairdner', 'galactosamine', 'galactose1phosphate', 'galactosidase', 'galactosyltransferase', 'galangin', 'gallate', 'gallectin', 'gallic', 'galliformes', 'gallisepticum', 'galloylhexahydroxydiphenoyl', 'galt', 'gambia', 'gambiasenegal', 'gambles', 'game', 'games', 'gamma', 'gammaherpesvirus', 'gammainterferon', 'gammaretroviruses', 'gammaridae', 'ganciclovir', 'ganglia', 'ganglioside', 'gangliosides', 'gankeshuangqing', 'gap', 'gaps', 'gaptreating', 'garante', 'garcinia', 'gard', 'gardens', 'garlic', 'garp', 'garps', 'gas', 'gastmeier', 'gastric', 'gastro', 'gastroenteritiden', 'gastroenteritis', 'gastroenterological', 'gastroenterologie', 'gastroenterology', 'gastrointestinal', 'gastrointestinales', 'gastrointestinaltrakt', 'gastropoda', 'gata2', 'gated', 'gatekeepers', 'gatewaytm', 'gathering', 'gatherings', 'gau', 'gauging', 'gaussia', 'gaussian', 'gaza', 'gb', 'gbaren', 'gbv', 'gbvc', 'gc', 'gcrv', 'gcsf', 'gcsfinduced', 'gd', 'gd1a', 'ge', 'geburtsgewicht', 'geburtshilfe', 'gedacht', 'gedanken', 'geeignete', 'gefahrenlagen', 'gefordert', 'gegen', 'gel', 'gelatinase', 'gelatinaseassociated', 'gem', 'gemcitabine', 'gemcitabineinduced', 'gemeinsam', 'gemeinsame', 'gemeinsamen', 'gemeinschaft', 'geminivirus', 'gender', 'gendered', 'genderspecific', 'gene', 'gene1', 'genebased', 'genera', 'general', 'generalist', 'generalists', 'generalizable', 'generalized', 'generally', 'generando', 'generate', 'generated', 'generating', 'generation', 'genes', 'genetic', 'genetically', 'genetics', 'geneva', 'genic', 'genital', 'genographic', 'genome', 'genomebased', 'genomefingerprinter', 'genomefingerprints', 'genomelandscaper', 'genomes', 'genomewide', 'genomic', 'genomics', 'genosept', 'genotoxic', 'genotoxicity', 'genotype', 'genotypes', 'genotypic', 'genotypically', 'genotyping', 'genpolymorphismen', 'gentherapie', 'gentransfer', 'genuity', 'genus', 'genustorovirus', 'geocomputational', 'geographic', 'geographical', 'geography', 'geolocation', 'geometric', 'geometry', 'geomicrobiologicalinsitu', 'georgia', 'geosimulation', 'geospatial', 'geoweb', 'gerais', 'gerberding', 'geriatric', 'gerinnung', 'germ', 'germacrone', 'german', 'germany', 'germes', 'germfree', 'germicidal', 'germinable', 'germinal', 'germination', 'germline', 'germplasm', 'germs', 'gerontology', 'geroprotective', 'gesamten', 'gesellschaft', 'gesepoc', 'gesichert', 'gesneriaceae', 'gesnerioideae', 'gesprek', 'gestation', 'gestational', 'gesunden', 'gesundheit', 'gesundheitspolitik', 'gesundheitsvorschriften', 'gesundheitswesen', 'gesundheitswesens', 'get', 'getah', 'getting', 'gevoel', 'gewinnung', 'gewonde', 'gfap', 'gfh', 'gh', 'gh3', 'ghana', 'ghanaian', 'ghitm', 'ghost', 'gi', 'gi16', 'giaim', 'giant', 'giants', 'giardia', 'gico', 'gideon', 'gies', 'gii', 'gii4', 'giip17', 'gilbertiodendron', 'gilgit', 'gilt', 'gilthead', 'ginseng', 'ginsenoside', 'girl', 'girls', 'gitype', 'giving', 'giviti', 'gkj', 'gkjhk', 'glance', 'gland', 'glands', 'glass', 'glasswing', 'glaucoma', 'gleamviz', 'gles', 'glia', 'glial', 'glichkeiten', 'gliders', 'glioblastoma', 'glioma', 'gliomas', 'gliopathy', 'glittering', 'glob', 'global', 'globalhealth', 'globalisation', 'globalizado', 'globalization', 'globalized', 'globally', 'globe', 'globigii', 'globule', 'globulin', 'glomerular', 'glomerulonephritis', 'glomerulosclerosis', 'gloom', 'glossina', 'gloves', 'gltig', 'glucagon', 'glucocorticoids', 'gluconate', 'glucose', 'glucose6phosphate', 'glucoseinduced', 'glucuronidase', 'glutamate', 'glutamine', 'glutaminerich', 'glutamyl', 'glutathione', 'gluteal', 'glycan', 'glycanbinding', 'glycans', 'glycation', 'glycemic', 'glyco', 'glycocalyx', 'glycoconjugates', 'glycoengineered', 'glycoform', 'glycogen', 'glycol', 'glycolmediated', 'glycolytic', 'glycopeptide', 'glycoprotein', 'glycoproteins', 'glycoproteins1', 'glycosidase', 'glycosides', 'glycosylase', 'glycosylated', 'glycosylation', 'glycosylphosphatidylinositol', 'glycosyltransferase', 'glycosyltransferases', 'glycyrrhetinic', 'glycyrrhiza', 'glycyrrhizic', 'glycyrrhizin', 'glycyrrhizinic', 'glypican3', 'glypicans', 'gm', 'gm1', 'gm2', 'gmcsf', 'gmos', 'gn', 'gne', 'gnotobiotic', 'gnpi', 'go', 'goat', 'goats', 'goes', 'gold', 'goldcoated', 'golden', 'golgi', 'golgiretained', 'gonadotrophin', 'gonadotropin', 'gondar', 'gondii', 'gondiispecific', 'gonorrhoeae', 'good', 'goods', 'google', 'goose', 'gorgonian', 'gorilla', 'gorillas', 'gossypol', 'got', 'goulako', 'governance', 'governing', 'government', 'governorate', 'governs', 'gp', 'gp1', 'gp120', 'gp2', 'gp41', 'gp5mosaic', 'gpcrs', 'gpge', 'gpi', 'gpi0100', 'gpianchored', 'gpienriched', 'gprotein', 'gps', 'gpu', 'gpvi', 'gquadruplex', 'gquadruplexbased', 'gr', 'grade', 'gradient', 'graduates', 'graft', 'grafting', 'grafts', 'graftversus', 'graftversushost', 'grain', 'gramnegative', 'granatum', 'grand', 'granins', 'granular', 'granule', 'granules', 'granulocyte', 'granulocytemacrophage', 'granulocytes', 'granulocytic', 'granulocytopenic', 'granulomatosen', 'granulomatosis', 'granulomatous', 'granulomatse', 'granulomatser', 'granulosa', 'granulosus', 'granzyme', 'grape', 'grapevine', 'graph', 'graphautomorphism', 'graphbased', 'graphdistance', 'graphene', 'graphs', 'grasp', 'grass', 'grassland', 'grave', 'graves', 'gravimetric', 'gravit', 'gray', 'great', 'greater', 'greatly', 'greedy', 'green', 'greenland', 'greets', 'gregarious', 'gren', 'grenze', 'grenzen', 'griep', 'gripe', 'grippale', 'grippe', 'grips', 'grk2', 'gro', 'groove', 'ground', 'groundnut', 'grounds', 'group', 'grouper', 'groupers', 'grouping', 'groupinterest', 'groups', 'growing', 'grown', 'grows', 'growth', 'growthattenuated', 'growthpromoting', 'grundlagen', 'grundrechtliche', 'gruppe', 'gs115', 'gsh', 'gsk3', 'gsk3beta', 'gsr', 'gstm1', 'gtpases', 'gu', 'gua', 'guam', 'guangxi', 'guangzhou', 'guanidine', 'guanosine', 'guanylate', 'guard', 'guardians', 'guas', 'guatemala', 'guertu', 'guest', 'guiana', 'guidance', 'guide', 'guideline', 'guidelines', 'guidelines2016', 'guiding', 'guiera', 'guillain', 'guinea', 'guizhou', 'gulae', 'gulf', 'guns', 'gut', 'gute', 'guy', 'guys', 'gvhd', 'gyeonggi', 'gyeongju', 'gyn', 'gynaecologic', 'gynecologic', 'gynecological', 'gynkologie', 'gyrase', 'h10n7', 'h10n8', 'h1n1', 'h1n109', 'h1n1a', 'h1n1induced', 'h1n1infection', 'h1n1pandemie', 'h1n1pdm09', 'h1n1related', 'h1n1v', 'h275y', 'h2k', 'h2n2', 'h3k79', 'h3n2', 'h3n8', 'h5n1', 'h5n2', 'h5n6', 'h5nx', 'h6n1', 'h7n9', 'h7n9infected', 'h7n9specific', 'h9n2', 'ha', 'ha1', 'ha1101', 'ha330', 'haben', 'habitat', 'habitats', 'habituated', 'habronattus', 'hacat', 'hadve4', 'haemagglutinating', 'haemagglutinin', 'haemagglutininspecific', 'haematological', 'haematology', 'haematopoietic', 'haemobaphes', 'haemodiafiltration', 'haemodialysis', 'haemoglobin', 'haemolymphatic', 'haemolysis', 'haemominutum', 'haemonchus', 'haemophagocytic', 'haemophilus', 'haemoproteus', 'haemorrhage', 'haemorrhagic', 'haemotherapy', 'hainan', 'hair', 'hairpin', 'haiti', 'haitian', 'hajj', 'hakam', 'hakusan', 'half', 'halfempty', 'halflife', 'halfway', 'hallgr', 'hallmark', 'hallucinosis', 'haloferax', 'halofuginone', 'halogenated', 'halovest', 'halsnasenohren', 'halting', 'halts', 'halved', 'halyomorpha', 'halys', 'hamburg', 'hamediated', 'hammer', 'hampers', 'hamster', 'hamsters', 'han', 'hana', 'hand', 'handassisted', 'handelns', 'handheld', 'handle', 'handling', 'handlungstheorie', 'handsoff', 'handwashing', 'hannover', 'hantaan', 'hantavirus', 'hantaviruses', 'hantavirusinfektion', 'hantavirusinfektionen', 'hap2gcs1', 'haploidentical', 'haplotype', 'haplotypes', 'happened', 'haptoglobin', 'harbin', 'harbor', 'harbored', 'harboring', 'hardware', 'harm', 'harmful', 'harmless', 'harmonic', 'harnessing', 'harvested', 'hate', 'hatfield', 'hausarzt', 'hause', 'hausrztlichen', 'hautblutungen', 'hautes', 'havemeyer', 'hawaii', 'haystack', 'hazard', 'hazardous', 'hazards', 'hbeagpositive', 'hbec3kt', 'hbonding', 'hbv', 'hbz', 'hcap', 'hcap18ll', 'hcmv', 'hcov', 'hcov229e', 'hcovemc', 'hcpro', 'hcv', 'hcvinduced', 'hcvinfected', 'hdl', 'head', 'headline', 'headlines', 'healing', 'health', 'healthcare', 'healthcareassociated', 'healthfacility', 'healthier', 'healthrelated', 'healthseeking', 'healthy', 'hearing', 'heart', 'heat', 'heathland', 'heating', 'heatlabile', 'heatoxidative', 'heatshock', 'heatstressed', 'heavy', 'heavychainonly', 'hec2016', 'hedgehog', 'hedgehogs', 'hef', 'hefte', 'hei', 'heidelberger', 'height', 'heightened', 'heilkunde', 'heilmittelrezepte', 'hela', 'held', 'helical', 'helicase', 'helicasedependent', 'helicases', 'helices', 'helicobacter', 'heliox', 'helium', 'help', 'helper', 'helpful', 'helsinki', 'helvum', 'hemagglutination', 'hemagglutinin', 'hemagglutinins', 'hemangioma', 'hematemesis', 'hematologic', 'hematological', 'hematology', 'hematoma', 'hematopoiesis', 'hematopoietic', 'heme', 'hemikolektomie', 'hemingway', 'hemisphere', 'hemoadsorption', 'hemocytes', 'hemodiafiltration', 'hemodialysis', 'hemodynamic', 'hemoglobin', 'hemolysisingel', 'hemolytic', 'hemophagocytic', 'hemophilia', 'hemoptysis', 'hemorrhage', 'hemorrhages', 'hemorrhagic', 'hemozoin', 'hen', 'henan', 'hendra', 'henipavirus', 'hens', 'henselae', 'hep', 'hepaciviruses', 'hepadnavirus', 'heparan', 'heparanase', 'heparg', 'heparin', 'heparinrelated', 'heparins', 'hepatic', 'hepatica', 'hepatitis', 'hepatitisassociated', 'hepatitisbimpfstoffe', 'hepatocellular', 'hepatocyte', 'hepatocytes', 'hepatoma', 'hepatomaderived', 'hepatoprotective', 'hepatosplenomegalie', 'hepatotropic', 'hepatoviruses', 'hepatozoon', 'hepcidin', 'heptadrepeat', 'heptanucleotides', 'her', 'her2neu', 'herausforderung', 'herbaceous', 'herbal', 'herbert', 'herbs', 'herbsttagung', 'hercules', 'herd', 'herds', 'herne', 'hernia', 'hero', 'heroin', 'heroism', 'herpes', 'herpesinfektionen', 'herpessimplexinfektionen', 'herpesviral', 'herpesviridae', 'herpesvirus', 'herpesvirus1', 'herpesviruses', 'herpetic', 'herz', 'herzchirurgie', 'herzchirurgischen', 'herzentnahme', 'herzinfarkt', 'hesitancy', 'het', 'heteroclinics', 'heteroclitic', 'heterocycle', 'heterocycles', 'heterodimer', 'heterodimers', 'heterogeneity', 'heterogeneous', 'heterohybridomas', 'heterologous', 'heteromyeloma', 'heteroplasmy', 'heteropolyacids', 'heterosubtypic', 'heterotrimer', 'heterotypic', 'hetesim', 'heuristic', 'heute', 'hev', 'hevein', 'hexon', 'hfmd', 'hfnc', 'hgeborener', 'hgf', 'hgn194', 'hhd', 'hhdac6', 'hhdp', 'hhenmedizin', 'hhra', 'hhs', 'hhv', 'hhv6', 'hidden', 'hides', 'hierarchical', 'hierarchy', 'hif', 'hif1', 'hig', 'high', 'highaffinity', 'highaltitude', 'highconsequence', 'highcontent', 'highdensity', 'highdose', 'higher', 'higherlevel', 'highfat', 'highfidelity', 'highflow', 'highfrequency', 'highgrowth', 'highimpactfactor', 'highlevel', 'highlight', 'highlighted', 'highlighting', 'highlights', 'highly', 'highmannose', 'highpathogenicity', 'highperformance', 'highresolution', 'highrisk', 'highspeed', 'hightech', 'highthroughput', 'hightiter', 'highvolume', 'highvs', 'higkeit', 'hijacking', 'hijakt', 'hilar', 'hilic', 'hilly', 'himalayan', 'hind', 'hinokiflavone', 'hint', 'hip', 'hipaa', 'hipec', 'hippocampal', 'hippocratic', 'hipposideros', 'hirnstammenzephalitis', 'hirschsprung', 'his', 'hispidus', 'histamine', 'histidine', 'histidines', 'histiocytic', 'histoblood', 'histocampatibility', 'histocompatibility', 'histoinhibitory', 'histological', 'histologische', 'histology', 'histolytica', 'histone', 'histopathological', 'histophilus', 'histoplasmosis', 'historia', 'historical', 'historically', 'history', 'hitoshi', 'hiv', 'hiv1', 'hiv1infected', 'hivaids', 'hivassociated', 'hiver', 'hivernales', 'hivgp41', 'hivhcv', 'hivhost', 'hivinfected', 'hivinfektion', 'hivnegative', 'hivpositive', 'hivrelated', 'hivspecific', 'hivuninfected', 'hj16', 'hk20', 'hk70', 'hku1', 'hl', 'hl60', 'hla', 'hlaa', 'hlaa0201', 'hlaa2', 'hlaa2restricted', 'hlac', 'hladmb', 'hladr', 'hlaphenotypically', 'hlarestricted', 'hling', 'hmato', 'hmatoonkologische', 'hmatoonkologischen', 'hmatopoetischer', 'hmgb1', 'hmgb1mediated', 'hmorrhagic', 'hmyh', 'hndehygiene', 'hne', 'hnf1b', 'hnliche', 'hnp1', 'ho', 'hoarding', 'hoc', 'hoch', 'hochauflsende', 'hochkontagi', 'hochuekkito', 'hockey', 'hocl', 'hoct1', 'hodgkin', 'hodgkins', 'hog', 'hoima', 'hokkaido', 'hold', 'holes', 'hollow', 'hollowcored', 'holmes', 'holoautoimmunity', 'holobiont', 'holobionts', 'holoimmunity', 'holstein', 'homburg', 'home', 'homelessness', 'homemade', 'homeostasis', 'homes', 'hominid', 'hominis', 'homo', 'homogeneous', 'homoharringtonine', 'homolog', 'homologous', 'homologousstructure', 'homologs', 'homologue5', 'homology', 'homologyindependent', 'homomultimerization', 'homophilic', 'homoptera', 'homosexual', 'homotrimer', 'homotypic', 'homozygous', 'honey', 'honeybee', 'hong', 'hongjie', 'hongkongensis', 'honokiol', 'honolulu', 'honorary', 'hookworm', 'hope', 'hopeful', 'hopes', 'hopper', 'hopping', 'horizon', 'horizons', 'horizontal', 'hormonal', 'hormone', 'hormoneregulated', 'hormones', 'horse', 'horses', 'horseshoe', 'hospice', 'hospital', 'hospitalacquired', 'hospitalario', 'hospitalbased', 'hospitali', 'hospitalisation', 'hospitalised', 'hospitalization', 'hospitalizations', 'hospitalized', 'hospitals', 'host', 'hostbody', 'hostdirected', 'hostdriven', 'hostpathogen', 'hostprimed', 'hostprotective', 'hostproteome', 'hostrange', 'hosts', 'hosttargeting', 'hostvirus', 'hot', 'hotel', 'hotspot', 'hotspots', 'hour', 'hours', 'house', 'household', 'households', 'housekeeping', 'housing', 'houttuynia', 'hovon', 'hpai', 'hpc1', 'hplc', 'hplcuv', 'hptlc', 'hpv', 'hpv16', 'hpv18', 'hpvassociated', 'hrigen', 'hrt', 'hrung', 'hrungswissenschaftliche', 'hrv', 'hsct', 'hses', 'hsp', 'hsp27eif4e', 'hsp40', 'hsp70', 'hsp72', 'hsp90', 'hspg2', 'hsv', 'hsv1', 'hsv2', 'ht', 'ht22', 'ht29', 'htlv', 'htlv1', 'hts', 'htsdriven', 'https', 'hua14ped96', 'huang', 'hubei', 'hugh', 'hugonnet', 'huifn', 'huitime', 'human', 'humane', 'humaninfecting', 'humanitarian', 'humanized', 'humans', 'humantohuman', 'humanwildlife', 'humid', 'humidity', 'humoral', 'hun', 'hundred', 'hung', 'hungary', 'hunters', 'hunting', 'huntington', 'hurdles', 'hurlers', 'hurricane', 'husbandry', 'huvecs', 'huxleyi', 'hx', 'hy5', 'hyaline', 'hybrid', 'hybridization', 'hybridoma', 'hybridomas', 'hybrids', 'hydrate', 'hydrazide', 'hydrazones', 'hydrazonoindolin2ones', 'hydrobiologia', 'hydrocephalus', 'hydrochloride', 'hydrocortisone', 'hydrodynamic', 'hydrogen', 'hydrolase', 'hydrolases', 'hydrological', 'hydrolysates', 'hydrolysis', 'hydrolyzing', 'hydropathy', 'hydrophilic', 'hydrophobic', 'hydrophytes', 'hydrosphere', 'hydroxocobalamin', 'hydroxy', 'hydroxyalkyl', 'hydroxyalkyl2', 'hydroxyalkyl2benzyl', 'hydroxycytidine', 'hydroxyvalerate', 'hyenas', 'hygiene', 'hygieneregeln', 'hygine', 'hygrothermal', 'hymenocallis', 'hymenoptera', 'hyorhinis', 'hype', 'hyperalgesia', 'hypercapnia', 'hypercholesterolaemic', 'hypercytokinemia', 'hyperdiverse', 'hyperexpression', 'hyperferritinmie', 'hyperglycaemiainduced', 'hyperigm', 'hyperimmune', 'hyperimmunglobulin', 'hyperinfection', 'hyperleucocytose', 'hyperlipidemia', 'hypermobility', 'hyperoxemia', 'hyperphosphorylation', 'hyperpolarization', 'hyperreactivity', 'hyperresponsiveness', 'hypersensitivity', 'hypertension', 'hypertensive', 'hypertonie', 'hypertriglyceridaemia', 'hypertrophic', 'hypertrophy', 'hypervariable', 'hypervirulence', 'hypervirulent', 'hypoalbuminemia', 'hypoallergen', 'hypokalemia', 'hypomorphic', 'hypoosmolality', 'hypoperfusion', 'hypothalamic', 'hypothermia', 'hypothesis', 'hypothetical', 'hypotonia', 'hypovolemic', 'hypox', 'hypoxaemia', 'hypoxemia', 'hypoxemic', 'hypoxia', 'hypoxiaregulated', 'hypoxiareoxygenation', 'hypoxic', 'hypsugo', 'hypsugopoxvirus', 'hytrosavirus', 'hz', 'ia', 'iabs', 'iacoangeli', 'iaeh', 'iasos', 'iav', 'ib', 'ibdv', 'iberian', 'ibis', 'ibr', 'ibuprofen', 'ibv', 'ic', 'ic43', 'icam1', 'icar', 'icd10', 'icd10cm', 'icd11', 'ice', 'iceberg', 'iceland', 'iceman', 'icheme', 'ichnoviruses', 'icon', 'iconverting', 'icosahedral', 'icovax', 'icpic', 'icr', 'ics', 'ictvsponsored', 'icu', 'icuacquired', 'icuadmitted', 'icus', 'icutreated', 'id', 'idaho', 'ideal', 'ideas', 'ideation', 'identic', 'identical', 'identically', 'identifiability', 'identificacin', 'identification', 'identified', 'identifies', 'identify', 'identifying', 'identifyisolate', 'identity', 'idiopathic', 'idiopathicimmunerelated', 'idiopathischen', 'idiosyncrasylike', 'idn5706', 'ido', 'idoorchestrated', 'idx184', 'iecaaraii', 'ifit1', 'ifit2', 'ifit2isg54', 'ifitm', 'ifitm1', 'ifitm3', 'ifitm32', 'ifitm3mediated', 'ifitm5', 'ifn', 'ifnalpha', 'ifnar', 'ifnar1', 'ifng', 'ifninduced', 'ifnl3', 'ifnl4', 'ifnlr1', 'ifns', 'ig', 'iga', 'igaactivated', 'igaigg', 'ige', 'igg', 'igg1', 'igg1igg2', 'igg2', 'igg2deficient', 'iggigm', 'iggs', 'igiene', 'igm', 'ignored', 'igpcrdrug', 'igy', 'ihr', 'ihre', 'ihrer', 'ii', 'iia', 'iiangiotensin', 'iib', 'iii', 'iiinduced', 'iipositive', 'iirestricted', 'ijdp', 'ikksnf', 'ikterus', 'il', 'il1', 'il12', 'il13', 'il13r', 'il15', 'il15mediated', 'il17', 'il17ainduced', 'il18bp', 'il1b', 'il22', 'il22il', 'il27', 'il28b', 'il35', 'il4', 'il4il', 'il6', 'il8', 'ilcs', 'ileal', 'ileostomy', 'ileum', 'ilex', 'ili', 'ilirviral', 'ill', 'illegal', 'illlogic', 'illness', 'illnesses', 'illuminating', 'illumination', 'illustrate', 'illustrative', 'iloprost', 'iltv', 'im', 'image', 'imagebased', 'imagerie', 'images', 'imaging', 'imagining', 'imatinibresistant', 'imbalance', 'imcd', 'imediated', 'imgvr', 'iminodipropionitrile', 'imipenem', 'immediate', 'immigrant', 'immigrants', 'immobilization', 'immortal', 'immortalization', 'immortalized', 'immunantwort', 'immune', 'immuneadjuvanting', 'immunerelated', 'immuneresponse', 'immunestimulated', 'immunesurveillance', 'immunetherapy', 'immunfunktion', 'immunglobulingabe', 'immunisation', 'immunisations', 'immunitaire', 'immunity', 'immunityrelated', 'immunization', 'immunizations', 'immunized', 'immunkom', 'immuno', 'immunoadsorption', 'immunoassay', 'immunoassays', 'immunobiological', 'immunobiology', 'immunoblot', 'immunoblotting', 'immunocomp', 'immunocompetency', 'immunocompetent', 'immunocompromis', 'immunocompromised', 'immunocytochemical', 'immunocytochemistry', 'immunod', 'immunodeficiencies', 'immunodeficiency', 'immunodeficient', 'immunodetection', 'immunodiagnostic', 'immunodominant', 'immunoelectron', 'immunoenhancement', 'immunofluorescence', 'immunogen', 'immunogenetic', 'immunogenic', 'immunogenicity', 'immunogenomics', 'immunogens', 'immunoglobulin', 'immunoglobulins', 'immunohistochemical', 'immunohistochemistry', 'immunoinformatic', 'immunoinformatics', 'immunolabelling', 'immunologic', 'immunological', 'immunologically', 'immunologie', 'immunologiste', 'immunology', 'immunome', 'immunomediated', 'immunomics', 'immunomodulating', 'immunomodulation', 'immunomodulatory', 'immunomorphologic', 'immunopathogenesis', 'immunopathology', 'immunoperoxidase', 'immunopharmacoinformatics', 'immunophenotyping', 'immunopotentiators', 'immunoprophylaxis', 'immunoproteasome', 'immunoreactivity', 'immunoreceptor', 'immunoregulation', 'immunoregulator', 'immunoregulatory', 'immunoscreening', 'immunosenescence', 'immunosensor', 'immunosensors', 'immunosorbent', 'immunostimulators', 'immunostimulatory', 'immunosuppressed', 'immunosuppression', 'immunosuppressive', 'immunotherapies', 'immunotherapy', 'immunsupprimierten', 'impact', 'impaction', 'impactors', 'impacts', 'impair', 'impaired', 'impairment', 'impairments', 'impairs', 'impart', 'impedance', 'impede', 'impediment', 'impediments', 'imperative', 'imperfect', 'impfbereitschaft', 'impfstoff', 'impfungen', 'impingement', 'implantable', 'implement', 'implementation', 'implemented', 'implicated', 'implication', 'implications', 'import', 'importance', 'important', 'importations', 'imported', 'importing', 'imprimatur', 'improve', 'improved', 'improvement', 'improves', 'improving', 'in', 'inability', 'inaccuracy', 'inactivate', 'inactivated', 'inactivation', 'inactive', 'inadequacy', 'inaugural', 'inborn', 'inbred', 'incentives', 'inching', 'incidence', 'incidental', 'incidents', 'incinerator', 'include', 'including', 'inclusion', 'inclusions', 'income', 'incompatibility', 'incorporate', 'incorporating', 'incorporation', 'incorrectly', 'increase', 'increased', 'increases', 'increasing', 'increasingly', 'incremental', 'incretin', 'incretinbased', 'incubation', 'independence', 'independency', 'independent', 'independently', 'indepth', 'index', 'india', 'indian', 'indiana', 'indicaciones', 'indicates', 'indicating', 'indication', 'indications', 'indicator', 'indicators', 'indices', 'indicus', 'indigenous', 'indigotica', 'indikation', 'indikationen', 'indirect', 'indirecte', 'indirectly', 'indirubin', 'indispensable', 'individual', 'individualbased', 'individualisation', 'individualized', 'individuallevel', 'individuals', 'individualto', 'indoasian', 'indolealkylamine', 'indoleamine', 'indoline', 'indonesia', 'indoor', 'induce', 'induced', 'inducedliver', 'inducement', 'inducer', 'induces', 'inducible', 'inducing', 'induction', 'induite', 'industrial', 'industrialised', 'industrie', 'industriel', 'industries', 'industry', 'indutch', 'ine', 'ineffective', 'ineffectiveness', 'inequalities', 'inequality', 'inescherichia', 'inexpensive', 'infancy', 'infant', 'infantile', 'infants', 'infanttoddler', 'infantum', 'infarct', 'infarcted', 'infarction', 'infecci', 'infecciones', 'infecciosa', 'infecciosas', 'infecciosos', 'infect', 'infected', 'infectiepreventie', 'infecties', 'infectieuses', 'infectieux', 'infectieziektebestrijding', 'infecting', 'infection', 'infectioncontrol', 'infectiondiary', 'infectioninduced', 'infectioninflammation', 'infections', 'infectious', 'infectiousness', 'infective', 'infectivity', 'infects', 'infeed', 'infektiologie', 'infektion', 'infektionen', 'infektionsassoziierte', 'infektionsepidemiologie', 'infektionsepidemiologische', 'infektionserreger', 'infektionskontrolle', 'infektionskrankheiten', 'infektionspr', 'infektionsprvention', 'infektionsrisiken', 'infektionsschutzrecht', 'infektise', 'inference', 'inferential', 'inferior', 'inferred', 'inferring', 'infertility', 'infestation', 'infield', 'infiltrate', 'infiltrates', 'infiltration', 'inflamed', 'inflammasome', 'inflammasomes', 'inflammation', 'inflammationrelated', 'inflammatories', 'inflammatorischen', 'inflammatory', 'inflight', 'inflorescences', 'influence', 'influenced', 'influences', 'influencia', 'influencing', 'influenza', 'influenzaa', 'influenzaah1n1', 'influenzaassociated', 'influenzalike', 'influenzapandemie', 'influenzapandemiemanagements', 'influenzapandemieplan', 'influenzapandemieplanung', 'influenzarelated', 'influenzaschweinegrippe', 'influenzavirus', 'influsim', 'influx', 'infolge', 'inform', 'informal', 'informatics', 'information', 'informational', 'informationen', 'informatique', 'informe', 'informed', 'informing', 'informs', 'infoveillance', 'infraglottic', 'inframe', 'infrastructure', 'infusion', 'ingesting', 'ingredient', 'ingreso', 'inhabituelles', 'inhalation', 'inhalational', 'inhalationinduced', 'inhalationinstillation', 'inhalativem', 'inhaled', 'inhaltsverzeichnis', 'inharmonious', 'inheritance', 'inherited', 'inhibit', 'inhibited', 'inhibiting', 'inhibition', 'inhibitions', 'inhibitor', 'inhibitors', 'inhibitory', 'inhibits', 'inhomogeneity', 'inhospital', 'inhouse', 'inhumane', 'initial', 'initiale', 'initiate', 'initiated', 'initiation', 'initiative', 'initiator', 'injection', 'injections', 'injured', 'injuries', 'injury', 'inklusive', 'inkrafttreten', 'inletoutlet', 'inmis', 'innamora', 'innate', 'innere', 'innocent', 'innocua', 'innovation', 'innovationen', 'innovations', 'innovative', 'innsbruck', 'inoculated', 'inoculation', 'inoculum', 'inos', 'inositol', 'inpatient', 'inpatients', 'inputs', 'inrdrug', 'ins', 'insect', 'insecticide', 'insectivorous', 'insects', 'insectspecific', 'insecttransmitted', 'insecurity', 'insemination', 'insensitive', 'insert', 'insertion', 'insertiondeletion', 'insertionsequence', 'inservice', 'inside', 'insider', 'insight', 'insights', 'insipidus', 'insitu', 'insoluble', 'inspection', 'inspiration', 'inspired', 'instability', 'institucional', 'institucionales', 'institut', 'institute', 'institutes', 'institution', 'institutional', 'institutions', 'instituts', 'instructive', 'instructs', 'instrument', 'instrumental', 'instruments', 'insufficiency', 'insufficient', 'insuffisance', 'insuffizienz', 'insulin', 'insulindependent', 'insulinlike', 'insulinreceptor', 'int', 'intact', 'intake', 'intakes', 'integral', 'integrate', 'integrated', 'integrating', 'integration', 'integrative', 'integrin', 'integrindependent', 'integrins', 'integrity', 'intellectual', 'intellectually', 'intelligence', 'intelligent', 'intended', 'intensification', 'intensity', 'intensive', 'intensivismo', 'intensivist', 'intensivists', 'intensivland', 'intensivmanagement', 'intensivmedizin', 'intensivmediziner', 'intensivmedizinische', 'intensivmedizinischen', 'intensivmedizinischer', 'intensivpatienten', 'intensivpflegepatienten', 'intensivpflichtigen', 'intensivstation', 'intensivtherapeutischen', 'intensivtherapie', 'intensivtherapiestation', 'intention', 'intentional', 'intentions', 'inter', 'interact', 'interacting', 'interaction', 'interactions', 'interactive', 'interactome', 'interactomics', 'interacts', 'intercellular', 'interchangeable', 'interconnected', 'intercontinental', 'intercountry', 'interdependence', 'interdependent', 'interdisciplinary', 'interdisziplin', 'interduck', 'interest', 'interesting', 'interface', 'interfaces', 'interfere', 'interference', 'interferencemediated', 'interferes', 'interfering', 'interferon', 'interferonalpha', 'interferonbeta', 'interferongamma', 'interferoninduced', 'interferoninducible', 'interferonlike', 'interferonmediated', 'interferonresponsive', 'interferons', 'interferonstimulated', 'interfollicular', 'intergroup', 'interhost', 'interim', 'interklinisch', 'interlaken', 'interleukin', 'interleukin1', 'interleukin10', 'interleukin18', 'interleukin2', 'interleukin22', 'interleukin4', 'interleukin4ppar', 'interleukin6', 'interleukin8', 'intermediate', 'intermediates', 'intermittent', 'intermolecular', 'intern', 'internacional', 'internal', 'internalization', 'internalized', 'international', 'internationale', 'internationalen', 'internationaler', 'internationales', 'internet', 'internetbased', 'internetofthings', 'internistenkongresses', 'internistische', 'internistischer', 'interoperability', 'interorganizational', 'interpeptide', 'interplay', 'interpretation', 'interpretations', 'interpreted', 'interpreting', 'interrater', 'interrelationship', 'interrupt', 'intersection', 'interspecies', 'interspersed', 'interstitial', 'interstitielle', 'interstitieller', 'intertwining', 'interval', 'intervention', 'interventional', 'interventions', 'interview', 'interviews', 'intestinal', 'intestinalis', 'intestinalmucosaassociated', 'intestine', 'intestines', 'intimacy', 'intolerance', 'intoxication', 'intra', 'intraabdomineller', 'intraarterial', 'intracellular', 'intracerebral', 'intracranial', 'intracrine', 'intractable', 'intradermal', 'intraepithelial', 'intraerythrocytic', 'intrahepatic', 'intrahost', 'intramolecular', 'intramuscular', 'intranasal', 'intranasally', 'intraneuronal', 'intraoperative', 'intraparenchymal', 'intrapartum', 'intraperitoneal', 'intrapulmonary', 'intrapurine', 'intrapyrimidine', 'intraspecies', 'intraspinal', 'intrathecal', 'intratracheal', 'intratypic', 'intrauterine', 'intravascular', 'intravenous', 'intraventricular', 'intravital', 'intriguingly', 'intrinsic', 'intrinsically', 'introduced', 'introducing', 'introduction', 'introductions', 'introductory', 'intron', 'intubated', 'intubation', 'inununoglobulin', 'invading', 'invariant', 'invasion', 'invasions', 'invasive', 'invasiveness', 'inventory', 'invernal', 'inversion', 'invertebrates', 'investigate', 'investigated', 'investigating', 'investigation', 'investigational', 'investigations', 'investigator', 'investition', 'investment', 'investments', 'invited', 'invitro', 'involved', 'involvement', 'involves', 'iodine', 'iododeoxyuridine', 'ion', 'ionic', 'ionisation', 'ionisationcleavable', 'ionization', 'ionizing', 'ions', 'iontophoretic', 'iontrap', 'iowa', 'ip', 'ipec', 'ipomoelin', 'iprotsub', 'ips1', 'ipsilateral', 'iqdiscrepant', 'irak1', 'iran', 'iranian', 'iraq', 'iras', 'irav', 'irbg74', 'ire1', 'ire1dependent', 'irea', 'ireland', 'ires', 'iresdependent', 'iresmediated', 'irestricted', 'irf', 'irf1', 'irf3dependent', 'irf5', 'iridovirus', 'iris', 'irish', 'iron', 'ironchelating', 'irradiation', 'irreversible', 'irritability', 'irritation', 'irs', 'is', 'is88500', 'isatin', 'isatins', 'isatis', 'isccm', 'ische', 'ischemia', 'ischemiareperfusion', 'ischemic', 'ischen', 'ischia', 'isg15', 'isg15crossreactive', 'isg20', 'isgs', 'isgylated', 'isgylome', 'islamabad', 'island', 'islands', 'isle', 'islet', 'islets', 'isnv', 'isoferritins', 'isoflurane', 'isoform', 'isoforms', 'isogenic', 'isoindoline', 'isolate', 'isolated', 'isolates', 'isolating', 'isolation', 'isoliquiritigenin', 'isomer', 'isomerase', 'isomeraselike', 'isomerisation', 'isomers', 'isopeptide', 'isoprinosine', 'isothermal', 'isotype', 'isotypespecific', 'isoxazole', 'isozymes', 'isppd', 'israel', 'israeli', 'issi', 'issue', 'issues', 'ist', 'isw', 'italian', 'italiana', 'italics', 'italy', 'itch', 'item', 'iterative', 'itraqcoupled', 'its1', 'its2', 'iubs', 'iv', 'ivanovii', 'ivermectin', 'ivi', 'ivig', 'ivoire', 'iwa', 'ixodes', 'ixodidae', 'jab', 'jacalinrelated', 'jacchus', 'jack', 'jacked', 'jackknife', 'jahre', 'jahreskongress', 'jahrestagung', 'jail', 'jak', 'jakstat', 'jakstat1', 'jamaican', 'jamaicensis', 'janerio', 'january', 'januase', 'janus', 'japan', 'japanese', 'japonicae', 'japonicum', 'jaws', 'jc', 'jeddah', 'jejunal', 'jejuni', 'jejunum', 'jerusalem', 'jessore', 'jet', 'jev', 'jevinduced', 'jfh1', 'jhm', 'jiangsu', 'jihadist', 'jilin', 'jingzhou', 'jirovecii', 'jmk', 'jnk', 'jnkmediated', 'joannidis', 'job', 'john', 'join', 'joint', 'jong', 'jonge', 'jordan', 'joseph', 'journal', 'journals', 'journalwatchpcrj', 'journey', 'joy', 'js', 'jsls12015', 'jubatus', 'judged', 'jugendalter', 'jugendheilkunde', 'jugendmedizin', 'juglanin', 'juglone', 'julie', 'july', 'jump', 'jumping', 'jun', 'junction', 'junctions', 'june', 'junge', 'juni', 'junin', 'juniperus', 'junn', 'jurisdiction', 'jurkat', 'just', 'justice', 'justification', 'justify', 'justintime', 'juvenile', 'juxtamembrane', 'k14jb01', 'k88acpositive', 'kafue', 'kakkonto', 'kallikrein', 'kallistatin', 'kampf', 'kangfuxinye', 'kangtai', 'kann', 'kap', 'kapitel', 'kaposi', 'kaposis', 'kappa', 'kappab', 'kappadependent', 'kappaphycus', 'karbala', 'kardiovaskul', 'karl', 'kasai', 'katastrophe', 'kathmandu', 'katnal1', 'kaushue', 'kawasaki', 'kazakhstan', 'kb', 'kbv', 'kc', 'kcnk5', 'kd', 'kda', 'keep', 'keeping', 'keggin', 'kennis', 'kennisuitwisseling', 'kenya', 'keratan', 'keratin', 'keratinizing', 'keratinocyte', 'keratinocytes', 'keratitis', 'keratoconjunctivitis', 'kerch', 'kericho', 'ketamine', 'keto', 'ketone', 'key', 'keystone', 'keyword', 'keywords', 'kgf', 'ki', 'kibale', 'kibera', 'kidney', 'kids', 'killer', 'killing', 'killings', 'kilombero', 'kinase', 'kinasepositive', 'kinases', 'kinder', 'kinderchirurgie', 'kinderen', 'kinderkrankenpflege', 'kindern', 'kindes', 'kinetic', 'kinetics', 'king', 'kingdom', 'kingdoms', 'kinomewide', 'kinsith', 'kir21', 'kirligand', 'kit', 'kits', 'kittens', 'klassifikation', 'klaus', 'klebsiella', 'klimaschutzes', 'klinik', 'klinische', 'klinischen', 'klug', 'km', 'km22', 'knee', 'knob', 'knochenmarktransplantation', 'knockdown', 'knockdowns', 'knockout', 'knots', 'know', 'knowledge', 'knowledgebased', 'knowlesi', 'known', 'ko', 'koala', 'kobuvirus', 'koch', 'kognitive', 'kognitiver', 'kolin', 'kolonischmie', 'komat', 'kombucha', 'kommission', 'kommunen', 'kompetenz', 'komplexer', 'komplikationen', 'kondylome', 'kong', 'kongo', 'kongress', 'kongresspr', 'konsequenz', 'kontext', 'kontinuierliches', 'kontrollen', 'konzeptualisierung', 'koopmans', 'kopf', 'korea', 'korean', 'kosher', 'kotry', 'kpax2', 'kpna2', 'krankenhauses', 'krankenhaushygiene', 'krankenhausinfektionen', 'krankheit', 'krankheiten', 'krankheitsverlauf', 'krasnoozerskoye', 'krebspatienten', 'krinko', 'krise', 'kritische', 'krt5', 'ks', 'kshv', 'kumar', 'kunjin', 'kupffer', 'kurz', 'kuwait', 'kynurenic', 'kynurenine', 'kyoto', 'kyphosis', 'l1e6e7', 'l3t4cd4', 'la', 'lab', 'label', 'labelfree', 'labeling', 'labelled', 'labelling', 'laboratories', 'laboratory', 'laboratoryacquired', 'laboratorybased', 'laboratoryconfirmed', 'labral', 'labs', 'labsafety', 'labyrinth', 'laccase', 'lack', 'lacking', 'lacrimal', 'lactamase', 'lactate', 'lactation', 'lactic', 'lactiflora', 'lactis', 'lactobacillus', 'lactococcal', 'lactococcus', 'lactoferrin', 'lactulose', 'ladjuvant', 'lag3', 'lage', 'lagekonferenz', 'lagerstroemia', 'lagos', 'lahore', 'lait', 'lake', 'lambda', 'lambdoid', 'lamblia', 'lambs', 'lamc2', 'lamellae', 'lamellar', 'lamina', 'laminin', 'lammert', 'lamp', 'lancet', 'lancets', 'land', 'landscape', 'landscapes', 'landsea', 'landuse', 'language', 'languish', 'langzeitergebnisse', 'lanka', 'laos', 'lap', 'laparoscopic', 'laparoscopy', 'large', 'largeeddy', 'largeplaque', 'largescale', 'laribacter', 'larmediated', 'larval', 'larvatus', 'laryngeal', 'laryngotracheitis', 'larynx', 'las', 'laser', 'lasercapture', 'lassa', 'last', 'late', 'latency', 'latent', 'latently', 'later', 'lateral', 'lates', 'latest', 'latex', 'lathyrus', 'latin', 'latitude', 'lattice', 'lattices', 'launches', 'lavage', 'law', 'lawrence', 'laws', 'lay', 'layer', 'layers', 'layerstrain', 'laying', 'lazio', 'lbc', 'lc', 'lc3', 'lc3interacting', 'lcb2', 'lcmsms', 'lcmv', 'ldependent', 'ldlt', 'le', 'lead', 'leader', 'leaders', 'leadership', 'leading', 'leadless', 'leadlike', 'leads', 'leaf', 'leafnosed', 'leak', 'leaksyndrome', 'leap', 'learn', 'learned', 'learners', 'learning', 'learnings', 'learns', 'least', 'leave', 'leavell', 'leaves', 'lebanon', 'lebendspende', 'lebensbedrohliche', 'lebensbedrohlichen', 'lebensqualit', 'leber', 'leberchirurgie', 'lebertransplantation', 'leberversagen', 'leberversagens', 'lecb', 'lectin', 'lectincarbohydrate', 'lectine', 'lectins', 'lecture', 'lectures', 'led', 'lee', 'left', 'leftsided', 'leg', 'legacy', 'legal', 'legend', 'leghorn', 'legionella', 'legionnaires', 'legumain', 'lehrst', 'leider', 'leishimaniasis', 'leishmania', 'leishmaniasis', 'leishmaniavirus', 'leishmanicidal', 'leishmaniosis', 'leistungsf', 'leitlinie', 'leitlinien', 'leitsymptom', 'lelystad', 'lemierre', 'lemur', 'lendoscopie', 'length', 'lengthening', 'lenguaje', 'lens', 'lentiviral', 'lentiviralmediated', 'lentiviralvector', 'lentivirus', 'lentivirusmediated', 'lentivirustransduced', 'leo', 'leone', 'leopard', 'leopards', 'lepidoptera', 'lepidopteran', 'leptospira', 'leptospiral', 'leptospiravaccinated', 'leptospirosis', 'leptospirosisassociated', 'leptum', 'ler', 'lernen', 'les', 'leschenaulti', 'lesion', 'lesions', 'less', 'lessons', 'let', 'letalem', 'letaler', 'letea', 'lethal', 'letter', 'letters', 'leucine', 'leucocytes', 'leuconostoc', 'leuk', 'leukaemia', 'leukemia', 'leukemialymphoma', 'leukemias', 'leukemic', 'leukmie', 'leukmiepatient', 'leukocidin', 'leukocyte', 'leukocytederived', 'leukocytes', 'leukocytopenia', 'leukodystrophy', 'leukoencephalitis', 'leukoencephalopathy', 'leukonychia', 'leukopenia', 'leukoreduced', 'leukosis', 'leukotoxins', 'leukotrienes', 'leung', 'lev', 'level', 'levels', 'leveraging', 'levofloxacin', 'levofloxacinrelated', 'levofloxacinresistant', 'lewhan', 'lewis', 'lfa1', 'lgionellose', 'lglutamine', 'li', 'liaison', 'liaisons', 'liaoning', 'liberia', 'libraries', 'library', 'libres', 'licence', 'lichen', 'licorice', 'lie', 'lieu', 'life', 'lifecycle', 'lifeomics', 'lifethreatening', 'ligand', 'ligandprotein', 'ligands', 'ligase', 'ligases', 'ligated', 'light', 'lightresponsive', 'lignite', 'ligula', 'like', 'likelihood', 'likely', 'limb', 'limbic', 'limelight', 'liminaire', 'limit', 'limitations', 'limited', 'limitedresource', 'limits', 'lincrnap21', 'line', 'lineage', 'lineages', 'linear', 'linedependent', 'lines', 'lingering', 'lingual', 'lining', 'link', 'linkage', 'linkages', 'linkagespecific', 'linked', 'linking', 'links', 'linn', 'linoleic', 'linstitut', 'lintestin', 'lions', 'lipase', 'lipid', 'lipidated', 'lipidation', 'lipidationindependent', 'lipidbased', 'lipidcontaining', 'lipidome', 'lipidomic', 'lipidomics', 'lipids', 'lipocalin', 'lipogenesis', 'lipoid', 'lipopeptide', 'lipopeptides', 'lipophages', 'lipopolysaccharide', 'lipopolysaccharideinduced', 'lipoprotein', 'lipoproteins', 'liposomal', 'liposomecoupled', 'liposomeencapsulated', 'liposomeencapsulation', 'liposomenmediierter', 'liposomes', 'lipoteichoic', 'liquid', 'liquordiagnostik', 'lir', 'lisboa', 'lisbon', 'list', 'listeria', 'listeriolysin', 'lit', 'literacy', 'literatur', 'literature', 'little', 'littoralis', 'live', 'liveattenuated', 'lively', 'liver', 'liverlocalized', 'livers', 'lives', 'livestock', 'living', 'livingdonor', 'livivo', 'll37', 'lle', 'llen', 'lmp1', 'ln', 'lna', 'lncrnaprotein', 'lncrnas', 'load', 'loaded', 'local', 'localisation', 'locality', 'localization', 'localized', 'locally', 'located', 'locatelli', 'location', 'locations', 'loci', 'locked', 'locomotory', 'locus', 'loeffler', 'loewenkids', 'lofreq', 'logistics', 'lohnende', 'lohnt', 'lokobe', 'lombardy', 'lombroso', 'london', 'long', 'longacting', 'longdistance', 'longer', 'longest', 'longevity', 'longitudinal', 'longlasting', 'longlived', 'longread', 'longrun', 'longtail', 'longterm', 'longtermcare', 'longum', 'lonicerae', 'look', 'looking', 'looms', 'loop', 'loopmediated', 'loops', 'lorestan', 'loris', 'lorne', 'los', 'lose', 'losing', 'loss', 'lossoffunction', 'lost', 'louis', 'louise', 'louisiana', 'love', 'low', 'lowcost', 'lowdensity', 'lowdose', 'lower', 'lowerextremity', 'lowering', 'lowexpression', 'lowfidelity', 'lowincome', 'lowland', 'lowpathogenicity', 'lowphinduced', 'lowresource', 'lowtemperature', 'lox1', 'lozenges', 'lp', 'lps', 'lpsgaln', 'lpsinduced', 'lrf', 'lsectin', 'lsectincrd', 'lsign', 'lsm11', 'lt', 'lta', 'lta4h', 'ltii', 'ltiple', 'ltr', 'ltryptophan', 'ltype', 'luc', 'luciferase', 'luciferasebased', 'lucifugus', 'ludwig', 'luftwegsobstruktion', 'lumbar', 'lumbosacral', 'luminescent', 'luminex', 'lumping', 'lumpy', 'lung', 'lunge', 'lungen', 'lungenbefall', 'lungenerkrankungen', 'lungenersatzverfahren', 'lungenfibrosen', 'lungenkrankheiten', 'lungentoxizitt', 'lungentransplantation', 'lungentuberkulose', 'lungenversagen', 'lunglocalized', 'lungs', 'lupus', 'lur', 'lurks', 'lvii', 'ly', 'ly6c', 'lycorine', 'lycorineoleic', 'lycoris', 'lyme', 'lymph', 'lymphadenopathy', 'lymphangiogenic', 'lymphangitis', 'lymphatic', 'lymphoblastic', 'lymphoblastoid', 'lymphocyte', 'lymphocytemediated', 'lymphocytemyelin', 'lymphocytepredominant', 'lymphocytes', 'lymphocytic', 'lymphoepithelioma', 'lymphohistiocytosis', 'lymphohistiocytosisassociated', 'lymphoid', 'lymphokines', 'lymphoma', 'lymphomas', 'lymphopenia', 'lymphoproliferative', 'lymphotoxin', 'lymphotropic', 'lynx', 'lyophilized', 'lys315', 'lysine', 'lysis', 'lysophosphatidic', 'lysophosphatidylcholine', 'lysosomal', 'lysosomes', 'lysozyme', 'lyssaviruses', 'lysyl', 'lyt', 'lyt2', 'lytic', 'lytically', 'm13ko7', 'm1like', 'm2e', 'm2ehbc', 'maar', 'mab', 'mabs', 'mac', 'macaca', 'macaco', 'macaque', 'macaques', 'machine', 'machinery', 'machupo', 'macro', 'macrobiomolecules', 'macrod1', 'macrod2', 'macrodomain', 'macroevolutionary', 'macrolide', 'macrolidebased', 'macrolideresistant', 'macrolides', 'macromolecular', 'macromolecules', 'macronutrients', 'macrophage', 'macrophagemediated', 'macrophagemicroglia', 'macrophagemigration', 'macrophages', 'macropinocytosis', 'macropinocytosislike', 'macular', 'madagascar', 'made', 'madrid', 'madsbox', 'maedi', 'mafaa', 'mafosfamidepurged', 'mageg1interacting', 'magnesium', 'magnetic', 'magnification', 'magnitude', 'magnoliae', 'magnolol', 'mahabaleshwar', 'maharashtra', 'main', 'mainland', 'maintain', 'maintained', 'maintains', 'maintenance', 'maize', 'major', 'make', 'makes', 'making', 'malabsorption', 'malacia', 'maladie', 'maladies', 'malaria', 'malariaassociated', 'malariaendemic', 'malariainfected', 'malarial', 'malariaspecific', 'malawi', 'malaysia', 'malaysian', 'malditof', 'male', 'maleic', 'males', 'malformation', 'malian', 'malignancies', 'malignancy', 'malignant', 'malik', 'mallards', 'malnourished', 'malnutrition', 'malondialdehyde', 'malpractice', 'malsoor', 'maltophilia', 'mammaire', 'mammal', 'mammalian', 'mammalianadapting', 'mammals', 'mammarenaviral', 'mammary', 'man', 'manage', 'managed', 'management', 'managing', 'manahmen', 'mandatory', 'maneuvers', 'manifestation', 'manifestationen', 'manifestations', 'manifesting', 'manifesto', 'manifold', 'manila', 'manipulate', 'manipulated', 'manipulating', 'manipulation', 'manitoba', 'manmade', 'mann', 'mannan', 'manner', 'mannitol', 'mannose', 'mannosebinding', 'mannosespecific', 'mannosylated', 'manoeuvres', 'manpower', 'manson', 'manual', 'manufacture', 'manufacturing', 'manure', 'manures', 'manuscripts', 'many', 'map', 'map30', 'map3k7mtor', 'mapk', 'mapkap', 'mapkerk', 'mapped', 'mapping', 'maps', 'maputo', 'mar', 'marama', 'marburg', 'marc', 'marc145', 'march', 'marchapril', 'mare', 'marek', 'mareks', 'mares', 'marginreflex', 'marine', 'marion', 'maripa', 'maritime', 'marked', 'markedly', 'marker', 'markers', 'market', 'marketing', 'markets', 'marking', 'markov', 'markovian', 'marmorata', 'marmorated', 'marmoset', 'marmosets', 'marneffei', 'marr', 'marrow', 'marseilleviridae', 'martinique', 'mas', 'masao', 'masccisoo', 'masernschutzgesetzes', 'mask', 'masked', 'masking', 'masks', 'maskwearing', 'mass', 'massachusetts', 'masses', 'massgathering', 'massive', 'massively', 'masslike', 'mast', 'master', 'mastiff', 'mastitis', 'matched', 'matching', 'material', 'materials', 'materias', 'maternal', 'maternally', 'maternallyderived', 'mathematical', 'mati', 'matlab', 'matologie', 'matrices', 'matrix', 'matsuoka', 'matter', 'matters', 'matur', 'maturation', 'maurizio', 'mauro', 'max', 'maxillary', 'maxillofacial', 'maximal', 'maximus', 'may', 'mayan', 'mayaro', 'mayor', 'mbbsmph', 'mbds', 'mbl', 'mblc', 'mbp', 'mbrab', 'mbrcd', 'mcanique', 'mcl1', 'mcp1', 'mcsf', 'md', 'mda5', 'mdc', 'mdck', 'mdico', 'mdl', 'mds', 'mdx', 'mean', 'meanderings', 'meaningful', 'means', 'measles', 'measlesinduced', 'measure', 'measured', 'measurement', 'measurements', 'measures', 'measuring', 'meat', 'mecca', 'mechanical', 'mechanically', 'mechanics', 'mechanism', 'mechanismbased', 'mechanismen', 'mechanisms', 'mechanistic', 'mechanobiological', 'mechanopharmacology', 'meco', 'mecp2', 'med', 'medaka', 'medi', 'medi8852', 'media', 'mediante', 'mediastinum', 'mediate', 'mediated', 'mediates', 'mediating', 'mediator', 'mediators', 'medical', 'medically', 'medication', 'medications', 'medicina', 'medicinal', 'medicine', 'medicines', 'medienberichterstattung', 'medikamenteninduzierte', 'medikamenteninteraktionen', 'mediterranean', 'medium', 'mediumsized', 'medizin', 'medizinische', 'medizinischen', 'medulla', 'meerschweinchen', 'meet', 'meeting', 'meets', 'meg3', 'megacities', 'megaloblastic', 'mehr', 'mehrfachverletzten', 'meisterst', 'mekelle', 'mekerk', 'mekong', 'melanogaster', 'melanoleuca', 'melanoma', 'melanomas', 'melatonin', 'melatonincortisol', 'meld', 'meles', 'mellifera', 'mellitus', 'melphalan', 'melt', 'melting', 'member', 'members', 'membrane', 'membranebound', 'membranedestabilizing', 'membranedisruptive', 'membraneinterrupting', 'membraneless', 'membranes', 'membranous', 'membranoxygenierung', 'memish', 'memorial', 'memory', 'memorylike', 'men', 'mengovirus', 'meningitis', 'meningitisencephalitis', 'meningococcal', 'meningoencephalitis', 'meningoencephalomyelitis', 'meningokokken', 'meningoradiculomyelitis', 'menno', 'menschen', 'menschenverstand', 'menschlichen', 'mensen', 'mental', 'mentorship', 'meps', 'mercantour', 'mergentes', 'mergents', 'merging', 'merits', 'meropenem', 'merops', 'merozoite', 'mers', 'merscov', 'merseyside', 'mesalamine', 'mesangial', 'mesenchymal', 'mesh', 'meshwork', 'meso', 'mesoaccumbens', 'mesocricetus', 'mesostigmatid', 'mesothelinbased', 'mesothelioma', 'mess', 'message', 'messages', 'messenger', 'messengers', 'met', 'meta', 'metaanalyses', 'metaanalysis', 'metabarcoding', 'metabolic', 'metabolism', 'metabolite', 'metabolites', 'metabolize', 'metabolomic', 'metabolomics', 'metadata', 'metagenomic', 'metagenomics', 'metal', 'metallo', 'metalloprotease', 'metalloproteinase', 'metallothionein', 'metamodeling', 'metaphors', 'metapneumovirus', 'metarbolomics', 'metaregression', 'metastable', 'metastasectomy', 'metastases', 'metastasis', 'metastasisassociated', 'metastatic', 'metasynthesis', 'metatranscriptomics', 'meteorolgicos', 'meteorological', 'methamphetamineassociated', 'methanolic', 'methicillin', 'methicillinresistant', 'methionine', 'method', 'methoden', 'methodological', 'methodologies', 'methodology', 'methods', 'methoxybenzaldehyde', 'methyl', 'methylase', 'methylation', 'methylome', 'methyltransferase', 'meticillinresistant', 'metrics', 'metritis', 'metropolitan', 'metropolitana', 'mevalonate', 'mexicaanse', 'mexican', 'mexico', 'meyer', 'mf59', 'mf59adjuvanted', 'mg63', 'mgb', 'mhc', 'mhcexpressing', 'mhci', 'mhcii', 'mhealth', 'mhv', 'mhv3', 'mhv4', 'mhvjhm', 'mice', 'michael', 'micro', 'microanalysis', 'microangiopathies', 'microangiopathy', 'microarray', 'microarraybased', 'microarrays', 'microbe', 'microbeads', 'microbes', 'microbial', 'microbialcontaminants', 'microbicide', 'microbicides', 'microbiological', 'microbiologiques', 'microbiologists', 'microbiology', 'microbiome', 'microbiomegutbrain', 'microbiomes', 'microbiometranscriptome', 'microbiota', 'microbiotaassociated', 'microcalorimetric', 'microcapillary', 'microcarrier', 'microcephaly', 'microcephalyassociated', 'microchip', 'microcirculatory', 'microdissection', 'microdiverse', 'microdomains', 'microdroplets', 'microemulsions', 'microenvironment', 'microfilters', 'microflora', 'microfluidic', 'microfluidics', 'microginins', 'microglia', 'microgliaintrinsic', 'microglial', 'microglobulin', 'microlitre', 'micronanoparticles', 'microneedle', 'microneedles', 'microorganisms', 'microparasites', 'microparticlebased', 'microparticles', 'microplate', 'microplus', 'micropolymorphism', 'microporous', 'microrna', 'microrna21a3p', 'microrna34a', 'micrornabased', 'micrornalike', 'micrornamediated', 'micrornas', 'microsatellite', 'microsatellites', 'microscope', 'microscopic', 'microscopy', 'microsomal', 'microspheres', 'microstructure', 'microtubule', 'microvascular', 'microvesicle', 'microvesicles', 'microwave', 'midazolam', 'middle', 'middleincome', 'midgut', 'midkine', 'midlands', 'midseason', 'midst', 'midwestern', 'mie', 'mig', 'migrant', 'migrants', 'migrating', 'migration', 'migratory', 'mikroangiopathien', 'mikrobiologie', 'milan', 'milchglas', 'mild', 'mile', 'milestone', 'miliary', 'military', 'milk', 'millenium', 'millennium', 'miller', 'million', 'milstein', 'mimetics', 'mimic', 'mimicking', 'mimicry', 'mimiviridae', 'mimivirus', 'mimotopes', 'mimox', 'min', 'minas', 'mind', 'mindset', 'mined', 'minefield', 'mineralising', 'mineraloilspread', 'minerva', 'mini', 'miniature', 'minibody', 'minibronchoalveolar', 'minigene', 'minimal', 'minimally', 'minimaxing', 'minimieren', 'minimize', 'minimizing', 'mining', 'minion', 'ministers', 'mink', 'minnesota', 'minor', 'minority', 'mint3apba3', 'minutes', 'miocarditis', 'miologie', 'mip', 'mip1beta', 'mipepbase', 'mique', 'mir', 'mir1306', 'mir181b', 'mir1883p', 'mir21', 'mir23a', 'mir26a', 'mir30b', 'miracles', 'mirna', 'mirnalike', 'mirnomes', 'miro1', 'mis', 'miscellanea', 'mischer', 'misdiagnosis', 'misdirected', 'mise', 'miseq', 'misfolding', 'mislocalisation', 'mismatch', 'mismatched', 'misoprostol', 'missense', 'misshapen', 'missing', 'mistakes', 'mistrust', 'misuse', 'mit', 'mitarbeiterinnen', 'mites', 'mitigate', 'mitigates', 'mitigation', 'mitis', 'mitochondria', 'mitochondrial', 'mitochondriarelated', 'mitogen', 'mitogenactivated', 'mitogeninduced', 'mitogenomics', 'mitogens', 'mitomycin', 'mitophagy', 'mitral', 'mitteilung', 'mitteilungen', 'mitteilungsseiten', 'mittel', 'mittierten', 'mix', 'mixed', 'mixing', 'mixture', 'miyazaki', 'mizoram', 'mizoribine', 'ml29', 'mlkl', 'mm', 'mma', 'mmc', 'mmp8', 'mnmc', 'mnmeg', 'mo', 'mobile', 'mobilehealth', 'mobilise', 'mobilised', 'mobility', 'mobilization', 'modalities', 'modality', 'mode', 'model', 'modelbased', 'modeling', 'modelings', 'modell', 'modelling', 'modelo', 'models', 'moderate', 'moderately', 'moderates', 'modern', 'modernen', 'moderner', 'modernization', 'modernize', 'modes', 'modest', 'modifiable', 'modification', 'modifications', 'modified', 'modifiers', 'modifies', 'modifying', 'modular', 'modularity', 'modulate', 'modulated', 'modulates', 'modulating', 'modulation', 'modulators', 'module', 'moesin', 'moglobin', 'mohs', 'moieties', 'mokola', 'mold', 'molded', 'moldiness', 'mole', 'molecular', 'molecularbased', 'molecularly', 'molecule', 'moleculegrabbing', 'molecules', 'moleculestabilized', 'molestia', 'mollusca', 'molluscum', 'moloney', 'molt', 'molysierenden', 'momentum', 'momordica', 'monacense', 'monascus', 'monate', 'monday', 'monensin', 'money', 'mongolei', 'mongolia', 'monitor', 'monitored', 'monitoring', 'monitors', 'monkey', 'monkeypox', 'monkeypoxvirus', 'monkeys', 'monoadpribosylation', 'monoclonal', 'monocyte', 'monocytederived', 'monocytes', 'monocytesmacrophages', 'monocytic', 'monocytogenes', 'monodominant', 'monodon', 'monoglucuronide', 'monoinfected', 'monolayer', 'monomeric', 'mononegavirales', 'mononuclear', 'monophosphate', 'monopole', 'monotherapy', 'monoubiquitination', 'monovalent', 'monoxide', 'montagne', 'month', 'months', 'montpellierensis', 'montr', 'montreal', 'mood', 'moonlighting', 'moose', 'mopeia', 'mopeialassa', 'mophgozytisches', 'mops', 'moptoe', 'moral', 'morale', 'morbid', 'morbidity', 'morbillivirus', 'morelos', 'mori', 'morophology', 'morphinemediated', 'morphogenesis', 'morphogenetic', 'morpholines', 'morpholino', 'morpholinobased', 'morpholinos', 'morphologic', 'morphological', 'morphologically', 'morphologie', 'morphologist', 'morphology', 'morphometric', 'morphometry', 'mort', 'mortalit', 'mortality', 'mosaic', 'mosaics', 'mosmann', 'mosquito', 'mosquitoborne', 'mosquitoes', 'mother', 'motherinfant', 'mothers', 'motherto', 'motif', 'motifcontaining', 'motifs', 'motile', 'motivated', 'motivators', 'motor', 'motscl', 'mottle', 'mould', 'mount', 'mountain', 'mouse', 'mouseadapted', 'mousehuman', 'mousetrap', 'mousevk', 'moutan', 'mouth', 'mov10', 'move', 'movement', 'moves', 'moving', 'mozambique', 'mp12', 'mpfung', 'mph', 'mpp', 'mr', 'mrc', 'mri', 'mrna', 'mrnamediated', 'mrnas', 'mrsa', 'ms', 'ms2', 'msm', 'mspl', 'msson', 'mt', 'mt111', 'mtbrif', 'mtdna', 'mth', 'mtor', 'much', 'mucin', 'mucosa', 'mucosae', 'mucosal', 'mucositis', 'mucous', 'mucronata', 'mucus', 'multi', 'multiagent', 'multiantigen', 'multicellular', 'multicenter', 'multicentre', 'multicentric', 'multicistronic', 'multicompartment', 'multicomponent', 'multicriteria', 'multicycle', 'multiday', 'multidimensional', 'multidisciplinaire', 'multidisciplinary', 'multidrug', 'multidrugresistant', 'multienzyme', 'multiepitope', 'multiethnic', 'multifaceted', 'multiflorae', 'multifocal', 'multiforme', 'multifunctional', 'multigene', 'multihost', 'multilevel', 'multilocularis', 'multilocus', 'multimechanistic', 'multimethod', 'multimodal', 'multimodality', 'multinational', 'multiobjective', 'multiomics', 'multiorgan', 'multiorganism', 'multiparametric', 'multipartite', 'multiphoton', 'multiple', 'multiplesequence', 'multiplex', 'multiplexed', 'multiplication', 'multiprotein', 'multiregions', 'multiscale', 'multiserotype', 'multisite', 'multispecies', 'multistate', 'multistrain', 'multisystem', 'multisystemic', 'multitargeted', 'multitep', 'multitissue', 'multivalent', 'multivariate', 'multivesicular', 'multivisceral', 'multiyear', 'multocida', 'mumps', 'munc', 'mundo', 'mung', 'munich', 'murine', 'murinus', 'murphys', 'murray', 'musacearum', 'muscle', 'muscles', 'muscular', 'musculocutaneous', 'musculoskeletal', 'museum', 'muskelschmerzen', 'muss', 'muster', 'mutagen', 'mutagenesis', 'mutagenic', 'mutans', 'mutant', 'mutants', 'mutating', 'mutation', 'mutational', 'mutationresistant', 'mutations', 'muti', 'mutimodal', 'mva', 'mvavectored', 'mvbased', 'mwcnts', 'mx', 'mxa', 'myanmar', 'mycelial', 'mycn', 'mycobacterial', 'mycobacterium', 'mycophenolic', 'mycoplama', 'mycoplasma', 'mycoplasmas', 'mycoses', 'mycotoxicosis', 'mycotoxin', 'mycoviral', 'myd88', 'myd88dependent', 'myelin', 'myelinating', 'myelination', 'myelitis', 'myeloablative', 'myelodysplasia', 'myelodysplastic', 'myelofibrosis', 'myelogenous', 'myeloid', 'myeloischer', 'myeloma', 'myelomonocytic', 'myeloperoxidase', 'myelosuppressive', 'mykiss', 'mykobakteriosen', 'myoblast', 'myocardial', 'myocarditis', 'myocardium', 'myoelectrical', 'myofibroblast', 'myometrial', 'myopathies', 'myopathy', 'myopericarditis', 'myosin', 'myotis', 'myotubes', 'myricetin', 'myricitrin', 'mysteries', 'mysterious', 'mystery', 'myth', 'mythimna', 'mythos', 'myths', 'myxovirus', 'na', 'nabs', 'nacetyl', 'nacetylcysteine', 'nacetylgalactosamine', 'nacetylgalactosaminyltransferase', 'nacetylmannosamine', 'nach', 'nachsorge', 'nachweis', 'nachwuchspreises', 'nadph', 'naga', 'nairobi', 'nairos', 'nairovirus', 'naive', 'nakatpase', 'naked', 'nalp3', 'nam', 'name', 'names', 'namibia', 'namibian', 'naming', 'nano', 'nanocarriers', 'nanocomposite', 'nanodevices', 'nanodiamonds', 'nanoemulsions', 'nanofluidic', 'nanogel', 'nanohybrids', 'nanomaterials', 'nanomechanical', 'nanomechanics', 'nanomedicine', 'nanomedicines', 'nanoparticle', 'nanoparticlebased', 'nanoparticles', 'nanoplasmid', 'nanopore', 'nanorobot', 'nanoscale', 'nanoshells', 'nanostructure', 'nanostructures', 'nanotechnologic', 'nanotechnology', 'nanotechnologybased', 'nanovaccine', 'nanovaccines', 'nanowires', 'nanozno', 'nanshan', 'nanus', 'naphthalen', 'naphthoquinone', 'napn', 'naringenin', 'narkosebeatmung', 'narrative', 'narratives', 'narrow', 'nasal', 'nasoencephalitis', 'nasopharyng', 'nasopharyngeal', 'nasopharyngitis', 'nasopharynx', 'natality', 'nation', 'national', 'nationale', 'nationaler', 'nations', 'nationwide', 'native', 'nativelike', 'natriuretic', 'natrix', 'natural', 'naturalistic', 'naturally', 'naturallyoccurring', 'nature', 'nava', 'nave', 'nazionale', 'ncd13', 'ncer', 'nci', 'ncih292', 'ncimb', 'nckrelated', 'ncov', 'ncri', 'ncrna', 'ncrosantes', 'ncs', 'nder', 'ndern', 'ndigkeiten', 'ndliche', 'ndm', 'ndrome', 'ndv', 'near', 'nearby', 'nearfatal', 'nearinfrared', 'nearly', 'nearpatient', 'nearterm', 'nebovirus', 'nebulisation', 'nebulizer', 'necator', 'necessary', 'necessitating', 'necessity', 'neck', 'necroinflammation', 'necrolysis', 'necrophorum', 'necroptosis', 'necrosis', 'necrotic', 'necrotising', 'necrotizing', 'nedd4', 'nederland', 'need', 'needed', 'needle', 'needlestick', 'needs', 'nef', 'negative', 'negatively', 'negativestrand', 'negativity', 'neglectable', 'neglected', 'negligible', 'negotiations', 'neighborhood', 'neisseria', 'nekrotisierende', 'nelfinavir', 'nematode', 'nematodes', 'nemesis', 'nemuro', 'nen', 'neo', 'neoantigen', 'neoformans', 'neol', 'neonatal', 'neonate', 'neonates', 'neonatologie', 'neonatologischen', 'neonatology', 'neoplasia', 'neoplasms', 'neoplastic', 'neopopulism', 'neopterin', 'neoromicia', 'neospora', 'neosporosis', 'neotropical', 'nepal', 'nepalese', 'nephritis', 'nephrology', 'nephropathia', 'nephropathogenic', 'nephropathy', 'nephrotic', 'nerve', 'nerves', 'nervous', 'nestedness', 'net', 'netherlands', 'network', 'networking', 'networks', 'neu', 'neue', 'neuen', 'neuer', 'neues', 'neugeborenen', 'neuigkeiten', 'neumann', 'neumon', 'neumona', 'neun', 'neural', 'neuralgia', 'neurally', 'neuraminidase', 'neuraminidaseremmers', 'neuraminidases', 'neuraxial', 'neuritis', 'neuroantigen', 'neurobiology', 'neuroblastom', 'neuroblastoma', 'neurochir', 'neurocognitive', 'neurocritical', 'neurodegeneration', 'neurodegenerative', 'neuroendocrine', 'neuroevolutionary', 'neurofilament', 'neurogenic', 'neuroimmunology', 'neuroinflammation', 'neuroinvasiveness', 'neurologic', 'neurological', 'neurologischer', 'neurology', 'neuromonitoring', 'neuromuscular', 'neuron', 'neurona', 'neuronal', 'neuronalspecific', 'neurons', 'neuronspecific', 'neuropathogenesis', 'neuropathogenicity', 'neuropathological', 'neuropathologische', 'neuropathy', 'neuropeptides', 'neuroprotection', 'neuroprotective', 'neuropsychiatric', 'neuroscience', 'neurosurgery', 'neurosurgical', 'neuroterrorism', 'neurotoxicity', 'neurotropic', 'neurotropism', 'neurovascular', 'neurovirulence', 'neurovirulent', 'neuter', 'neutral', 'neutralisation', 'neutralising', 'neutralization', 'neutralize', 'neutralizes', 'neutralizing', 'neutropenia', 'neutropenic', 'neutrophil', 'neutrophilic', 'neutrophils', 'nevada', 'never', 'new', 'newborn', 'newborns', 'newcastle', 'newer', 'newly', 'newonset', 'newport', 'newqis', 'news', 'newsletter', 'newspaper', 'newsroom', 'newtyped', 'next', 'nextgeneration', 'nf', 'nfb', 'nfe2l2', 'nfkb', 'nftige', 'ngeo', 'nglycans', 'nglycosylation', 'ngr', 'ngs', 'ngsbased', 'nheterocyclic', 'nhs', 'nhydroxy', 'nhydroxyphthalimide', 'niaid', 'nica', 'nicaraguan', 'nicarbazin', 'nice', 'niche', 'nichedefining', 'niches', 'nicht', 'nichtinfektise', 'nichtinvasive', 'nichtpharmakologisches', 'nichtpulmonale', 'nichttuberkul', 'niclosamide', 'nicotine', 'nicotinespecific', 'nicotinic', 'nicu', 'nidality', 'nidovirus', 'niere', 'nieuwe', 'nieuws', 'nigeria', 'nightmare', 'nih', 'nihr', 'nile', 'niloticus', 'nine', 'nineveh', 'ningocoque', 'ninth', 'nios', 'nipah', 'nipponicae', 'nitazoxanide', 'nitrate', 'nitric', 'nitride', 'nitrile', 'nitrite', 'nitro', 'nitrosamine', 'niv', 'nivolumab', 'nk', 'nkg2d', 'nkt', 'nl4', 'nl63', 'nlinked', 'nlphl', 'nlrp3', 'nlrp3caspase1', 'nm', 'nme2h', 'nmr', 'nmyc', 'nn', 'nnalign', 'nnen', 'nnschicht', 'nnv', 'noa36', 'nobel', 'nocere', 'noctuidae', 'nod', 'nodavirus', 'node', 'nodeal', 'nodeomics', 'nodes', 'nodular', 'nodulation', 'nogob', 'noise', 'nologie', 'nombre', 'nombreuses', 'nomenclature', 'nominated', 'nominations', 'non', 'nona', 'nonaids', 'nonalcoholic', 'nonanatural', 'nonanticoagulant', 'nonantimicrobial', 'nonapical', 'nonaqueous', 'nonards', 'nonatopic', 'nonbacterial', 'nonbronchoscopic', 'noncanonical', 'noncell', 'nonclassical', 'nonclinical', 'noncoding', 'noncomplete', 'noncongenital', 'nonconservative', 'noncontact', 'nondemyelinating', 'nondesmoglein', 'nondisplaced', 'nondisposable', 'nonelderly', 'nonendemic', 'nonenveloped', 'nonenzymatic', 'nonfatal', 'nonformal', 'nonhemagglutinating', 'nonhematological', 'nonhepatic', 'nonhiv', 'nonhodgkin', 'nonhuman', 'nonhydrolyzable', 'nonidentical', 'nonimmunocompromised', 'noninfected', 'noninfectious', 'noninfluenza', 'nonintegrin', 'nonintensive', 'noninvasive', 'nonlethal', 'nonlinear', 'nonlymphoid', 'nonmalignant', 'nonmethamphetamine', 'nonms', 'nonmyeloablative', 'nonnative', 'nonneoformans', 'nonneoplastic', 'nonneutral', 'nonneutropenic', 'nonnucleoside', 'nonoverlapping', 'nonpancreatic', 'nonparametric', 'nonparenteral', 'nonpathogenic', 'nonpermissive', 'nonpharmaceutical', 'nonpneumonic', 'nonpregnant', 'nonprescription', 'nonpulmonary', 'nonrandomized', 'nonrecombinant', 'nonrespiratory', 'nonrodent', 'nonselective', 'nonsensemediated', 'nonsensory', 'nonsevere', 'nonspecific', 'nonstandard', 'nonstationarity', 'nonsteroid', 'nonstreptococcal', 'nonstructural', 'nonsurgical', 'nontargeted', 'nontemplated', 'nontraditional', 'nontransplant', 'nontraumatic', 'nontreg', 'nontuberculous', 'nontumor', 'nonuv', 'nonvenereal', 'nonvh169', 'nonviral', 'noradrenaline', 'norbert', 'norepinephrine', 'norkurarinol', 'norm', 'normal', 'normalization', 'normative', 'norovirus', 'noroviruses', 'noroviruslike', 'norovirusspecific', 'north', 'northeastern', 'northern', 'northsouth', 'northwest', 'northwestern', 'norwalk', 'norway', 'norwegian', 'nos2', 'nose', 'nosebrain', 'nosema', 'nosocomial', 'nosocomiale', 'nosokomiale', 'nosokomialer', 'notch1', 'note', 'notes', 'notfall', 'notfallmedizin', 'notfallmedizinische', 'notfallplan', 'notflle', 'nothing', 'notiert', 'notification', 'notruf', 'notwendigkeit', 'nourrison', 'nourrisson', 'nouveau', 'nouveauts', 'nouvelle', 'novartis', 'novartisimpfstoffs', 'novel', 'novelty', 'november', 'novo', 'nowcasting', 'nox', 'nox2', 'nox2deficient', 'noxp38', 'np', 'npc', 'npc1', 'npl4', 'nps', 'npv', 'nr', 'nrdna', 'ns', 'ns1', 'ns1elicited', 'ns1truncated', 'ns2a', 'ns2b', 'ns2bns3', 'ns2bns3pro', 'ns3', 'ns3interacting', 'ns4a', 'ns4b', 'ns5', 'ns5a', 'ns5ans5b', 'ns6', 'nschter', 'nscirir', 'nsclc', 'nsg', 'nsp11', 'nsp12coding', 'nsp2', 'nsp3', 'nsp4', 'nsp5', 'nss', 'nssdeleted', 'nstemi', 'nstliche', 'nsubstituted', 'nterminal', 'nterminus', 'ntesis', 'ntp', 'ntprobnp', 'nuanced', 'nuclear', 'nucleases', 'nuclei', 'nucleic', 'nucleobase', 'nucleocapsid', 'nucleolar', 'nucleolarnucleoplasmic', 'nucleolus', 'nucleopolyhedrovirus', 'nucleoprotein', 'nucleoproteins', 'nucleoside', 'nucleosides', 'nucleosome', 'nucleotide', 'nucleotidegated', 'nucleotides', 'nucleus', 'nude', 'nuestra', 'nueva', 'nuevas', 'nuevo', 'nuisance', 'null', 'number', 'numbers', 'numcer', 'numeracy', 'numerate', 'numerical', 'numerically', 'nun', 'nurse', 'nurseries', 'nurses', 'nursing', 'nursings', 'nurturing', 'nutrient', 'nutrients', 'nutrition', 'nutritional', 'nuts', 'nutzen', 'nutzung', 'nw', 'nxf1', 'nyc', 'nycticebus', 'o157h7', 'oas1', 'oas3', 'oath', 'oatp', 'obere', 'obese', 'obesity', 'obituary', 'object', 'objectifs', 'objectives', 'obliterans', 'obliteration', 'oblitermscurrent', 'observable', 'observational', 'observations', 'observed', 'observer', 'obst', 'obstetric', 'obstetrical', 'obstruction', 'obstructiva', 'obstructive', 'obtained', 'oc2', 'oc43', 'occlusion', 'occult', 'occupational', 'occur', 'occurrence', 'occurring', 'ocean', 'oceania', 'oceanic', 'ochraceus', 'ochratoxina', 'oct4', 'octaguanidinium', 'octamer', 'octarepeat', 'octasulfate', 'october', 'octocorals', 'ocular', 'oder', 'odontogenic', 'odontoglossum', 'odontoid', 'oedema', 'oestroneoestradiol', 'of', 'off', 'offense', 'offered', 'offers', 'office', 'offices', 'officials', 'officinalis', 'offlabel', 'offloading', 'offs', 'offspring', 'ofhelix', 'ofin', 'oft', 'oglycosylation', 'oh', 'ohio', 'oil', 'oiladjuvanted', 'oilinwater', 'oils', 'okada', 'okavango', 'ola', 'old', 'older', 'oldwonder', 'oleanolic', 'oleic', 'olfactory', 'oligoclonal', 'oligodendrocyte', 'oligodendrocytes', 'oligodendroglial', 'oligodeoxynucleotides', 'oligomer', 'oligomeric', 'oligomerization', 'oligomers', 'oligonucleotide', 'oligonucleotidebased', 'oligonucleotides', 'oligosaccharides', 'oligosaccharidylsubstituted', 'olivaceus', 'olive', 'olympic', 'oman', 'omics', 'ompalike', 'ompb', 'on', 'onat', 'onchocerca', 'oncocytoma', 'oncogene', 'oncogenes', 'oncogenesis', 'oncogenic', 'oncological', 'oncologique', 'oncology', 'oncolytic', 'oncoproteins', 'oncorhynchus', 'one', 'onechild', 'onemedicine', 'oneplasmid', 'onepot', 'onestep', 'oneyear', 'ongoing', 'onkologen', 'onkologie', 'onkologische', 'online', 'onmycoplasma', 'onset', 'onsite', 'ontario', 'onto', 'ontological', 'ontology', 'ontologybased', 'onyx015', 'oocyte', 'op', 'opa', 'opacities', 'opacity', 'open', 'openair', 'openlabel', 'openmpbased', 'openness', 'operate', 'operating', 'operation', 'operational', 'operationalising', 'operationalizing', 'operationen', 'operations', 'operationstraumas', 'operativen', 'operatives', 'opinion', 'opinions', 'oportunidad', 'oportunidades', 'opportunistic', 'opportunities', 'opportunity', 'opposing', 'opsonizing', 'optaids', 'optic', 'optical', 'optically', 'opticnerve', 'optimal', 'optimism', 'optimismpessimism', 'optimization', 'optimize', 'optimized', 'optimizes', 'optimizing', 'option', 'optionen', 'options', 'optofluidic', 'optogenetics', 'oral', 'orale', 'orally', 'orbivirus', 'orchestrating', 'orchid', 'orchidectomized', 'orchitis', 'order', 'ordered', 'orders', 'oreochromis', 'orf', 'orf1', 'orf2', 'orf3', 'orf6', 'orfs', 'org', 'organ', 'organe', 'organelles', 'organellespecific', 'organfunktionen', 'organic', 'organisatie', 'organisation', 'organisations', 'organising', 'organism', 'organismal', 'organisms', 'organization', 'organizational', 'organizations', 'organized', 'organizing', 'organocatalyzed', 'organoprotection', 'organotin', 'organs', 'organspecific', 'organspender', 'organtransplantationen', 'oriental', 'orientalis', 'orientation', 'orientational', 'oriented', 'orienter', 'orientia', 'origen', 'origin', 'originate', 'originated', 'originating', 'origins', 'orl', 'orma', 'ormycoplasma', 'ornithogalum', 'oropharyngeal', 'orphan', 'orthobunyavirus', 'orthomyxovirus', 'orthopaedic', 'orthopdie', 'orthopedic', 'orthoreovirus', 'orthotopic', 'orthotropic', 'oscillation', 'oscillations', 'oscillatory', 'oseltamivir', 'oseltamivirperamivir', 'oseltamivirresistant', 'oseltamivirzanamivir', 'oshitani', 'oslers', 'oslerweberrendu', 'ospa', 'osteoarthritis', 'osteoarthropathy', 'osteoblast', 'osteoblastlike', 'osteoclast', 'osteogenic', 'osteomyelitis', 'osteonecrosis', 'osteopontin', 'osteoporosis', 'osteosarcoma', 'ostertagi', 'ostertagia', 'ostriches', 'others', 'otitis', 'otolaryngologist', 'otorrinolaringol', 'otras', 'otros', 'otu', 'ou', 'ouderen', 'outbreak', 'outbreaks', 'outbreaktools', 'outbred', 'outcome', 'outcomes', 'outdoor', 'outer', 'outflow', 'outline', 'outlook', 'outofhospital', 'outpatient', 'outpatients', 'output', 'outs', 'outside', 'outsider', 'outstanding', 'ovale', 'ovarian', 'ovariectomized', 'ovaries', 'ovary', 'over', 'overall', 'overcome', 'overcoming', 'overdose', 'overestimation', 'overexpression', 'overkill', 'overlap', 'overlapping', 'overload', 'overlooked', 'overproduce', 'overproduction', 'overseas', 'oversialylated', 'overt', 'overview', 'oviducts', 'ovine', 'ovo', 'ovulation', 'owl', 'owners', 'ox40', 'oxa', 'oxidase', 'oxidation', 'oxidative', 'oxide', 'oxidecoated', 'oxidemediated', 'oxidoreductases', 'oxoindolin', 'oxyg', 'oxygen', 'oxygenase1', 'oxygenase1expressing', 'oxygenasecarbon', 'oxygenation', 'oxygenationsupported', 'oxygenator', 'oxygenic', 'oxymatrine', 'oxymetazoline', 'oxytocin', 'ozone', 'p110', 'p1coding', 'p2x7', 'p2y12', 'p2y12independent', 'p53mediated', 'p62s', 'p75ntrassociated', 'pa', 'pacbio', 'pacemakers', 'paciente', 'pacientes', 'pacific', 'pacificus', 'pacing', 'pacinginduced', 'package', 'packaging', 'paco2', 'pactinduced', 'padlock', 'paediatic', 'paediatric', 'paediatrician', 'paediatrics', 'paeonia', 'page', 'pages', 'pain', 'painless', 'pair', 'pairs', 'pakistan', 'pakistani', 'palate', 'palbociclib', 'paleoherb', 'paleoviruses', 'palliative', 'pallidum', 'palmatum', 'palmitoylation', 'palmitoyltransferase', 'palmtop', 'pals1', 'palsy', 'paludisme', 'pamp', 'pamphlet', 'pan', 'panad3', 'pancreas', 'pancreatic', 'pancreatitis', 'pancytopenia', 'pand', 'panda', 'pandemia', 'pandemic', 'pandemics', 'pandemie', 'pandemien', 'pandemiepl', 'pandemische', 'pandmie', 'pandora', 'panebolavirus', 'panel', 'panels', 'panencephalitis', 'panenterovirus', 'paneuropean', 'pangenome', 'panhandle', 'panic', 'paniscus', 'pankreatitis', 'panleukopenia', 'panspermia', 'panthera', 'panthers', 'panton', 'pantonvalentine', 'pantonvalentinleukozidin', 'pao', 'papain', 'papainlike', 'papaya', 'papb1', 'papel', 'paper', 'paperbased', 'papers', 'papg', 'papilloma', 'papillomavirus', 'papillomaviruses', 'papova', 'papovavirus', 'papua', 'papyrifera', 'par', 'para', 'paracetamol', 'paracino', 'paracrine', 'paracrinology', 'paradigm', 'paradigms', 'paradox', 'paradoxical', 'paraguay', 'parahaemolyticus', 'parainfluenza', 'paralemmin3', 'paralichthys', 'parallel', 'paralog', 'paralogous', 'paralysis', 'paramecium', 'paramedic', 'parameter', 'parameters', 'paramyxoviridae', 'paramyxovirinae', 'paramyxovirus', 'paramyxovirus1', 'paramyxoviruses', 'paraneoplastic', 'paraphenylenediamine', 'parapneumonic', 'paraquat', 'paraquatinduced', 'parareal', 'parasitaemia', 'parasite', 'parasitemia', 'parasites', 'parasitic', 'parasitism', 'parasitized', 'parasuis', 'parasympathetic', 'paratuberculosis', 'paraventricular', 'pardinus', 'parechovirus', 'parenchyma', 'parenchymal', 'parenchymatse', 'parent', 'parental', 'parenteral', 'parenterally', 'parents', 'paresthesias', 'paris', 'park', 'parkinmediated', 'parkinson', 'parkinsonism', 'parkinsonismdementia', 'parkinsons', 'parks', 'parotid', 'parotitis', 'parp1', 'parrots', 'pars', 'part', 'parte', 'partetravirus', 'partial', 'partialis', 'partially', 'participant', 'participantcollected', 'participants', 'participates', 'participation', 'particle', 'particles', 'particularits', 'particulate', 'partie', 'partitioning', 'partner', 'partners', 'partnerships', 'party', 'parv4', 'parvifolia', 'parvoviral', 'parvovirus', 'parvoviruses', 'parvoviruspositive', 'parvum', 'passage', 'passengers', 'passerine', 'passive', 'passport', 'past', 'paste', 'pasteur', 'pasteurella', 'pastoris', 'pat', 'patagonicus', 'patch', 'patches', 'patchouli', 'patchy', 'patella', 'patent', 'patents', 'path', 'pathobiology', 'pathogen', 'pathogenese', 'pathogenesis', 'pathogenetic', 'pathogenic', 'pathogenicity', 'pathogens', 'pathogenspecific', 'pathologic', 'pathological', 'pathologie', 'pathologies', 'pathologists', 'pathology', 'pathophysiologic', 'pathophysiological', 'pathophysiologie', 'pathophysiology', 'paths', 'pathway', 'pathways', 'patient', 'patientcontrolled', 'patienten', 'patientoccupied', 'patients', 'patrick', 'pattern', 'patternrecognition', 'patterns', 'paucimannose', 'paul', 'paulo', 'paulownia', 'paulskirche', 'pausing', 'pave', 'pavetta', 'paving', 'pax', 'pay', 'payne', 'paywall', 'pb', 'pb1f2', 'pb2', 'pb2588', 'pbmc', 'pbrb', 'pc12', 'pcb', 'pcd', 'pclsr', 'pcp', 'pcr', 'pcrbased', 'pcrelectrospray', 'pd', 'pdcs', 'pde4', 'pdf', 'pdiatriques', 'pdm09', 'pdpc', 'pea', 'peace', 'peacock', 'peak', 'peaks', 'pearlwort', 'peculiar', 'pedi', 'pediatra', 'pediatric', 'pediatrics', 'pedigreed', 'pediococcus', 'peduncular', 'pedv', 'peep', 'peginterferon', 'pegylated', 'peiris', 'pelargonium', 'pelves', 'pelvic', 'pemphigus', 'penaeid', 'penaeus', 'pendelluft', 'penetrate', 'penetration', 'penguins', 'penicillamine', 'penicillin', 'penicilliosis', 'penicillium', 'penile', 'peninsula', 'pennsylvania', 'pension', 'pentaacetic', 'pentapeptide', 'pentraxin', 'people', 'peoplecentred', 'peperomia', 'pepgrs', 'pepitope', 'peplomer', 'pepmapper', 'pepper', 'peptidase', 'peptidase4', 'peptidases', 'peptide', 'peptidebased', 'peptideconjugate', 'peptideconjugated', 'peptidemediated', 'peptidemhc', 'peptides', 'peptidespecific', 'peptidoglycan', 'peptidome', 'peptidomic', 'peptidyltransfer', 'per', 'perceived', 'perception', 'perceptions', 'percutaneous', 'perdida', 'perennial', 'perfil', 'perforated', 'perforation', 'perforin', 'perform', 'performance', 'performativity', 'perfusion', 'perhaps', 'peribunyaviridae', 'pericytes', 'peril', 'perinatal', 'period', 'periodontal', 'periods', 'perioperative', 'peripartale', 'peripheral', 'peripherally', 'peritoneal', 'peritoneum', 'peritonitis', 'peritrophic', 'perivascular', 'perk', 'perkinsus', 'permanent', 'permeability', 'permissive', 'permissivity', 'permit', 'pernix', 'peroxidation', 'peroxisome', 'persian', 'persica', 'persistence', 'persistent', 'persistently', 'persisting', 'personal', 'personalised', 'personalized', 'personnel', 'personnels', 'personnes', 'persons', 'persontoperson', 'perspectivas', 'perspective', 'perspectives', 'perspicillata', 'pertaining', 'pertinent', 'perturbation', 'perturbations', 'perturbed', 'perturbs', 'pertussis', 'peru', 'perv', 'pervasive', 'pessimism', 'pest', 'peste', 'pestis', 'pestiviruses', 'pet', 'petits', 'petra', 'petri', 'peyer', 'pflanzenprodukten', 'pfs4845', 'pfswib', 'pglycoprotein', 'pgrs', 'ph', 'ph1n1', 'phaeohyphomycosis', 'phaeomoniellachlamydospora', 'phage', 'phagedisplayed', 'phagelike', 'phagocyte', 'phagocytes', 'phagocytic', 'phalaenopsis', 'phantom', 'pharmaceutical', 'pharmaceuticals', 'pharmachild', 'pharmacists', 'pharmacokinetic', 'pharmacokinetics', 'pharmacological', 'pharmacologically', 'pharmacology', 'pharmacophore', 'pharmacotherapy', 'pharmacy', 'pharmakologie', 'pharyngitis', 'pharyngotonsillitis', 'phase', 'phases', 'phasic', 'phbv', 'pheasant', 'pheics', 'phellodendron', 'phenanthrenes', 'phenanthroquinolizidines', 'phenazine', 'phenolic', 'phenolrich', 'phenomenon', 'phenotype', 'phenotypes', 'phenotypic', 'phenotyping', 'phenylalanine', 'phenylbenzamides', 'pheochromocytoma', 'phever', 'phi29amplification', 'phikz', 'philadelphia', 'philippinarum', 'philippines', 'phillyrin', 'phindependent', 'phlebotomus', 'phlebovirus', 'phleboviruses', 'phloroglucinols', 'phlorotannins', 'phmediated', 'phoenix', 'phone', 'phones', 'phosphatase', 'phosphate', 'phosphatidylcholine', 'phosphatidylinositol', 'phosphatidylinositol3phosphate', 'phosphoinositidebinding', 'phospholipase', 'phosphoprotein', 'phosphoproteomicbased', 'phosphoproteomics', 'phosphorylated', 'phosphorylation', 'photoassimilateresponding', 'photocatalysis', 'photocatalytic', 'photochemical', 'photodynamic', 'photoinduced', 'photolyasecryptochrome', 'photoreceptor', 'photoreceptors', 'photosynthesis', 'phototherapy', 'phyllostomid', 'phylodynamic', 'phylogenetic', 'phylogenetics', 'phylogenomic', 'phylogeny', 'phylogenybased', 'phylogeographic', 'phylogeography', 'physical', 'physician', 'physicianmodified', 'physicians', 'physicianstaffed', 'physicochemical', 'physik', 'physiologic', 'physiological', 'physiologically', 'physiology', 'physiopathologie', 'phytochemistry', 'phytocystatins', 'phytopharmacological', 'pi3', 'pi3k', 'pi3kakt', 'pichia', 'picobirnaviruses', 'picornaviral', 'picornavirus', 'picornaviruses', 'picu', 'picv', 'pid', 'pidotimod', 'piece', 'pietrain', 'piezoelectric', 'pig', 'pigeon', 'pigeons', 'piggery', 'piglet', 'piglets', 'pigletsa', 'pigment', 'pigmentosa', 'pigs', 'pil33', 'pilgrimage', 'pilgrims', 'pill', 'pillars', 'pilot', 'piloto', 'pilus', 'pine', 'pink', 'pinocytosis', 'pioneering', 'pip6apmo', 'pip6pmo', 'pipeline', 'piperaceae', 'piperacillin', 'pipiens', 'pipistrelle', 'piptoporus', 'pital', 'pitfalls', 'pituitary', 'pitx2', 'pivotal', 'pizooties', 'pj', 'pkc', 'pkr', 'place', 'placebo', 'placebocontrolled', 'placement', 'placentaderived', 'placental', 'places', 'plague', 'plan', 'plane', 'planet', 'planetary', 'planned', 'planning', 'plans', 'plant', 'planta', 'plantago', 'plantar', 'plantarum', 'plantbased', 'plantderived', 'plantmade', 'plants', 'plantsrules', 'planus', 'plaque', 'plaquefocus', 'plaquereduction', 'plasma', 'plasmacytoid', 'plasmapherese', 'plasmaserum', 'plasmid', 'plasmids', 'plasminogen', 'plasmodium', 'plasmonic', 'plaster', 'plasticbased', 'plasticity', 'plastid', 'plastoquinone', 'plate', 'plateau', 'platelet', 'plateletderived', 'platelets', 'platform', 'platforms', 'platinumcontaining', 'plaudits', 'plausibility', 'play', 'players', 'playing', 'plays', 'plea', 'pledges', 'pleiotropic', 'pleiotropy', 'plenary', 'plenum', 'pleomorphic', 'pleura', 'pleural', 'pleurasonographie', 'pleurisy', 'pleuropneumoniae', 'plex', 'plexus', 'plga', 'plot', 'plum', 'pluripotent', 'plus', 'pmethylaminophenol', 'pmo', 'pneumatic', 'pneumococcal', 'pneumococcalspecific', 'pneumococci', 'pneumocystis', 'pneumocystosis', 'pneumologie', 'pneumomediastinum', 'pneumonia', 'pneumoniae', 'pneumoniaeamong', 'pneumoniainduced', 'pneumoniarelated', 'pneumonias', 'pneumonie', 'pneumonieentwicklung', 'pneumonien', 'pneumonitis', 'pneumopathies', 'pneumophila', 'pneumosepsis', 'pneumothorax', 'pneumovirus', 'poaching', 'poales', 'poc', 'poca', 'pochonin', 'pocket', 'pockets', 'podocyte', 'podocytic', 'pohang', 'point', 'pointofcare', 'pointofuse', 'poisoning', 'poisson', 'pol', 'poland', 'polarity', 'polarization', 'polarized', 'polerovirus', 'policies', 'policy', 'polio', 'poliomyelitis', 'poliovirus', 'polioviruses', 'polish', 'political', 'politics', 'politik', 'politikberatung', 'pollination', 'pollutant', 'pollutants', 'pollution', 'polly', 'poly', 'poly3hydroxybutyrate', 'polyadenylate', 'polyadenylation', 'polyallylamine', 'polyamine', 'polyangiitis', 'polyanhydride', 'polyanhydridebased', 'polyanions', 'polybasic', 'polycations', 'polychlorinated', 'polyclonal', 'polycrylamide', 'polycyclic', 'polyethyelene', 'polyethylene', 'polyethylenimine', 'polyethyleniminebased', 'polyfunctional', 'polygalasaponin', 'polyherbal', 'polyic', 'polyinosinicpolycytidylic', 'polykaryocyte', 'polylactic', 'polymer', 'polymerase', 'polymerases', 'polymers', 'polymicrobial', 'polymorphic', 'polymorphism', 'polymorphisms', 'polymorphonuclear', 'polymyxin', 'polynesia', 'polyneuromyopathy', 'polyneuropathie', 'polyneuropathy', 'polyomavirus', 'polyomaviruses', 'polypeptide', 'polypeptides', 'polyphagy', 'polyphenol', 'polyphenolrich', 'polyploidy', 'polypore', 'polyposis', 'polyprotein', 'polypyridyl', 'polysaccharides', 'polysemous', 'polyunsaturated', 'polyvalent', 'pomacea', 'pomalidomideinduced', 'pomatia', 'pomona', 'pool', 'pooled', 'poor', 'poorer', 'poorest', 'population', 'populationbased', 'populationlevel', 'populations', 'populi', 'por', 'porcine', 'pore', 'poreforming', 'porintype', 'porphyromonas', 'port', 'portable', 'portal', 'portion', 'portosystemic', 'portrait', 'portugal', 'porzine', 'pose', 'posed', 'position', 'positional', 'positioning', 'positions', 'positive', 'positiven', 'positivesense', 'positivestrand', 'positivity', 'possesses', 'possibilities', 'possibility', 'possible', 'possibly', 'possum', 'post', 'postards', 'postelimination', 'poster', 'postergraduate', 'posterior', 'posters', 'postexposure', 'postgraduate', 'postherpetic', 'posthoc', 'postinfecciosos', 'postkidneytransplant', 'postmodernity', 'postmolar', 'postmortem', 'postnatal', 'postoperative', 'postpartum', 'postpcr', 'postsars', 'poststimulation', 'poststroke', 'postsurgical', 'postsynaptic', 'posttranscriptional', 'posttranscriptionally', 'posttransfusion', 'posttranslational', 'posttransplant', 'posttransplantation', 'posttraumatic', 'postvaccination', 'postweaning', 'potamochoerus', 'potassium', 'potato', 'potencies', 'potency', 'potent', 'potential', 'potentially', 'potentials', 'potentiate', 'potentiates', 'potentiating', 'potentielle', 'potently', 'potenzial', 'potyviridae', 'potyvirus', 'potyviruses', 'poult', 'poultry', 'poults', 'pour', 'poverty', 'povidone', 'powassan', 'powder', 'power', 'powered', 'powerful', 'pox', 'poxvirus', 'ppar', 'ppca', 'ppcbe', 'ppmos', 'ppseudophyllidea', 'ppxy', 'pr', 'pr55gag', 'practical', 'practice', 'practicebased', 'practices', 'practitioner', 'practitioners', 'prader', 'pragmatic', 'praktische', 'pratique', 'pratiques', 'prattii', 'praxis', 'pre', 'preactivation', 'preamplification', 'precautions', 'precedes', 'preceding', 'precipitants', 'precipitation', 'precipitin', 'precise', 'precisely', 'precision', 'preclinical', 'precommitment', 'preconditioning', 'precursor', 'precursors', 'pred', 'predating', 'predator', 'predict', 'predictability', 'predicted', 'predicting', 'prediction', 'predictions', 'predictive', 'predictor', 'predictors', 'predicts', 'predisposes', 'predisposing', 'predisposition', 'predominant', 'predominantly', 'predominate', 'preeclampsia', 'preemptive', 'preerythrocytic', 'preexisting', 'preexposure', 'preextubation', 'prefecture', 'prefer', 'preference', 'preferential', 'preferentially', 'preferred', 'prefusion', 'prefusionlike', 'pregnancy', 'pregnancyassociated', 'pregnancyspecific', 'pregnant', 'prehospital', 'preis', 'preliminary', 'premature', 'prematurely', 'prematurity', 'premi', 'premier', 'premrna', 'prenatal', 'preoperative', 'prepandemic', 'preparation', 'preparations', 'preparative', 'prepare', 'prepared', 'preparedness', 'preparing', 'prepost', 'preprints', 'preprocedural', 'preprocessing', 'prepropeptide', 'preprosomatostatin', 'prepubertal', 'prequeuosine', 'presatovir', 'preschool', 'prescribe', 'prescribing', 'prescription', 'presence', 'present', 'presentation', 'presentations', 'presented', 'presenter', 'presenters', 'presenting', 'presents', 'preservation', 'preserve', 'preserved', 'preserves', 'preserving', 'preset', 'president', 'presidential', 'press', 'presse', 'pressekonferenz', 'pressure', 'pressureassisted', 'pressures', 'pressurized', 'presumed', 'presynaptic', 'preterm', 'pretransplant', 'pretravel', 'pretreated', 'pretreatment', 'prevalence', 'prevalent', 'prevenci', 'prevent', 'preventable', 'preventative', 'preventing', 'prevention', 'preventiva', 'preventive', 'prevents', 'previous', 'previously', 'prfung', 'price', 'prim', 'primaquine', 'primaria', 'primarily', 'primary', 'primate', 'primates', 'primatetohuman', 'prime', 'primeboost', 'primegp5', 'primer', 'primera', 'primers', 'priming', 'primum', 'prince', 'principal', 'principle', 'principles', 'print', 'printed', 'prinzipielle', 'prinzipien', 'prion', 'prions', 'prior', 'priorities', 'prioritisation', 'prioritization', 'prioritized', 'prioritizing', 'priority', 'priscilla', 'prise', 'private', 'privilege', 'privileged', 'prize', 'prm', 'prmenv', 'pro', 'proactive', 'proanthocyanidin', 'proapelin', 'proapoptotic', 'probability', 'probable', 'probably', 'probe', 'probebased', 'probes', 'probesets', 'probing', 'probiotic', 'probiotics', 'probiotiques', 'problem', 'probleme', 'problemkeime', 'problems', 'procalcitonin', 'procat', 'procedimientos', 'procedure', 'procedures', 'proceedings', 'process', 'processed', 'processes', 'processing', 'processivity', 'proclamation', 'procollagen', 'proctitis', 'prodect', 'prodrug', 'prodrugs', 'produce', 'produced', 'produces', 'producing', 'product', 'production', 'productive', 'productivity', 'products', 'proenkephalin', 'prof', 'profession', 'professional', 'professionals', 'professionnels', 'professorin', 'profile', 'profiled', 'profiles', 'profiling', 'profilometry', 'profoundly', 'progenitor', 'progenitors', 'progeny', 'progesterone', 'prognose', 'prognosis', 'prognostic', 'prognostische', 'prognostisches', 'program', 'programmable', 'programme', 'programmed', 'programmes', 'programming', 'programs', 'progress', 'progression', 'progressive', 'progressivem', 'prohibitin', 'prohibitins', 'proinflammatory', 'project', 'projected', 'projection', 'projections', 'projects', 'prokaryote', 'prokaryotes', 'prokaryotic', 'proliferation', 'proliferative', 'proliferatoractivated', 'prologue', 'prolonged', 'prolonging', 'prolongs', 'prominent', 'promise', 'promises', 'promising', 'promonocyte', 'promote', 'promoted', 'promoter', 'promoters', 'promotes', 'promoting', 'promotion', 'prompt', 'prompts', 'prone', 'pronounced', 'proof', 'proofing', 'proofofconcept', 'proopiomelanocortin', 'prop', 'propagating', 'propagation', 'propagative', 'propensity', 'proper', 'properties', 'property', 'prophage', 'prophylactic', 'prophylaxe', 'prophylaxis', 'propofol', 'propofolinduced', 'propolis', 'proportion', 'proportionate', 'propos', 'proposal', 'proposals', 'proposed', 'propranolol', 'propria', 'proprotein', 'propsito', 'propylpentane', 'prorenin', 'proresolving', 'pros', 'prosaposin', 'prospeccts', 'prospecting', 'prospective', 'prospects', 'prospektiven', 'prostaglandin', 'prostaglandins', 'prostate', 'prosthetic', 'prosurvival', 'protagonismo', 'protease', 'proteaseadapted', 'proteasedependent', 'proteases', 'proteasomal', 'proteasome', 'proteasomedependent', 'proteasomemediated', 'protect', 'protected', 'protecting', 'protection', 'protections', 'protective', 'protects', 'protein', 'protein60', 'proteina', 'proteinase', 'proteinases', 'proteinaseubiquitin', 'proteinb', 'proteinbased', 'proteinchip', 'proteincoding', 'proteincontaining', 'proteind', 'proteindependent', 'proteinexpressing', 'proteininadjuvant', 'proteinosis', 'proteinprotein', 'proteinreactive', 'proteins', 'proteobacteria', 'proteoforms', 'proteogenomics', 'proteoglycan', 'proteoglycans', 'proteolipid', 'proteolysis', 'proteolytic', 'proteome', 'proteomes', 'proteomewide', 'proteomic', 'proteomics', 'prothrombin', 'proto', 'protocol', 'protocolized', 'protocolo', 'protocols', 'proton', 'protonation', 'protooncogene', 'prototype', 'prototyping', 'protozoa', 'protozoan', 'protozoans', 'prove', 'proven', 'provent', 'provide', 'providers', 'provides', 'providing', 'province', 'provinces', 'provincial', 'proviral', 'provision', 'provokes', 'proximal', 'proximity', 'prpsc', 'prr', 'prrs', 'prrsv', 'prrsvinfected', 'prvabc59', 'prvention', 'ps', 'pseudallescheria', 'pseudo', 'pseudoangiosarcoma', 'pseudoatoms', 'pseudogymnoascus', 'pseudoknot', 'pseudoknots', 'pseudoknotted', 'pseudomonas', 'pseudoparasites', 'pseudorabies', 'pseudotuberculosis', 'pseudotype', 'pseudotypebased', 'pseudotyped', 'pseudoviral', 'pseudovirus', 'pseudovirusencapsidated', 'psg1', 'psite', 'psittacosis', 'psittacus', 'psoaslumbar', 'psoriasis', 'psoriatic', 'psyche', 'psychiatric', 'psychiatry', 'psychoimmunology', 'psychological', 'psychology', 'psychometric', 'psychomotor', 'psychoorganischer', 'psychosis', 'psychosocial', 'psychosomatic', 'psychotropic', 'psyllids', 'psylloidea', 'pt', 'ptb', 'pten', 'pteropine', 'pteropus', 'pterygoid', 'pth134', 'ptrgo', 'ptx3', 'pubblica', 'puberty', 'public', 'publication', 'publications', 'publichealth', 'publichealthethik', 'publicly', 'publicprivate', 'publikationen', 'publis', 'published', 'publishing', 'puerto', 'pul21a', 'pullets', 'pulmonale', 'pulmonalen', 'pulmonar', 'pulmonary', 'pulsed', 'puma', 'pumc', 'pumpless', 'pune', 'punica', 'punjab', 'punta', 'pupae', 'puppies', 'purification', 'purified', 'purinergic', 'purity', 'purpura', 'pursuing', 'pursuits', 'push', 'pushing', 'pustular', 'putative', 'puts', 'puumala', 'puzzle', 'puzzles', 'puzzling', 'pv', 'pvcrto', 'pvl', 'pvm', 'pvmdr1', 'pvtrag38', 'pwp2', 'pycnogenol', 'pylori', 'pyloric', 'pyogenes', 'pyomyositis', 'pyr', 'pyranodioxine', 'pyrazolylnucleosides', 'pyridine', 'pyridylimidazo', 'pyrilamine', 'pyroptosis', 'pyrosequencing', 'pyruvate', 'pythons', 'pzt', 'q370r', 'qa1', 'qar', 'qinghaosu', 'qpcr', 'qrt', 'qrtpcr', 'qsar', 'qsarassisted', 'qstr', 'qtl', 'qtof', 'qu', 'quadruplexes', 'quadrupole', 'quagmire', 'quail', 'qualitative', 'quality', 'quantification', 'quantified', 'quantify', 'quantifying', 'quantitation', 'quantitative', 'quantity', 'quarantine', 'quarantined', 'quartalen', 'quarterly', 'quartzexposed', 'quasi', 'quasienveloped', 'quasiperiodic', 'quasispecies', 'quateur', 'quatitating', 'que', 'quebec', 'queensland', 'quelle', 'quenching', 'quercetin', 'quercus', 'queries', 'query', 'querying', 'quest', 'question', 'questionnaire', 'questionnaires', 'questions', 'quimioprofilaxis', 'quinoline', 'quinolones', 'quinoxaline', 'quinquefasciatus', 'quintessential', 'quitensis', 'quiz', 'qxlike', 'qxtype', 'r5tropic', 'r_1', 'raas', 'rab5', 'rab5mediated', 'rabbit', 'rabbits', 'rabgdi', 'rabies', 'rabiesbased', 'race', 'races', 'radar', 'radial', 'radiata', 'radiated', 'radiation', 'radiationinduced', 'radical', 'radicals', 'radiculomyelopathy', 'radioaerosol', 'radiofrequency', 'radiograph', 'radiographic', 'radiographs', 'radiography', 'radioimmunological', 'radiologic', 'radiological', 'radiologische', 'radiologist', 'radiology', 'radionuclides', 'radioonkologie', 'radiotherapy', 'radium223', 'radix', 'rafts', 'rag1', 'rage', 'rahmen', 'rahmenbedingungen', 'rain', 'rainbow', 'rainfall', 'raise', 'raised', 'raisers', 'raises', 'rajaraman', 'raji', 'rale', 'rallying', 'ramada', 'rami', 'ran', 'ranaviruses', 'ranbp2', 'ranbp5', 'random', 'randomised', 'randomized', 'randomness', 'range', 'ranges', 'ranging', 'ranimation', 'ranitidine', 'rank', 'ranking', 'ranks', 'rantes', 'rapamycin', 'rapd', 'rapeutiques', 'rapid', 'rapidly', 'rapie', 'rare', 'rarr', 'ras', 'rasch', 'rash', 'rasputin', 'rat', 'rate', 'rates', 'ratg', 'rather', 'ratification', 'ratified', 'ratio', 'rational', 'rationale', 'rationality', 'rationalizing', 'rationally', 'rationnel', 'rats', 'rats1', 'raw', 'raw264', 'raw2647', 'ray', 'rayo', 'rb1', 'rc', 'rca', 'rcn', 'rcp', 'rct', 'rd', 'rd114', 'rds', 're', 'rea', 'reabsorption', 'reach', 'reachability', 'reached', 'react', 'reacted', 'reaction', 'reactionpyrosequencing', 'reactions', 'reactivation', 'reactive', 'reactivities', 'reactivity', 'reactogenicity', 'reactors', 'read', 'readiness', 'reading', 'readings', 'reads', 'readthrough', 'ready', 'readytouse', 'reaktionen', 'reaktives', 'real', 'realising', 'realistic', 'realit', 'reality', 'reallife', 'really', 'realtime', 'reanalysis', 'reanimatiefront', 'reanimation', 'reanimationsmanahmen', 'reared', 'rearing', 'reasoning', 'reassessing', 'reassortant', 'reassortants', 'reassortment', 'reawakening', 'receding', 'receipt', 'receive', 'receiving', 'recensiones', 'recent', 'recently', 'receptor', 'receptor1', 'receptorbased', 'receptorbinding', 'receptorlike', 'receptormediated', 'receptors', 'recession', 'rechtliche', 'rechtsherzversagen', 'rechtsmedizin', 'recipient', 'recipients', 'reciprocal', 'reclassification', 'recode2', 'recognising', 'recognition', 'recognize', 'recognized', 'recognizes', 'recognizing', 'recollections', 'recombinant', 'recombinantb', 'recombinants', 'recombinase', 'recombination', 'recombine', 'recomendaciones', 'recommandations', 'recommendation', 'recommendations', 'recommended', 'reconciling', 'reconocimiento', 'reconstituted', 'reconstitution', 'reconstructing', 'reconstruction', 'record', 'recording', 'records', 'recovered', 'recovery', 'recruit', 'recruitability', 'recruitment', 'recruits', 'rectal', 'recurrence', 'recurrent', 'recyclable', 'recycle', 'recycling', 'red', 'redefining', 'redesign', 'redesigned', 'redirecting', 'redistribution', 'redonda', 'redox', 'reduce', 'reduced', 'reduces', 'reducing', 'reductase', 'reductases', 'reduction', 'redundancy', 'reduning', 'reed', 'reedfrost', 'reemergence', 'reemergent', 'reemerging', 'reese', 'reesei', 'reevaluating', 'reexcretion', 'reference', 'references', 'referral', 'refine', 'refined', 'reflect', 'reflecting', 'reflection', 'reflections', 'reflex', 'reflexive', 'reform', 'reforming', 'reforms', 'refractive', 'refractory', 'refresher', 'refugees', 'regard', 'regarding', 'regenerated', 'regenerating', 'regeneration', 'regimen', 'regimenrelated', 'regimens', 'regimes', 'region', 'regional', 'regions', 'register', 'registered', 'registering', 'registry', 'regression', 'regulate', 'regulated', 'regulates', 'regulating', 'regulation', 'regulations', 'regulator', 'regulators', 'regulatory', 'rehabilitation', 'reinforce', 'reinforcement', 'reinitiation', 'reinvention', 'reinvigorate', 'reisemedizin', 'reisen', 'rejection', 'rekombinante', 'rekonvaleszentenplasma', 'rel', 'rela', 'relapse', 'relapsed', 'relapsing', 'relate', 'related', 'relating', 'relation', 'relationship', 'relationships', 'relative', 'relaxation', 'release', 'released', 'releasedactive', 'releasing', 'relevance', 'relevant', 'relevante', 'reliability', 'reliable', 'relieves', 'religious', 'relive', 'relocating', 'relocation', 'rely', 'remain', 'remains', 'remarkable', 'remdesivir', 'remedies', 'remembering', 'reminiscent', 'remission', 'remitting', 'remnant', 'remodel', 'remodeled', 'remodeling', 'remote', 'removal', 'removing', 'remyelination', 'ren', 'renal', 'renalases', 'rename', 'renewed', 'renin', 'reninangiotensin', 'reninangiotensinaldosterone', 'reorganization', 'reoviridae', 'reovirus', 'reoviruses', 'reoviruslike', 'reovirusmediated', 'rep', 'repair', 'repairing', 'repatriation', 'repeat', 'repeatcontaining', 'repeated', 'repeatedly', 'repeats', 'reperfused', 'reperfusion', 'repertoire', 'repertoires', 'repetitive', 'repiratory', 'replace', 'replacement', 'replacers', 'replicable', 'replicase', 'replicate', 'replicated', 'replicates', 'replicatingcompetent', 'replication', 'replicationcompetent', 'replicationselective', 'replicon', 'repliconbased', 'replicons', 'reply', 'report', 'reported', 'reporter', 'reporterexpressing', 'reporting', 'reports', 'repositioning', 'repository', 'represent', 'representation', 'representations', 'representing', 'repress', 'repressing', 'repression', 'reproducibility', 'reproducible', 'reproduction', 'reproductive', 'reprogramming', 'republic', 'republik', 'repurpose', 'repurposed', 'repurposing', 'request', 'requests', 'requiem', 'require', 'required', 'requirement', 'requirements', 'requires', 'requiring', 'rer', 'rerio', 'res', 'rescue', 'rescued', 'rescues', 'research', 'researcher', 'researchers', 'resected', 'resection', 'resektion', 'resembling', 'resequencing', 'reservoir', 'reservoirs', 'reshaping', 'residence', 'residency', 'resident', 'residential', 'residents', 'residing', 'residual', 'residuals', 'residue', 'residues', 'resilience', 'resilient', 'resindirected', 'resistance', 'resistanceassociated', 'resistant', 'resisting', 'resolution', 'resolves', 'resonance', 'resorption', 'resource', 'resourcelimited', 'resourcepoor', 'resources', 'respect', 'respected', 'respir', 'respiration', 'respirationstrakts', 'respiratoire', 'respiratoires', 'respirator', 'respiratoria', 'respiratorias', 'respiratorio', 'respiratorios', 'respiratorische', 'respiratorischer', 'respirators', 'respiratory', 'respiratorytract', 'respirovirus', 'respond', 'respondentdriven', 'responders', 'responding', 'responds', 'response', 'responses', 'responsibilities', 'responsible', 'responsive', 'responsiveness', 'respuestas', 'ressourcenknappheit', 'resting', 'restoration', 'restore', 'restores', 'restrains', 'restraint', 'restrict', 'restricted', 'restricting', 'restriction', 'restrictions', 'restrictive', 'restricts', 'restrospective', 'result', 'resultant', 'resulted', 'resulting', 'results', 'resurgence', 'resurrected', 'resuscitation', 'resveratrol', 'retail', 'retain', 'retardation', 'retarded', 'retention', 'retesting', 'rethink', 'rethinking', 'reti', 'reticular', 'reticulata', 'reticulocytebinding', 'reticulocytes', 'reticuloendotheliosis', 'reticulum', 'retikulre', 'retina', 'retinal', 'retinitis', 'retinoic', 'retinopathy', 'reto', 'retos', 'retransplantation', 'retrieval', 'retroactive', 'retrograde', 'retrospective', 'retrospektive', 'retrotransposons', 'retroviral', 'retrovirology', 'retrovirus', 'retroviruses', 'retrovirusmediated', 'return', 'returned', 'returning', 'returns', 'reuse', 'reuteri', 'revalidation', 'revamp', 'revascularization', 'reveal', 'revealed', 'revealing', 'reveals', 'reverse', 'reverses', 'reversetranscription', 'reversibility', 'reversible', 'reversibly', 'reversion', 'review', 'reviews', 'revise', 'revised', 'revising', 'revision', 'revisions', 'revisited', 'revisiting', 'revisits', 'revolution', 'revue', 'rewarding', 'rewards', 'reworks', 'rezeptorblockers', 'rfam', 'rgm', 'rhabdomyolysis', 'rhabdosarcoma', 'rhabdoviridae', 'rhabdoviruses', 'rheostats', 'rhesus', 'rheum', 'rheumatherapie', 'rheumatische', 'rheumatoid', 'rheumatologic', 'rheumatologische', 'rheumatology', 'rhinitis', 'rhinolophidae', 'rhinosinusitis', 'rhinovirus', 'rhinovirusassociated', 'rhinoviruses', 'rhizobia', 'rhizobium', 'rhizoctonia', 'rhizoma', 'rhodesain', 'rhodiola', 'rib', 'ribavarin', 'ribavirin', 'ribonuclease', 'ribonucleaseresistant', 'ribonucleases', 'ribonucleic', 'ribonucleoprotein', 'ribonucleoproteins', 'ribonucleotide', 'ribosomal', 'ribosome', 'ribosomes', 'riboswitch', 'ribosylation', 'ribozyme', 'rica', 'ricas', 'riccardo', 'rice', 'rich', 'richtige', 'ricin', 'rickettsia', 'rickettsial', 'rickettsioses', 'rico', 'ridd', 'ride', 'rience', 'riennes', 'riesgo', 'rift', 'rig', 'right', 'rights', 'rigi', 'rigida', 'rigilike', 'rin', 'ring', 'ringspot', 'rinitis', 'rinse', 'rio', 'riologique', 'riparian', 'rise', 'risico', 'risicoperceptie', 'risiken', 'risiko', 'risikoabsch', 'risikofaktoren', 'risikowahrnehmung', 'rising', 'risk', 'riskadjusted', 'risks', 'risque', 'risques', 'rituxan', 'rituximab', 'rituximabresistant', 'river', 'riverine', 'rki', 'rkp', 'rm', 'rna', 'rnabased', 'rnabinding', 'rnacontaining', 'rnadependent', 'rnaderived', 'rnadirected', 'rnai', 'rnamediated', 'rnaprotein', 'rnas', 'rnase', 'rnaseq', 'rnases', 'rnasilencing', 'rnatype', 'rntrpl', 'ro', 'roachallergic', 'road', 'roadblocks', 'roadmap', 'roadmaps', 'roads', 'robbers', 'robert', 'robinson', 'robust', 'robustness', 'robuuste', 'rocio', 'rock', 'rod', 'rodent', 'rodentium', 'rodentiuminfected', 'rodents', 'rodman', 'rods', 'role', 'roles', 'rolipram', 'roll', 'rolling', 'romania', 'rome', 'room', 'roomaged', 'rooms', 'root', 'rooting', 'roots', 'rootstocks', 'ros', 'rosae', 'rosea', 'rosettaes', 'rosiglitazone', 'rosmapk', 'rostral', 'rota', 'rotation', 'rotaviral', 'rotavirus', 'rotavirusassociated', 'rotaviruses', 'rotavirusinduced', 'rotavirusinfected', 'rougeole', 'rough', 'round', 'roundrobin', 'roundup', 'rousette', 'rousettus', 'route', 'routes', 'routine', 'royal', 'rp', 'rpern', 'rpipred', 'rpirls', 'rrna', 'rs12252', 'rs12252c', 'rs12979860', 'rs2077647', 'rs2430561', 'rs4804803', 'rsv', 'rsvinfektion', 'rsvspecific', 'rt', 'rta', 'rtabcde', 'rti', 'rtis', 'rtlamp', 'rtpcr', 'rtpcrelectrospray', 'rtqpcr', 'rub', 'rubella', 'ruber', 'rubiaceae', 'rubulaviruses', 'rubus', 'ruditapes', 'ruffling', 'rule', 'rules', 'rumen', 'ruminant', 'ruminants', 'ruminis', 'rumours', 'run', 'rung', 'rungen', 'runs', 'rupintrivirresistant', 'rupture', 'rural', 'rush', 'russia', 'russian', 'rut', 'rutheniumii', 'rutin', 'ruxolitinib', 'rv', 'rv0297', 'rvaccinia', 'rvf', 'rwanda', 'rwandan', 'rx', 'ryegrass', 'rz', 'rzte', 's1binding', 's1p', 's1pr1', 's8orf2', 'sa', 'sa11', 'saa', 'saar', 'saarbr', 'sab', 'sabin', 'sac1p', 'saccharomyces', 'saccopteryx', 'sachregister', 'sachverzeichnis', 'sacwinged', 'saddle', 'saem', 'safe', 'safeguard', 'safeguards', 'safer', 'safety', 'saffold', 'sag1', 'sages', 'saikosaponind', 'saisonalen', 'sakk', 'salamanders', 'salar', 'salbutamol', 'sales', 'salicylaldehydes', 'saline', 'saliva', 'salivary', 'salivirusklassevirus', 'salix', 'salmon', 'salmonella', 'salmonellakilling', 'salmonellosis', 'salmonicida', 'salt', 'salticidae', 'salud', 'salutogenic', 'salvage', 'salvia', 'samewell', 'sample', 'sampled', 'samples', 'sampling', 'san', 'sanctuaries', 'sandfly', 'sandwichlateral', 'sandy', 'sanit', 'sanitario', 'sanitation', 'sanpoiwadake', 'sans', 'sant', 'santa', 'sao', 'sap', 'sapelovirus', 'saponins', 'sapovirus', 'saprophyte', 'sar', 'sarawak', 'sarcocystis', 'sarcoidosis', 'sarcoma', 'sarcomas', 'sarcopenia', 'sardinian', 'sargassum', 'sari', 'sarisurveillance', 'sarnat', 'sars', 'sarscoronavirus', 'sarscorrelated', 'sarscov', 'sarscov2', 'sarsfree', 'sarslike', 'sas', 'satellite', 'satisfaction', 'saturated', 'saudi', 'saurashtra', 'sav', 'savannah', 'savii', 'says', 'sc', 'scaffold', 'scaffolds', 'scalable', 'scale', 'scalefree', 'scales', 'scaling', 'scalingup', 'scalp', 'scanning', 'scans', 'scapularis', 'scarcity', 'scarier', 'scary', 'scattering', 'scauhn06', 'scd138', 'scenario', 'scenarios', 'scfv', 'scfvs', 'schedule', 'scheduling', 'scheld', 'scheme', 'schemes', 'scheuermann', 'schicksal', 'schiff', 'schistosoma', 'schistosomiasis', 'schizophrenia', 'schizophrenic', 'schlussfolgerungen', 'schmallenberg', 'schmidt', 'schnauzers', 'schneid', 'schockraummanagement', 'schocksyndroms', 'schon', 'school', 'schoolage', 'schoolaged', 'schools', 'schu', 'schutz', 'schwangerschaft', 'schwangerschaftsrelevante', 'schwangerschaftswoche', 'schwartz', 'schweinegrippe', 'schwere', 'schwerer', 'sciatic', 'scid', 'science', 'sciences', 'scientific', 'scientifically', 'scientists', 'scientometric', 'scintigraphy', 'scissors', 'sclerosing', 'sclerosis', 'scoliosis', 'scope', 'scoping', 'scopus', 'score', 'scorebased', 'scorecardbased', 'scorematched', 'scores', 'scoring', 'scorpine', 'scorpion', 'scotland', 'scott', 'scottish', 'scr', 'scrapie', 'screen', 'screened', 'screening', 'screens', 'scribble', 'script', 'scrub', 'scrystallin', 'sct', 'scylla', 'sd', 'sdd', 'sdra', 'se', 'sea', 'seabird', 'seabirds', 'seabream', 'seadornavirus', 'seals', 'search', 'searching', 'season', 'seasonal', 'seasonality', 'seasonally', 'seasons', 'seat', 'seaweeds', 'sebas', 'sec16a', 'second', 'secondary', 'secondgeneration', 'secret', 'secretase', 'secreted', 'secretes', 'secreting', 'secretion', 'secretions', 'secretions1', 'secretome', 'secretory', 'section', 'sectional', 'sector', 'secure', 'securing', 'security', 'sedation', 'sedative', 'sedentary', 'sediment', 'sedimentation', 'see', 'seed', 'seeger', 'seek', 'seekers', 'seeking', 'seen', 'seeplex', 'segment', 'segmented', 'segments', 'segregase', 'segregation', 'seguridad', 'sein', 'seine', 'seirs', 'seizures', 'sektion', 'sel', 'selangor', 'selcoecopurin', 'selditofms', 'select', 'selected', 'selectin', 'selecting', 'selection', 'selective', 'selectively', 'selectivity', 'selenium', 'selenoenzymes', 'selenoproteome', 'self', 'selfaggregating', 'selfamplifying', 'selfassembled', 'selfassembly', 'selfassessmentcpd', 'selfcollected', 'selfdefense', 'selfevaluations', 'selfgovernance', 'selfinterest', 'selfoligomerization', 'selfpoisoning', 'selfreported', 'selfswab', 'semantics', 'semen', 'semi', 'semidominant', 'seminal', 'seminar', 'semiquantitative', 'semisynthetic', 'semliki', 'sen', 'send', 'sendai', 'senecavirus', 'senegal', 'senegalensis', 'senescence', 'senlat', 'sensatas', 'sensational', 'sensationalisim', 'sense', 'sensing', 'sensitive', 'sensitivities', 'sensitivity', 'sensitization', 'sensitized', 'sensor', 'sensors', 'sensory', 'sentiment', 'sentinel', 'seoul', 'separata', 'separates', 'separation', 'separations', 'sepsis', 'sepsis3', 'sepsisassociated', 'sepsisinduced', 'sepsisseptic', 'septal', 'september', 'septic', 'septicaemia', 'septicemia', 'septoplasty', 'sequelae', 'sequence', 'sequencebased', 'sequenced', 'sequenceembedded', 'sequenceindependent', 'sequencequality', 'sequences', 'sequencestabilized', 'sequencing', 'sequencinga', 'sequencingbased', 'sequential', 'sequestering', 'ser', 'sera', 'serengeti', 'serial', 'series', 'serine', 'serines', 'serious', 'seroconversion', 'serodiagnosis', 'seroepidemiological', 'seroepidemiology', 'serologic', 'serological', 'serology', 'seronegative', 'seropositive', 'seropositivity', 'seroprevalence', 'seroprevalences', 'seroprvalenz', 'serostatus', 'serosurvey', 'serotests', 'serotherapy', 'serotonin', 'serotype', 'serotypes', 'serotypespecific', 'serotyping', 'serous', 'serovar', 'serovars', 'serpentes', 'serpentovirus', 'serpins', 'sers', 'serum', 'serumsodium', 'serve', 'server', 'servers', 'serves', 'service', 'services', 'ses', 'sesbania', 'session', 'sessions', 'set', 'setbacks', 'sets', 'setting', 'settings', 'settlement', 'setup', 'seuchen', 'seuchenalarmplanung', 'seuchenfall', 'seuchennotf', 'seul', 'seven', 'several', 'severe', 'severely', 'severemultiple', 'severity', 'severo', 'sewage', 'sewer', 'sex', 'sexspecific', 'sexual', 'sexually', 'sf2asf', 'sf9', 'sfco', 'sfspm', 'sftpc', 'sftpd', 'sftsv', 'sgiv', 'sgmg', 'sgrna', 'sgta', 'sh3glb2endophilin', 'shaanvirus', 'shadow', 'shake', 'shall', 'shandong', 'shanghai', 'shape', 'shaped', 'shapes', 'shapeshifting', 'shaping', 'share', 'shared', 'shares', 'sharing', 'shear', 'sheath', 'shed', 'shedding', 'sheddomedb', 'sheep', 'sheffield', 'shelf', 'shell', 'shellfish', 'shellless', 'shelter', 'sheltered', 'shelters', 'shenfu', 'shenzhen', 'sherlock', 'shift', 'shifting', 'shifts', 'shiga', 'shigella', 'shigellosis', 'shine', 'ship', 'shipped', 'shipping', 'ships', 'shiv', 'shiverer', 'shock', 'shoppers', 'short', 'shortage', 'shorter', 'shorthairpin', 'shorttailed', 'shortterm', 'shotgun', 'shots', 'showed', 'showing', 'shows', 'shrew', 'shrews', 'shrimp', 'shrnaexpressing', 'shuffling', 'shunt', 'shutoff', 'shuttling', 'si', 'sialadenitis', 'sialic', 'sialicacidspecific', 'sialoadhesin', 'sialodacryoadenitis', 'sialometabolism', 'sialylated', 'sialylglycopolymer', 'sibling', 'siblings', 'sich', 'sicherheit', 'sicherung', 'sicht', 'sichuan', 'sicilian', 'sick', 'sickle', 'sickness', 'side', 'sidechain', 'sidelines', 'sident', 'sidenten', 'sides', 'sidestream', 'sidoides', 'sie', 'sieb', 'sierra', 'sifem', 'siga', 'sight', 'siglec1', 'siglec8', 'siglo', 'sigma', 'sigmodon', 'sign', 'signal', 'signal1', 'signaled', 'signaling', 'signalling', 'signalmodulated', 'signalmoleculeprofiling', 'signalosome', 'signalregulated', 'signalregulatory', 'signals', 'signature', 'signatures', 'signes', 'significance', 'significant', 'significantly', 'signr', 'signr1', 'signs', 'siica', 'silac', 'sildenafil', 'silencing', 'silent', 'silentes', 'silica', 'silico', 'silicobased', 'silicon', 'silicone', 'silkworm', 'silver', 'simarteriviruses', 'simian', 'similar', 'similarities', 'similarity', 'simit', 'simple', 'simplex', 'simplex1', 'simplicity', 'simplified', 'simulaci', 'simulant', 'simulants', 'simulate', 'simulated', 'simulating', 'simulation', 'simulations', 'simultaneous', 'simultaneously', 'simvastatin', 'sin', 'sin3a', 'since', 'sincitial', 'sind', 'sindbis', 'sinensis', 'singapore', 'single', 'singlecenter', 'singlechain', 'singlenucleotide', 'singleparticle', 'singlestranded', 'singlevirus', 'sink', 'sintspeckles', 'sinusitis', 'sinusoidal', 'sir', 'sirna', 'sirnabased', 'sirnas', 'sirs', 'sirt1', 'sirt7dependent', 'sis', 'sistema', 'sisvet', 'site', 'sites', 'sitewise', 'siti', 'sitobion', 'sits', 'situ', 'situaciones', 'situation', 'situational', 'situations', 'siu', 'siv', 'sivh1n1p', 'six', 'sixmonth', 'sixth', 'sixyearold', 'size', 'sizeable', 'sizeandshape', 'sj', 'sjgren', 'sjl', 'sjlj', 'skeletal', 'ski1s1p', 'skin', 'skip', 'skipping', 'sklerose', 'skm1', 'sla', 'slam', 'slaughter', 'slaughtered', 'slco1a2', 'slco1b1', 'slco2b1', 'sleeping', 'slice', 'slides', 'sliding', 'slippage', 'slippery', 'slojh11', 'slovak', 'slow', 'slowbinding', 'slowentry', 'slurry', 'sm2', 'sm934', 'sma', 'smad', 'smad3', 'smad4', 'small', 'smaller', 'smallmolecule', 'smallpox', 'smallworld', 'smarca2regulated', 'smartphone', 'smartphones', 'smectic', 'smn', 'smn2', 'smoke', 'smokers', 'smoking', 'smooth', 'smoothing', 'smoothmuscle', 'sms', 'smsbased', 'snail', 'snakes', 'snapshot', 'sndrome', 'sndromes', 'sneeze', 'sniffles', 'snippets', 'snitroso', 'snow', 'snps', 'snrna', 'soap', 'sobemovirus', 'sobre', 'soci', 'social', 'sociali', 'socially', 'sociedad', 'societ', 'societal', 'societies', 'society', 'socioeconomic', 'sociospatial', 'sociotechnical', 'socs', 'socs1', 'socs3', 'socs5', 'sodium', 'sodiumdependent', 'sofa', 'softbill', 'software', 'soil', 'soins', 'soit', 'solani', 'soldier', 'sole', 'solid', 'solidarity', 'solider', 'solidphase', 'solitary', 'solubility', 'soluble', 'soluci', 'solution', 'solutions', 'solve', 'solved', 'solvents', 'somatic', 'somatostatin', 'something', 'sommergrippe', 'somni', 'somnus', 'sonic', 'sonication', 'sonoran', 'sophaguskarizinom', 'sophora', 'sorafenib', 'sore', 'sorrow', 'sortilin', 'sorting', 'sounding', 'source', 'sources', 'sous', 'sousestim', 'south', 'southeast', 'southeastern', 'southern', 'southwest', 'southwestern', 'sow', 'sowie', 'sows', 'sox2', 'soy', 'soyabean', 'soybean', 'soziale', 'sozialp', 'sozialpadiatrie', 'sp', 'space', 'spacer', 'spain', 'spalmitoylation', 'spaltlampe', 'span', 'spaniel', 'spanish', 'sparende', 'sparging', 'sparus', 'spatial', 'spatialbased', 'spatially', 'spatialtemporal', 'spatiotemporal', 'spatiotemporally', 'spcifique', 'spd', 'speak', 'speaker', 'spearheading', 'special', 'specialist', 'specialists', 'specialized', 'specialty', 'speciation', 'species', 'speciesspecific', 'specific', 'specifically', 'specificities', 'specificity', 'specimen', 'specimens', 'speciosa', 'spectra', 'spectrometry', 'spectroscopy', 'spectrum', 'speech', 'speed', 'spenderkriterien', 'sperm', 'spermatophytes', 'spezifisches', 'spg', 'sph', 'sphaeranthus', 'sphingosine', 'sphingosine1phosphate', 'sphre', 'spi1', 'spiders', 'spike', 'spill', 'spillover', 'spills', 'spin', 'spina', 'spinal', 'spine', 'spiral', 'spiro', 'spirochetes', 'spirocyclic', 'spironolactone', 'spiroplasma', 'spitzen', 'spleen', 'splenectomy', 'splenic', 'splenomegaly', 'splice', 'splicecorrection', 'spliced', 'spliceswitching', 'splicing', 'split', 'splitgfptagged', 'spm0211', 'spm1205', 'spm1206', 'spo0a', 'spodoptera', 'spondyloarthritis', 'sponges', 'spongiform', 'sponsored', 'spontaneous', 'spontanerfassungsdaten', 'sporadic', 'spores', 'sports', 'sporulation', 'spot', 'spotlight', 'spots', 'spotted', 'spp', 'spr', 'sprague', 'spraguedawley', 'spray', 'spread', 'spreading', 'spreads', 'sprout', 'sprue', 'spt', 'spur', 'sputum', 'squamous', 'squishy', 'sras', 'src', 'srcenhanced', 'srcfakmediated', 'sri', 'srl', 'srpk1mediated', 'srtmelt', 'srv1', 'ss', 'sscmir30d', 'sscolor', 'ssdna', 'ssea1', 'sseldorf', 'sshmicroarray', 'ssmov10', 'sspe', 'ssrna', 'ssrs', 'st', 'st2', 'staaten', 'stabilisation', 'stabilities', 'stability', 'stabilizers', 'stabilizes', 'stable', 'stack', 'stadium', 'staff', 'staffs', 'stage', 'staged', 'stages', 'stagespecific', 'staggering', 'staging', 'stakeholder', 'stakeholders', 'stalled', 'stalls', 'stammen', 'stammzellen', 'stammzelltransplantation', 'stamping', 'stand', 'standard', 'standardisation', 'standardization', 'standardized', 'standards', 'standing', 'staphylococcal', 'staphylococcus', 'star', 'starfish', 'start', 'starved', 'stat', 'stat1', 'stat2', 'stat3', 'stat5', 'state', 'stated', 'statement', 'stateof', 'stateofthe', 'states', 'static', 'statin', 'stationary', 'statistical', 'statistically', 'status', 'stave', 'stay', 'staying', 'ste20', 'steady', 'steadystate', 'stearoylcoa', 'steatohepatitis', 'steatosis', 'steers', 'stehen', 'stellenwert', 'stellungnahme', 'stellungnahmen', 'stem', 'stemleaf', 'stemlike', 'stemness', 'stemprogenitor', 'stemstromal', 'stenosis', 'stenotrophomonas', 'stent', 'stenting', 'step', 'stephen', 'stephensi', 'steps', 'stereology', 'steric', 'sterile', 'sterility', 'sterilize', 'sterk', 'sterne', 'steroid', 'steroidal', 'steroidassociated', 'steroide', 'steroidinduced', 'steroidogenic', 'steroidresistant', 'steroids', 'sterreich', 'sterreichische', 'sterreichischen', 'steve', 'stewardship', 'sthesie', 'sthesiologie', 'sthesisten', 'sthr', 'stichwortregister', 'stickstoffmonoxid', 'stico', 'stiffness', 'stigma', 'stil', 'still', 'stillborn', 'stillsyndrom', 'stimulate', 'stimulated', 'stimulates', 'stimulating', 'stimulation', 'stimulator', 'stimulatory', 'sting', 'stink', 'stirbt', 'stirred', 'stlr', 'stlr4', 'stndigen', 'stochastic', 'stockpile', 'stockpiled', 'stockpiling', 'stoichiometry', 'stomach', 'stomata', 'stomatitis', 'stomatitiszaire', 'stone', 'stool', 'stools', 'stop', 'storage', 'store', 'stories', 'storm', 'story', 'strahlenbiologie', 'straight', 'straightforward', 'strain', 'strains', 'strainspecific', 'strait', 'strand', 'stranded', 'strandspecific', 'strangles', 'strasbourg', 'strat', 'strategic', 'strategie', 'strategies', 'strategy', 'stratification', 'straw', 'stream', 'streamlined', 'streams', 'street', 'strengthen', 'strengthening', 'strengthens', 'streptococcal', 'streptococcosis', 'streptococcus', 'streptokokken', 'streptokokkenfolgeerkrankungen', 'streptomyces', 'streptozotocininduced', 'stress', 'stresses', 'stressinduced', 'stressmediated', 'stressors', 'stressresponsive', 'striata', 'striated', 'strict', 'striders', 'strigis', 'strikes', 'stringent', 'strip', 'strobe', 'stroke', 'stroma', 'stromal', 'strong', 'stronger', 'strongly', 'strongyloides', 'strongyloidiasis', 'structural', 'structurally', 'structure', 'structureactivity', 'structurebased', 'structured', 'structureefficacy', 'structures', 'structuretofunction', 'struelenspresident', 'struggle', 'struktur', 'strukturelle', 'strukturverschiebung', 'stt', 'stt3b', 'stuctureactivity', 'student', 'students', 'studie', 'studied', 'studien', 'studies', 'study', 'studying', 'stuhldrainagesystem', 'stung', 'stuttering', 'styles', 'stymie', 'sub', 'subacute', 'subalpine', 'subcellular', 'subchronic', 'subclinical', 'subclinically', 'subcomplex', 'subcomponents', 'subcriticality', 'subcutaneous', 'subdominant', 'subdue', 'subfamily', 'subgenomic', 'subgenotype', 'subgenus', 'subgroup', 'subgroups', 'subite', 'subject', 'subjected', 'subjective', 'subjects', 'sublines', 'sublingual', 'submerged', 'submicron', 'submitted', 'suboptimal', 'subphenotypes', 'subpial', 'subpopulation', 'subregion', 'subsaharan', 'subsequence', 'subsequent', 'subset', 'subsets', 'subsp', 'subspecies', 'substance', 'substances', 'substantial', 'substanzen', 'substituent', 'substitute', 'substituted', 'substitutes', 'substitution', 'substitutions', 'substrate', 'substrates', 'subsurface', 'subtilase', 'subtilis', 'subtilisin', 'subtipos', 'subtractive', 'subtype', 'subtypes', 'subtypespecific', 'subtyping', 'subunit', 'subunits', 'subversion', 'subvert', 'subviral', 'subvirion', 'succeed', 'success', 'successes', 'successful', 'successfully', 'succession', 'successive', 'suckling', 'sucrose', 'sudan', 'sudanese', 'sudden', 'suddenly', 'suffering', 'sufficient', 'sufficiently', 'sugar', 'sugarbinding', 'suggest', 'suggests', 'suglingen', 'suicidal', 'suicide', 'suilysinmediated', 'suis', 'suitability', 'suitable', 'suited', 'suivi', 'suivies', 'suivre', 'sulfate', 'sulfide', 'sulfonated', 'sulfone', 'summarizing', 'summary', 'summer', 'sumo', 'sumoylation', 'sun', 'suncus', 'sung', 'sunitinib', 'super', 'superamma', 'superantigen', 'superdiffusion', 'superfamily', 'superimposed', 'superinfection', 'superior', 'supermotifs', 'supernatant', 'supernatants', 'supernutritional', 'superoxide', 'superresolution', 'superspreaders', 'superspreading', 'supertypes', 'supervised', 'supplement', 'supplemental', 'supplementation', 'supplemented', 'supplementing', 'supplements', 'supply', 'support', 'supported', 'supporting', 'supportive', 'supports', 'suppress', 'suppressed', 'suppresses', 'suppressing', 'suppression', 'suppressor', 'suppressors', 'supraependymal', 'supranutritional', 'supraoptic', 'supreme', 'sur', 'sure', 'surepure', 'surface', 'surfacerelated', 'surfaces', 'surfactant', 'surfactants', 'surfactantsubstitutionstherapie', 'surge', 'surgeon', 'surgeons', 'surgery', 'surgical', 'surprise', 'surprisingly', 'surrogate', 'surveill', 'surveillance', 'surveillancecontainment', 'survey', 'surveys', 'survivability', 'survival', 'survive', 'surviving', 'survivors', 'sus', 'susceptibilities', 'susceptibility', 'susceptible', 'susceptibleinfectedrecovered', 'susceptibleinfectedsusceptible', 'suspect', 'suspected', 'suspects', 'suspension', 'suspensions', 'sustainability', 'sustainable', 'sustained', 'sustaining', 'sv', 'sv5', 'svepm', 'swab', 'swabs', 'swapping', 'swede', 'sweden', 'sweeps', 'sweet', 'swelling', 'swift', 'swine', 'swineorigin', 'swinepox', 'swing', 'swiss', 'switch', 'switching', 'switzerland', 'swog', 'sword', 'sybr', 'sybrecht', 'sydney', 'symbiogenesis', 'symbolic', 'sympathetic', 'symphony', 'symposia', 'symposium', 'symptom', 'symptomatic', 'symptoms', 'synapse', 'synaptic', 'synbiotic', 'synchronized', 'synchronous', 'syncytia', 'syncytial', 'syncytin1', 'syncytiogenic', 'syncytium', 'syndemic', 'syndemics', 'syndrom', 'syndrome', 'syndromes', 'syndromic', 'synergism', 'synergistic', 'synergy', 'syngeneic', 'synonymous', 'synoviae', 'synovial', 'syntaxin', 'synthase', 'synthase2', 'synthaseisoenzyme', 'synthese', 'synthesis', 'synthesized', 'synthetase', 'synthetases', 'synthetic', 'syphilis', 'syrian', 'syringae', 'sysgenet', 'system', 'systematic', 'systematically', 'systemerkrankungen', 'systemic', 'systemically', 'systemiconset', 'systemische', 'systemischen', 'systemischer', 'systems', 'systemslevel', 'systolic', 't2diacod', 't3ss', 't4ssmediated', 'taar1', 'table', 'tablet', 'tabletop', 'tablets', 'tablissement', 'tabloids', 'tacaribe', 'tace', 'tachycardia', 'tackle', 'tackles', 'tackling', 'tag', 'tagged', 'tagungspr', 'taiep', 'tail', 'tailed', 'tailing', 'tailored', 'tailormade', 'taiwan', 'taiwanese', 'taiwanjapan', 'taiwans', 'take', 'takes', 'takeshi', 'taking', 'takotsubo', 'taktisches', 'talaromyces', 'tale', 'talens', 'talk', 'tallinn', 'tambi', 'tamifluresistant', 'taming', 'tandem', 'tangminling', 'tanguticum', 'tank', 'tankbinding', 'tannins', 'tanshinone', 'tanzania', 'tanzanian', 'tapasin', 'tapering', 'taqman', 'tar', 'taraxacum', 'tarenna', 'targ1', 'target', 'targeted', 'targeting', 'targets', 'taro', 'task', 'tasks', 'taste', 'tat', 'tatinduced', 'tau', 'taught', 'taura', 'taurocholate', 'taxa', 'taxanebased', 'taxonomic', 'taxonomy', 'tbc2target', 'tbi', 'tbimel', 'tbk1', 'tbk1ikk', 'tcar', 'tcdc', 'tcell', 'tcells', 'tcm', 'tcr', 'tdap', 'tdp', 'tdp43', 'tdp43mediated', 'te', 'tea', 'teaching', 'teaderived', 'teal', 'tears', 'tecelac', 'techne', 'technetium99m', 'technical', 'techniken', 'technique', 'techniques', 'technologies', 'technology', 'teenaged', 'teenagers', 'tefloncoated', 'tegmentum', 'tegumental', 'teil', 'teleconnections', 'telefonisch', 'telefonische', 'telehealth', 'telerehabilitation', 'television', 'tell', 'telmisartan', 'telocyte', 'telocytes', 'telomerase', 'telomere', 'tembusu', 'tempcr', 'temperate', 'temperature', 'temperaturedependent', 'temperatures', 'temperaturesensitive', 'template', 'templates', 'tempo', 'temporal', 'temporally', 'temporary', 'temporomandibular', 'ten', 'tendencias', 'tendons', 'tennessee', 'teno', 'tensile', 'tension', 'tensorcalculator', 'tent', 'tentative', 'tenth', 'terap', 'teratoma', 'term', 'terminal', 'terminally', 'terminals', 'terminated', 'termination', 'terminationreinitiation', 'terminus', 'terms', 'ternary', 'terpene', 'terpenyl', 'terrestrial', 'terreus', 'territories', 'territory', 'terror', 'tertiary', 'terugblik', 'test', 'testable', 'tested', 'testes', 'testing', 'testis', 'testkit', 'tests', 'tetherin', 'tethering', 'tetra', 'tetrachloroethylene', 'tetrahydrohyperforin', 'tetrameric', 'tetraspanin', 'tetratricopeptide', 'tetravalent', 'texas', 'text', 'textile', 'tfh', 'tg', 'tg01', 'tg01gmcsf', 'tge', 'tgev', 'tgf', 'tgn3841', 'tgrop18', 'th', 'th1', 'th17', 'th17tregs', 'th1like', 'th1type', 'th2', 'th2th1', 'thai', 'thailand', 'thalassemia', 'thaliana', 'thank', 'the', 'thecoronaviridae', 'thecoronavirus', 'theiler', 'theilers', 'theimunopathogenesis', 'thelper', 'themes', 'theoretic', 'theoretical', 'theories', 'theory', 'theranostics', 'therapeautic', 'therapeutic', 'therapeutics', 'therapeutische', 'therapie', 'therapieform', 'therapieneue', 'therapieoption', 'therapies', 'therapiestudien', 'therapists', 'therapy', 'therapyrelated', 'therapyscore', 'thermal', 'thermally', 'thermodilution', 'thermodynamic', 'thermodynamics', 'thermogenesis', 'thermoresponsive', 'thermostable', 'theyambuku', 'thi', 'thiaheterocyclic', 'thiazolidines', 'thickness', 'thilo', 'thing', 'think', 'thinker', 'thinking', 'thiopurine', 'thioredoxin1', 'third', 'thirteen', 'thoracic', 'thoracoscopic', 'thoracoscopy', 'thorax', 'thoraxrntgen', 'thorns', 'thoughts', 'thrapeutique', 'thread', 'threat', 'threatens', 'threats', 'three', 'threedimensional', 'threegeneration', 'threeplayer', 'threeyear', 'threshold', 'thresholds', 'throat', 'thrombocytopaenia', 'thrombocytopenia', 'thrombocytopenic', 'thromboembolism', 'thrombomodulin', 'thrombopenie', 'thrombosis', 'thrombotic', 'thrombotische', 'thrombozytentransfusion', 'throughout', 'throughput', 'throws', 'thunnus', 'thuringiensis', 'thursday', 'thus', 'thwarts', 'thy1', 'thylakoid', 'thymic', 'thymocyte', 'thymoglobulin', 'thymus', 'thyroglobulin', 'thyroid', 'thyroidectomy', 'tib', 'tibetan', 'tibrovirus', 'tica', 'tick', 'tickborne', 'ticket', 'ticks', 'tidal', 'tie', 'tie2agonist', 'tie2expressing', 'tied', 'tier', 'ties', 'tiger', 'tight', 'tikur', 'tilapia', 'tilorone', 'tim', 'tim1', 'tim3galectin', 'time', 'timecontrolled', 'timedependent', 'timeliness', 'timely', 'timepoints', 'timeresolved', 'times', 'timeseries', 'timevarying', 'timing', 'tiny', 'tio', 'tio2', 'tions', 'tionssoziologie', 'tip', 'tipe2', 'tipping', 'tips', 'tirucalli', 'tissue', 'tissueresident', 'tissues', 'tissues1', 'tissuespecific', 'titania', 'titanium', 'titer', 'titers', 'title', 'titles', 'titration', 'titre', 'tlr', 'tlr2', 'tlr2mediated', 'tlr3', 'tlr4', 'tlr4mediated', 'tlr8', 'tlr9', 'tlrmediated', 'tlymphocytes', 'tmem27', 'tmev', 'tmprss2', 'tmprss2erg', 'tmv', 'tn', 'tnf', 'tnfinduced', 'to', 'toads', 'tobacco', 'tobamoviruses', 'tobramycin', 'today', 'todays', 'tof', 'together', 'toilet', 'tokyo', 'tolerability', 'tolerance', 'toll', 'tollip', 'tolllike', 'tombusviridae', 'tombusvirus', 'tome', 'tomentosa', 'tomography', 'tomorrow', 'tonb', 'tonic', 'tonsil', 'tonsillar', 'tool', 'toolbox', 'toolmgrat', 'tools', 'toona', 'top', 'topic', 'topical', 'topics', 'topische', 'topographic', 'topographical', 'topology', 'torilidis', 'toro', 'toronto', 'toroviridae', 'torovirus', 'torpedo', 'torque', 'torsional', 'tos', 'tostreptococcus', 'total', 'totalbody', 'totalcrp', 'touch', 'tour', 'tourism', 'toutes', 'toward', 'towards', 'towel', 'town', 'toxascaris', 'toxic', 'toxicity', 'toxicodynamics', 'toxicogenomic', 'toxicogenomics', 'toxicokinetics', 'toxicological', 'toxicology', 'toxicshocksyndrom', 'toxikologie', 'toxikologische', 'toxin', 'toxins', 'toxinsstimulated', 'toxischen', 'toxocara', 'toxoplasma', 'toxoplasmose', 'toxoplasmosis', 'toyoi', 'tp53', 'tpiece', 'trabajo', 'trabecular', 'tracer', 'tracers', 'traces', 'trachea', 'tracheal', 'tracheobronchial', 'tracheoesophageal', 'tracheostomy', 'tracheotomized', 'tracheotomy', 'tracing', 'track', 'tracking', 'tracks', 'tract', 'tracts', 'trade', 'tradeoffs', 'traders', 'trading', 'traditional', 'traf', 'traf3', 'traf6', 'traffic', 'trafficdriven', 'trafficking', 'tragedy', 'trail', 'train', 'trainees', 'training', 'traitees', 'traitement', 'traits', 'trajectories', 'trans', 'transactivator', 'transactivity', 'transaminases', 'transatlantic', 'transchromosomal', 'transchromosomic', 'transcript', 'transcriptase', 'transcription', 'transcriptional', 'transcriptionloopmediated', 'transcriptionpolymerase', 'transcriptions', 'transcriptlevel', 'transcriptome', 'transcriptomes', 'transcriptomewide', 'transcriptomic', 'transcriptomics', 'transcripts', 'transcytosis', 'transdermal', 'transducertriggered', 'transduction', 'transfection', 'transfer', 'transferase', 'transferred', 'transferrin', 'transferring', 'transfers', 'transformation', 'transforming', 'transfuse', 'transfusing', 'transfusion', 'transfusions', 'transfusionsreaktionen', 'transgender', 'transgene', 'transgenes', 'transgenesis', 'transgenic', 'transient', 'transit', 'transition', 'transitional', 'transitions', 'transitiontransversion', 'transjugular', 'translating', 'translation', 'translational', 'translations', 'translesion', 'translocation', 'translocations', 'transmediastinaler', 'transmembrane', 'transmissibility', 'transmissible', 'transmission', 'transmissionbased', 'transmissions', 'transmitted', 'transmural', 'transnasal', 'transnational', 'transparency', 'transparent', 'transpecies', 'transpeptidase', 'transplant', 'transplantable', 'transplantassociated', 'transplantation', 'transplanted', 'transplantrelated', 'transplants', 'transport', 'transport1', 'transportation', 'transported', 'transporter', 'transporters', 'transporting', 'transposase', 'transposon', 'transpulmonary', 'transspecies', 'transsulfuration', 'transsynaptic', 'transthoracic', 'transthorakaler', 'transvenous', 'trap', 'trappe', 'trapping', 'traps', 'trastornos', 'tratamiento', 'trauma', 'traumadornase', 'traumainformed', 'traumais', 'traumanetzwerk', 'traumaregister', 'traumarelated', 'traumatic', 'travel', 'travel23', 'traveler', 'travelers', 'traveling', 'traveller', 'travellers', 'travelling', 'travepinet', 'treat', 'treated', 'treating', 'treatment', 'treatmentresistant', 'treatments', 'treats', 'tree', 'treebased', 'treeinbud', 'treelike', 'trees', 'treg', 'tregs', 'tregulatory', 'trend', 'trending', 'trends', 'treponema', 'tresse', 'trfs', 'triad', 'triaditis', 'triage', 'trial', 'trialists', 'trials', 'triamcinolone', 'triamine', 'triantennary', 'triazolooxazine', 'tribute', 'trichoderma', 'trichophyton', 'trichotomum', 'triciens', 'trick', 'tricks', 'triclocarban', 'triclosan', 'trico', 'trif', 'trifluoromethylthiomethyl', 'trifolia', 'trigger', 'triggered', 'triggering', 'triggers', 'trim21', 'trim25', 'trim25mediated', 'trim41mediated', 'trim56mediated', 'trimarker', 'trimellitic', 'trimer', 'trimeric', 'trimesterdependent', 'trimethoprim', 'trimming', 'trinidad', 'trinkwasser', 'trinkwasseraufbereitung', 'trip', 'triphibious', 'triphosphatase', 'triple', 'triplenegative', 'triplestranded', 'triplet', 'triplets', 'triplex', 'tripsplus', 'tristeza', 'triterpenoid', 'triton', 'tritryp', 'trivalent', 'trivial', 'trna', 'trnalike', 'trne', 'trnl', 'troa', 'trojan', 'troopchief', 'tropenaufenthalt', 'tropenerkrankungen', 'tropheryma', 'trophoblastic', 'tropic', 'tropical', 'tropics', 'tropism', 'trotz', 'trouble', 'troubled', 'trout', 'trp', 'trpfcheninfektion', 'trpv6', 'true', 'truncation', 'trust', 'trusts', 'truth', 'trutip', 'trypanosoma', 'trypanosomal', 'trypanosomatid', 'trypanosome', 'trypanosomes', 'trypsin', 'trypsinogen', 'tryptophan', 'tsa58', 'tsen54', 'tsetse', 'tsg', 'tshaped', 'tsinghua', 'tsklinikum', 'tssf', 'tssg', 'tssk', 'tsutsugamushi', 'tt51', 'ttf1nkx2', 'ttingen', 'ttsuv1', 'ttsuv2', 'tube', 'tuber', 'tuberculosis', 'tuberculosisinfected', 'tuberculous', 'tuberkulose', 'tubes', 'tubular', 'tubule', 'tuesday', 'tularensis', 'tulathromycin', 'tumor', 'tumoren', 'tumorigenic', 'tumorigenicity', 'tumornekrosefaktors', 'tumors', 'tumortreating', 'tumour', 'tumourinfiltrating', 'tumours', 'tuna', 'tunisian', 'tunnel', 'turbidimetric', 'turbulator', 'turbulence', 'turkey', 'turkeys', 'turn', 'turning', 'turnip', 'tweaking', 'twelve', 'twentieth', 'twenty', 'twentyfirst', 'twentyfiveyear', 'twentyfour', 'twinspan', 'twist', 'twitter', 'two', 'twodimensional', 'twohybrid', 'twopatch', 'twophase', 'twospeed', 'twostage', 'twostep', 'twotarget', 'twoyear', 'ty21a', 'tylosema', 'tymv', 'type', 'type1', 'type2', 'typei', 'typeii', 'types', 'typespecific', 'typhimurium', 'typhoid', 'typhus', 'typing', 'tyrosinase', 'tyrosine', 'tzung', 'uba', 'ubiquitin', 'ubiquitination', 'ubiquitindependent', 'ubiquitinlike', 'ubiquitinproteasome', 'ubiquitinspecific', 'ubiquitylation', 'ucbg', 'uenza', 'ufd1', 'uganda', 'ugandan', 'uglingen', 'uk', 'ukraine', 'ul44', 'ulc', 'ulcerans', 'ulcerative', 'ulk12', 'ulmer', 'ultra', 'ultracentrifugation', 'ultradeep', 'ultralong', 'ultralow', 'ultramicroscopic', 'ultraschalldiagnostik', 'ultrasensitive', 'ultrasonography', 'ultrasound', 'ultrastructural', 'ultrastructure', 'ultraviolet', 'ultravioletc', 'ulzerierende', 'um', 'umbilical', 'umra', 'umrah', 'umweltbundesamt', 'un', 'una', 'unadjuvanted', 'unaffected', 'unanesthetized', 'unbalanced', 'unc93b1', 'uncertain', 'uncertainties', 'uncertainty', 'unclogging', 'uncoating', 'uncommon', 'uncomplicated', 'uncontrollable', 'unconventional', 'uncovered', 'uncovering', 'uncovers', 'uncultured', 'und', 'undecane', 'under', 'underestimate', 'underestimated', 'undergo', 'undergoing', 'underground', 'underlies', 'underlying', 'underpinning', 'underpinnings', 'underrecognized', 'underserved', 'understanding', 'understandings', 'underutilized', 'underway', 'undescribed', 'undesirable', 'undetectable', 'undifferentiated', 'undiluted', 'undppcr', 'une', 'unequivocal', 'unerw', 'unexpected', 'unexpectedly', 'unexplained', 'unfallchirurgie', 'unfolded', 'unfolding', 'unfolds', 'ungew', 'unicancer', 'unidentified', 'unidos', 'unified', 'uniform', 'unifying', 'unilateral', 'uninfected', 'uninsured', 'union', 'uniportal', 'unique', 'uniqueness', 'unit', 'unitacquired', 'united', 'units', 'unity', 'univ', 'universal', 'universally', 'universit', 'university', 'unklares', 'unknown', 'unknowns', 'unlikely', 'unmanipulated', 'unmasks', 'unmeasured', 'unmet', 'unobservable', 'unpackaging', 'unplanned', 'unprimed', 'unravel', 'unraveling', 'unravelling', 'unrealistic', 'unrelated', 'unresectable', 'unresponsive', 'unscheduled', 'unsealed', 'unsecured', 'unsinn', 'unter', 'unteren', 'unterschiedlichem', 'untersuchung', 'untersuchungen', 'untranslated', 'untreatable', 'unusual', 'unusually', 'unvaccinated', 'unveils', 'up', 'update', 'updated', 'updates', 'updating', 'uplc', 'upon', 'upper', 'upregulated', 'upregulates', 'upregulating', 'upregulation', 'upsetting', 'upstream', 'upsurge', 'uptake', 'uracil', 'uranium', 'urban', 'urbanisation', 'urbanite', 'urbanization', 'urchin', 'urealyticum', 'ureaplasma', 'urease', 'uremic', 'ureteral', 'urethral', 'urged', 'urgences', 'urgent', 'urgents', 'urges', 'uric', 'uridine', 'uridyltransferase', 'urinary', 'urine', 'urinstatus', 'urogenital', 'uropathogenic', 'uropeltid', 'uropeltidae', 'urothelial', 'ursache', 'uruguayan', 'us', 'usa', 'usacolorado2013', 'usage', 'usb1', 'uscap', 'use', 'used', 'useful', 'usefulness', 'user', 'userindependent', 'users', 'uses', 'using', 'usp15', 'usp18', 'usp46', 'uspio', 'usstyle', 'usual', 'usutu', 'utero', 'utico', 'utility', 'utilizaci', 'utilization', 'utilize', 'utilizes', 'utilizing', 'uukuniemi', 'uv', 'uvbinduced', 'uvc', 'uveitis', 'uvgi', 'v1v2', 'va1', 'vaa', 'vaca', 'vacainduced', 'vaccin', 'vaccinal', 'vaccinate', 'vaccinated', 'vaccinating', 'vaccination', 'vaccinations', 'vaccine', 'vaccineenhanced', 'vaccineinduced', 'vaccines', 'vaccines1', 'vaccinia', 'vaccinology', 'vaccinomics', 'vaches', 'vacuolar', 'vacuolartype', 'vacuolation', 'vacuole', 'vacv', 'vaginal', 'vaginosis', 'vagotomy', 'valencia', 'valentine', 'valid', 'validated', 'validation', 'validity', 'valley', 'valor', 'valoracin', 'valuation', 'value', 'valuer', 'values', 'valve', 'valves', 'vampire', 'van', 'vancomycin', 'vancomycinresistant', 'var', 'var2csa', 'varadharajan', 'variability', 'variable', 'variables', 'variafrica', 'variant', 'variants', 'variation', 'variations', 'varicella', 'varicellazoster', 'varices', 'varied', 'varieties', 'various', 'varizellazostersepsis', 'vary', 'varying', 'vascular', 'vascularized', 'vasculature', 'vasculitic', 'vasculitis', 'vasculotide', 'vaskulitiden', 'vasodilators', 'vasoplegic', 'vasopressin', 'vcpp97', 'veal', 'vecadherin', 'vector', 'vectorbased', 'vectorborne', 'vectored', 'vectores', 'vectormediated', 'vectors', 'vedotin', 'vegas', 'vegf', 'vehicle', 'veiceschi', 'veillonella', 'vein', 'veinoveineuse', 'vellore', 'velocity', 'velogenic', 'vence', 'venereal', 'venezuela', 'venezuelan', 'venoarterial', 'venom', 'venomous', 'venoms', 'venoocclusive', 'venous', 'venoustoarterial', 'venovenous', 'ventil', 'ventilated', 'ventilation', 'ventilationinduced', 'ventilationperfusion', 'ventilator', 'ventilatorassociated', 'ventilatorinduced', 'ventilators', 'ventilatory', 'ventilo', 'vention', 'ventionskonzepte', 'ventral', 'ventricular', 'ventrolateral', 'ventures', 'verantwortung', 'verbessern', 'verbreitung', 'verdachtsf', 'vereist', 'verf', 'verfahren', 'vergangenen', 'vergleich', 'verhalten', 'verified', 'verigene', 'verlauf', 'verleihung', 'vernakalant', 'vernakalantfacilitated', 'vernal', 'vero', 'verrucosum', 'vers', 'versatile', 'versatility', 'version', 'verslag', 'versorgung', 'verspteter', 'versus', 'vertebra', 'vertebral', 'vertebrate', 'vertebrates', 'verteilungsgerechtigkeit', 'vertical', 'vertrauen', 'vertrouwen', 'verursacht', 'verursachtes', 'verwendung', 'verzeichnis', 'vesicle', 'vesicles', 'vesicular', 'vesiculation', 'vesiculovirus', 'vessel', 'vessels', 'veterin', 'veterinarians', 'veterinary', 'vgc', 'vhh', 'vi', 'via', 'viability', 'viable', 'viajar', 'viajero', 'vial', 'vibrating', 'vibrio', 'vicarious', 'vicinity', 'victims', 'vid19', 'videoassisted', 'videos', 'viel', 'vientiane', 'viet', 'vietnam', 'vietnamese', 'view', 'viewer', 'viewing', 'viewpoint', 'views', 'vigen', 'vigilant', 'vignettes', 'vii', 'viia', 'viii', 'viiirelated', 'ville', 'villus', 'vimentin', 'vincristine', 'violence', 'vip', 'viraemia', 'viral', 'viralbacterial', 'virale', 'viralen', 'virales', 'viralinduced', 'virally', 'viralorfeome', 'viralspecific', 'viralvectored', 'viremia', 'viremic', 'viren', 'virhostnet', 'viridans', 'virion', 'virionloaded', 'virions', 'viroj', 'virologic', 'virological', 'virologique', 'virology', 'virolysis', 'virome', 'virophages', 'viroporins', 'viroses', 'virosomally', 'virotherapy', 'virtual', 'virtually', 'virtue', 'virucidal', 'virulence', 'virulent', 'virulentavirulent', 'virus', 'virus1', 'virus2', 'virus3', 'virusantibodyfree', 'virusassociated', 'virusbased', 'virusdesinfektion', 'virusdiscoverycdna', 'viruses', 'virusganjam', 'virusgenerated', 'virushost', 'virusimmune', 'virusin', 'virusinduced', 'virusinduzierter', 'virusinfected', 'virusinfektionen', 'virusjhm', 'viruskrankheiten', 'viruslike', 'virusmediated', 'virusneutralizing', 'virusreceptor', 'virusrelated', 'virussensing', 'virusspecific', 'virustransformed', 'virusvectored', 'viruzidie', 'visceral', 'viscosity', 'visibility', 'visible', 'visiblelightresponsive', 'visions', 'visitor', 'visitors', 'visits', 'visna', 'vistas', 'visual', 'visualization', 'visualized', 'visualizing', 'vitaceae', 'vital', 'vitalsigns', 'vitamin', 'vitamins', 'vith', 'vitiligo', 'vitreous', 'vitro', 'vivax', 'vivaxassociated', 'vivo', 'vivomorpholinos', 'vizions', 'vlp', 'vlps', 'vlse1', 'vntr', 'vo2', 'vocal', 'vod', 'vogelgriepvirus', 'voice', 'voiding', 'voie', 'voies', 'vol', 'volailles', 'volatile', 'volcanii', 'vole', 'voltage', 'voltammetric', 'volume', 'volumen', 'volumes', 'voluntary', 'volunteer', 'volunteered', 'volunteers', 'volution', 'volver', 'volvulus', 'vom', 'vomeronasal', 'vomiting', 'von', 'voor', 'vor', 'vorbereitungsfragen', 'vorbestimmt', 'vorgehen', 'vorn', 'vote', 'votu', 'vox', 'vp1', 'vp2', 'vp3', 'vp4', 'vp40', 'vp5', 'vp60', 'vpg', 'vps3', 'vps8', 'vpu', 'vr2332', 'vratza', 'vre', 'vrna', 'vrs', 'vs', 'vsels', 'vsig4', 'vsnare', 'vsv', 'vsvg', 'vue', 'vulgaris', 'vulnerability', 'vulnerable', 'vulnificus', 'vuong', 'vvecmo', 'waiting', 'wake', 'walds', 'wales', 'walk', 'walks', 'wall', 'walmrath', 'wand', 'wang', 'waning', 'want', 'war', 'ward', 'wards', 'warfare', 'warm', 'warming', 'warned', 'warning', 'warnings', 'warns', 'warum', 'wary', 'warzone', 'washes', 'washing', 'washington', 'waste', 'wastes', 'wastewater', 'wasting', 'watch', 'watchdogs', 'watchful', 'watching', 'water', 'waterassociated', 'waterborne', 'waterextractable', 'waterfowl', 'waterrelated', 'watershed', 'watersoluble', 'wave', 'waves', 'way', 'ways', 'wc3', 'wd40repeat', 'wdrepeat', 'weak', 'weakness', 'wealth', 'weaned', 'weaning', 'weanling', 'weapons', 'wearable', 'wearing', 'weather', 'web', 'webbased', 'webs', 'website', 'wednesday', 'weed', 'week', 'weekly', 'weeks', 'wei', 'weichteilinfektionen', 'weigh', 'weight', 'weihai', 'welfare', 'well', 'wellbeing', 'wenshan', 'werden', 'west', 'western', 'westlichen', 'wet', 'wetlands', 'wettbewerbsf', 'wfpha', 'wgs', 'wha', 'whale', 'whales', 'whats', 'wheeze', 'wheezing', 'whipplei', 'white', 'whitetoothed', 'whointegrate', 'whole', 'wholeblood', 'wholecell', 'wholegenome', 'wholegenomebased', 'whooping', 'whorl', 'whos', 'whose', 'wicked', 'wide', 'widely', 'widespread', 'wie', 'wiederbelebung', 'wiedermann', 'wien', 'wikipedia', 'wild', 'wildlife', 'wildtype', 'willdenowii', 'willebrand', 'willebrands', 'willi', 'william', 'willingness', 'wilms', 'wilt', 'windborne', 'window', 'winn', 'winner', 'winners', 'wins', 'winter', 'wir', 'wirelesscontrolled', 'wirelessly', 'wirksamkeit', 'wirkung', 'wirtschaftlichkeit', 'wisconsin', 'wishful', 'wissen', 'wissensbasiert', 'wissenschaften', 'wissenschaftliche', 'wistar', 'with', 'withanolides', 'within', 'withinand', 'withinflight', 'withinhost', 'withmycoplasma', 'without', 'witness', 'wiwanitkit', 'wnt3a', 'wobble', 'wobbling', 'wochenbett', 'woher', 'wolbachia', 'wolves', 'woman', 'women', 'woodall', 'woodchuck', 'woodland', 'word', 'work', 'worker', 'workers', 'workflow', 'workforce', 'workgroup', 'working', 'workload', 'workplace', 'workrelated', 'works', 'workshop', 'workshops', 'workup', 'world', 'worldwide', 'worms', 'worries', 'worrying', 'worsening', 'worsens', 'worst', 'worth', 'would', 'wound', 'wounds', 'wrapping', 'wrath', 'writing', 'wrong', 'wssv', 'wto', 'wu', 'wuhan', 'xanthine', 'xanthomonas', 'xautosomal', 'xb130', 'xbp1', 'xendou', 'xenogeneic', 'xenogeneicfree', 'xenograft', 'xenografts', 'xenon', 'xenotransplantation', 'xiao', 'xiaokang', 'xiap', 'xie', 'xiii', 'xiiith', 'xiith', 'xlinked', 'xmap', 'xmrv', 'xofigo', 'xpert', 'xray', 'xrays', 'xrn1', 'xtag', 'xth', 'xv', 'xvi', 'xxi', 'xxiv', 'xyloketal', 'yam', 'yao', 'year', 'years', 'yeast', 'yeasts', 'yellow', 'yellowemitting', 'yellowhead', 'yellowstone', 'yemen', 'yersinia', 'yersiniosis', 'yet', 'yield', 'yields', 'yl', 'ylidene', 'yokohama', 'yolk', 'yolks', 'york', 'young', 'youth', 'yu', 'yunnan', 'zaire', 'zaken', 'zambia', 'zanella', 'zap', 'zap70', 'zealand', 'zealands', 'zebrafish', 'zecken', 'zeichen', 'zeigt', 'zeitalter', 'zeiten', 'zeitgerechte', 'zell', 'zellbiologische', 'zellulre', 'zentralnervensystems', 'zero', 'zhejiang', 'zhong', 'zhu', 'ziad', 'zieke', 'ziele', 'zika', 'zikv', 'zimmermann', 'zinc', 'zip', 'zipper', 'ziziphus', 'zn2', 'zoia', 'zonal', 'zone', 'zoobenthos', 'zoological', 'zoonoses', 'zoonosis', 'zoonotic', 'zoonotics', 'zoonotische', 'zooplankton', 'zoster', 'zu', 'zucc', 'zuckerliganden', 'zufspzup1', 'zuk', 'zukunft', 'zulassungsstudie', 'zum', 'zur', 'zusammenarbeit', 'zusammenfassung', 'zust', 'zwei', 'zwischen', 'zwischenbilanz']\n"
     ]
    }
   ],
   "source": [
    "vectorizer = TfidfVectorizer(max_features=2 ** 15)\n",
    "X = vectorizer.fit_transform(clean_text)\n",
    "print(vectorizer.get_feature_names())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(10000, 16486)"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "X.shape"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Q1c)\tTF-IDF vectors are sparse and of large dimension. Reduce them into only 2 dimensions using PCA. [2 pt]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Perform PCA"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "pca = PCA(n_components = 2)\n",
    "X_principal = pca.fit_transform(X.toarray())\n",
    "X_principal = pd.DataFrame(X_principal)\n",
    "X_principal.columns = ['P1', 'P2']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>P1</th>\n",
       "      <th>P2</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>-0.001854</td>\n",
       "      <td>0.038506</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0.017017</td>\n",
       "      <td>0.031081</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0.010028</td>\n",
       "      <td>0.007727</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0.014998</td>\n",
       "      <td>0.036999</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>-0.054082</td>\n",
       "      <td>-0.059919</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9995</th>\n",
       "      <td>-0.028859</td>\n",
       "      <td>-0.010452</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9996</th>\n",
       "      <td>0.018941</td>\n",
       "      <td>-0.021871</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9997</th>\n",
       "      <td>0.028639</td>\n",
       "      <td>-0.003355</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9998</th>\n",
       "      <td>0.019879</td>\n",
       "      <td>-0.019424</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9999</th>\n",
       "      <td>0.017359</td>\n",
       "      <td>-0.032035</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>10000 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            P1        P2\n",
       "0    -0.001854  0.038506\n",
       "1     0.017017  0.031081\n",
       "2     0.010028  0.007727\n",
       "3     0.014998  0.036999\n",
       "4    -0.054082 -0.059919\n",
       "...        ...       ...\n",
       "9995 -0.028859 -0.010452\n",
       "9996  0.018941 -0.021871\n",
       "9997  0.028639 -0.003355\n",
       "9998  0.019879 -0.019424\n",
       "9999  0.017359 -0.032035\n",
       "\n",
       "[10000 rows x 2 columns]"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "X_principal"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#  Q2).\tPerform K-means clustering for different values of K (2,3,4,5) and evaluate the quality of clustering using Silhouette score. [4 points]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "# run kmeans with many different k\n",
    "distortions = []\n",
    "K = range(2, 6)\n",
    "for k in K:\n",
    "    k_means = KMeans(n_clusters=k, random_state=42, n_jobs=-1).fit(X_principal)\n",
    "    k_means.fit(X_principal)\n",
    "    distortions.append(sum(np.min(cdist(X_principal, k_means.cluster_centers_, 'euclidean'), axis=1)) / X.shape[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "X_line = [K[0], K[-1]]\n",
    "Y_line = [distortions[0], distortions[-1]]\n",
    "\n",
    "# Plot the elbow\n",
    "plt.plot(K, distortions, 'b-')\n",
    "plt.plot(X_line, Y_line, 'r')\n",
    "plt.xlabel('k')\n",
    "plt.ylabel('Distortion')\n",
    "plt.title('The Elbow Method showing the optimal k')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Q2a).\tFor each value of K, plot clusters (all cluster points in same cluster with same color, cluster points in different cluster in different colors). [2 pt]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "for k in range(2,6):\n",
    "    kmeans = KMeans(n_clusters=k)\n",
    "    y_pred = kmeans.fit_predict(X_principal)\n",
    "    df['y'] = y_pred\n",
    "\n",
    "    # plot\n",
    "    palette = sns.hls_palette(k, l=0.5, s=1)\n",
    "    sns.scatterplot(X_principal['P1'], X_principal['P2'], hue=y_pred, legend='full', palette=palette)\n",
    "    plt.title('For No. of Clusters = '+str(k))\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Plot Elbow Curve and SSE Curve"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "For n_clusters=2, the silhouette score is 0.7095192409952279\n",
      "For n_clusters=2, the SSE score is 66.655771691419\n",
      "\n",
      "\n",
      "For n_clusters=3, the silhouette score is 0.6401796490612037\n",
      "For n_clusters=3, the SSE score is 41.99673162072677\n",
      "\n",
      "\n",
      "For n_clusters=4, the silhouette score is 0.6680302696191669\n",
      "For n_clusters=4, the SSE score is 27.425426254195116\n",
      "\n",
      "\n",
      "For n_clusters=5, the silhouette score is 0.6691515086511521\n",
      "For n_clusters=5, the SSE score is 20.756311231598644\n",
      "\n",
      "\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "ss = []\n",
    "sse = []\n",
    "for k in range(2,6):\n",
    "    kmeans = KMeans(n_clusters=k).fit(X_principal)\n",
    "    ss.append([k,silhouette_score(X_principal,kmeans.labels_)])\n",
    "    sse.append([k,kmeans.inertia_])\n",
    "    silhouette_avg = silhouette_score(X_principal,kmeans.labels_)\n",
    "    print(\"For n_clusters={0}, the silhouette score is {1}\".format(k,silhouette_avg))\n",
    "    print(\"For n_clusters={0}, the SSE score is {1}\".format(k,kmeans.inertia_))\n",
    "    print(\"\\n\")\n",
    "    \n",
    "# Plotting for Silhouette Score & SSE\n",
    "temp = pd.DataFrame(ss)\n",
    "plt.plot(temp[0], temp[1], color='b', marker = 'o', markerfacecolor = 'r')\n",
    "plt.xlabel('Number of Clusters')\n",
    "plt.ylabel('Silhouette Score')\n",
    "plt.title(\"Measuring Clustering Quality, using Silhouette Score\")\n",
    "plt.show()\n",
    "\n",
    "# Plotting for SSE \n",
    "temp1= pd.DataFrame(sse)\n",
    "plt.plot(temp1[0], temp1[1], color='r', marker = 'o', markerfacecolor = 'b')\n",
    "plt.xlabel('Number of Clusters')\n",
    "plt.ylabel('SSE')\n",
    "plt.title(\"Measuring Clustering Quality, using SSE\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Q2b).\tDraw a bar graph with X-axis as K value and Y-axis as silhouette score. [1 pt]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "For n_clusters=2, the silhouette score is 0.7109395215266047\n",
      "For n_clusters=3, the silhouette score is 0.6401796490612037\n",
      "For n_clusters=4, the silhouette score is 0.6680302696191669\n",
      "For n_clusters=5, the silhouette score is 0.6691434471802775\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "ss = []\n",
    "for k in range(2,6):\n",
    "    kmeans = KMeans(n_clusters=k).fit(X_principal)\n",
    "    ss.append(silhouette_score(X_principal,kmeans.labels_))\n",
    "    silhouette_avg = silhouette_score(X_principal,kmeans.labels_)\n",
    "    print(\"For n_clusters={0}, the silhouette score is {1}\".format(k,silhouette_avg))\n",
    "\n",
    "k=[2,3,4,5]\n",
    "plt.bar(k, ss,color='b')\n",
    "plt.xlabel('Number of clusters', fontsize = 20)\n",
    "plt.ylabel('S (i)', fontsize = 20)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## For n_clusters = 4 have Silhouette Score = 0.6679"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Q2c)\tExplain (1-2 lines) which is the best clustering and why. [1 pt]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Answer 2c). \n",
    "\n",
    "## Inference : From the Silhouette Score(s) and SSE values plotted, the 'Best Cluster' is 4"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "#nltk.download()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "#!pip install apyori"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>clinical features cultureproven mycoplasma pne...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>nitric oxide proinflammatory mediator lung dis...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>surfactant proteind pulmonary host defense</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>role endothelin1 lung disease</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>gene expression epithelial cells response pneu...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                               title\n",
       "0  clinical features cultureproven mycoplasma pne...\n",
       "1  nitric oxide proinflammatory mediator lung dis...\n",
       "2         surfactant proteind pulmonary host defense\n",
       "3                      role endothelin1 lung disease\n",
       "4  gene expression epithelial cells response pneu..."
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_cleantext = pd.DataFrame(clean_text,columns=['title'])\n",
    "df_cleantext.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# 3).\tConsider the pre-processed title text of all articles and find words which frequently occur together. [4 points]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "records = []\n",
    "total_rows = df_cleantext.shape[0]\n",
    "for i, row in df_cleantext.iterrows():\n",
    "    records.append(word_tokenize(row.iat[0]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "def apply_apriori(records, min_support, min_confidence, min_lift, min_length):\n",
    "    association_rules = apriori(records, min_support=min_support, min_confidence=min_confidence, min_lift=min_lift, min_length=min_length)\n",
    "    return list(association_rules)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "def print_association_results(association_results):\n",
    "    for item in association_results:\n",
    "\n",
    "        # first index of the inner list\n",
    "        # Contains base item and add item\n",
    "        pair = item[0] \n",
    "        items = [x for x in pair]\n",
    "        print(\"Rule: \" + items[0] + \" -> \" + items[1])\n",
    "\n",
    "        #second index of the inner list\n",
    "        print(\"Support: \" + str(item[1]))\n",
    "\n",
    "        #third index of the list located at 0th\n",
    "        #of the third index of the inner list\n",
    "\n",
    "        print(\"Confidence: \" + str(item[2][0][2]))\n",
    "        print(\"Lift: \" + str(item[2][0][3]))\n",
    "        print(\"=====================================\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# 3a)\tMore specifically, find association rules of minimum length 2 with 20% confidence and 10% support. Other parameters you are free to decide on your own. How many such rules are there? List all the rules. Interpret any one rule. [2 pt]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [],
   "source": [
    "results = pd.DataFrame(columns = ['Support(%)', 'Confidence(%)', 'Total Association Results'])\n",
    "\n",
    "#Define Confidence Range from 0% to 100%\n",
    "confidence_range = [0.0,0.1,0.2,0.3,0.4,0.5,0.6,0.7,0.8,0.9,1.0]\n",
    "\n",
    "#Define Support values from 0.5%, 1%, 10%\n",
    "support_vals = [0.005,0.01,0.1,0.2, 0.5]\n",
    "association_results1 = 0\n",
    "for i in confidence_range:\n",
    "    for j in support_vals:\n",
    "        association_results = apply_apriori(records, min_support=j, min_confidence=i, min_lift=2, min_length=2)\n",
    "        if association_results1 == 0:\n",
    "            association_results1 = association_results\n",
    "        results = results.append({'Support(%)' : j*100, 'Confidence(%)' : i*100, 'Total Association Results' : len(association_results)}, \n",
    "                 ignore_index = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Support(%)</th>\n",
       "      <th>Confidence(%)</th>\n",
       "      <th>Total Association Results</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.5</td>\n",
       "      <td>0.0</td>\n",
       "      <td>64.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>17.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>10.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>20.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>50.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>0.5</td>\n",
       "      <td>10.0</td>\n",
       "      <td>64.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>1.0</td>\n",
       "      <td>10.0</td>\n",
       "      <td>17.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>10.0</td>\n",
       "      <td>10.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>20.0</td>\n",
       "      <td>10.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>50.0</td>\n",
       "      <td>10.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>0.5</td>\n",
       "      <td>20.0</td>\n",
       "      <td>57.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>1.0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>16.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>10.0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>20.0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>50.0</td>\n",
       "      <td>20.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>0.5</td>\n",
       "      <td>30.0</td>\n",
       "      <td>49.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>1.0</td>\n",
       "      <td>30.0</td>\n",
       "      <td>16.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>10.0</td>\n",
       "      <td>30.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>20.0</td>\n",
       "      <td>30.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>50.0</td>\n",
       "      <td>30.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>0.5</td>\n",
       "      <td>40.0</td>\n",
       "      <td>41.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>1.0</td>\n",
       "      <td>40.0</td>\n",
       "      <td>14.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>10.0</td>\n",
       "      <td>40.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>20.0</td>\n",
       "      <td>40.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>50.0</td>\n",
       "      <td>40.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>0.5</td>\n",
       "      <td>50.0</td>\n",
       "      <td>37.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>1.0</td>\n",
       "      <td>50.0</td>\n",
       "      <td>13.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>10.0</td>\n",
       "      <td>50.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>20.0</td>\n",
       "      <td>50.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>50.0</td>\n",
       "      <td>50.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>0.5</td>\n",
       "      <td>60.0</td>\n",
       "      <td>31.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>1.0</td>\n",
       "      <td>60.0</td>\n",
       "      <td>12.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>10.0</td>\n",
       "      <td>60.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>20.0</td>\n",
       "      <td>60.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>50.0</td>\n",
       "      <td>60.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>0.5</td>\n",
       "      <td>70.0</td>\n",
       "      <td>25.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>1.0</td>\n",
       "      <td>70.0</td>\n",
       "      <td>10.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>10.0</td>\n",
       "      <td>70.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>20.0</td>\n",
       "      <td>70.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>50.0</td>\n",
       "      <td>70.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>0.5</td>\n",
       "      <td>80.0</td>\n",
       "      <td>19.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>1.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>8.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>10.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>20.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>50.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>0.5</td>\n",
       "      <td>90.0</td>\n",
       "      <td>13.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>1.0</td>\n",
       "      <td>90.0</td>\n",
       "      <td>8.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>10.0</td>\n",
       "      <td>90.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>20.0</td>\n",
       "      <td>90.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>50.0</td>\n",
       "      <td>90.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>0.5</td>\n",
       "      <td>100.0</td>\n",
       "      <td>4.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>1.0</td>\n",
       "      <td>100.0</td>\n",
       "      <td>3.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>10.0</td>\n",
       "      <td>100.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>20.0</td>\n",
       "      <td>100.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>50.0</td>\n",
       "      <td>100.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    Support(%)  Confidence(%)  Total Association Results\n",
       "0          0.5            0.0                       64.0\n",
       "1          1.0            0.0                       17.0\n",
       "2         10.0            0.0                        0.0\n",
       "3         20.0            0.0                        0.0\n",
       "4         50.0            0.0                        0.0\n",
       "5          0.5           10.0                       64.0\n",
       "6          1.0           10.0                       17.0\n",
       "7         10.0           10.0                        0.0\n",
       "8         20.0           10.0                        0.0\n",
       "9         50.0           10.0                        0.0\n",
       "10         0.5           20.0                       57.0\n",
       "11         1.0           20.0                       16.0\n",
       "12        10.0           20.0                        0.0\n",
       "13        20.0           20.0                        0.0\n",
       "14        50.0           20.0                        0.0\n",
       "15         0.5           30.0                       49.0\n",
       "16         1.0           30.0                       16.0\n",
       "17        10.0           30.0                        0.0\n",
       "18        20.0           30.0                        0.0\n",
       "19        50.0           30.0                        0.0\n",
       "20         0.5           40.0                       41.0\n",
       "21         1.0           40.0                       14.0\n",
       "22        10.0           40.0                        0.0\n",
       "23        20.0           40.0                        0.0\n",
       "24        50.0           40.0                        0.0\n",
       "25         0.5           50.0                       37.0\n",
       "26         1.0           50.0                       13.0\n",
       "27        10.0           50.0                        0.0\n",
       "28        20.0           50.0                        0.0\n",
       "29        50.0           50.0                        0.0\n",
       "30         0.5           60.0                       31.0\n",
       "31         1.0           60.0                       12.0\n",
       "32        10.0           60.0                        0.0\n",
       "33        20.0           60.0                        0.0\n",
       "34        50.0           60.0                        0.0\n",
       "35         0.5           70.0                       25.0\n",
       "36         1.0           70.0                       10.0\n",
       "37        10.0           70.0                        0.0\n",
       "38        20.0           70.0                        0.0\n",
       "39        50.0           70.0                        0.0\n",
       "40         0.5           80.0                       19.0\n",
       "41         1.0           80.0                        8.0\n",
       "42        10.0           80.0                        0.0\n",
       "43        20.0           80.0                        0.0\n",
       "44        50.0           80.0                        0.0\n",
       "45         0.5           90.0                       13.0\n",
       "46         1.0           90.0                        8.0\n",
       "47        10.0           90.0                        0.0\n",
       "48        20.0           90.0                        0.0\n",
       "49        50.0           90.0                        0.0\n",
       "50         0.5          100.0                        4.0\n",
       "51         1.0          100.0                        3.0\n",
       "52        10.0          100.0                        0.0\n",
       "53        20.0          100.0                        0.0\n",
       "54        50.0          100.0                        0.0"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "538.0"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "results['Total Association Results'].sum()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 3a-1). \n",
    "\n",
    "## Total Number of Rules found : 538 (spread across 55 combination rows for Support %, Confidence %)\n",
    "\n",
    "### i). For the specified Support of 10%, Confidence of 20% and Min Length of 2, the Association Rules found are 0. (Refer Row #12 in table above)\n",
    "\n",
    "\n",
    "### ii). For the Support  of 0.5%, Confidence of 10% and Min Length of  2, the Association Rules found are 64. (Refer Row #5 in table above)\n",
    "\n",
    "\n",
    "### iii). For the Support  of 1%, Confidence of 20% and Min Length of  2, the Association Rules found are 16. (Refer Row #11 in table above)\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Q3a). List all the rules"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Printing the All Association Rules along with Corresponding Support, Confidence, Lift"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Rule: acute -> distress\n",
      "Support: 0.0104\n",
      "Confidence: 0.268733850129199\n",
      "Lift: 23.368160880799913\n",
      "=====================================\n",
      "Rule: injury -> acute\n",
      "Support: 0.0072\n",
      "Confidence: 0.18604651162790697\n",
      "Lift: 14.311270125223613\n",
      "=====================================\n",
      "Rule: lung -> acute\n",
      "Support: 0.0074\n",
      "Confidence: 0.19121447028423774\n",
      "Lift: 8.691566831101715\n",
      "=====================================\n",
      "Rule: acute -> patients\n",
      "Support: 0.0053\n",
      "Confidence: 0.13695090439276486\n",
      "Lift: 3.0501315009524466\n",
      "=====================================\n",
      "Rule: respiratory -> acute\n",
      "Support: 0.0199\n",
      "Confidence: 0.5142118863049097\n",
      "Lift: 9.40058293061992\n",
      "=====================================\n",
      "Rule: acute -> severe\n",
      "Support: 0.0062\n",
      "Confidence: 0.16020671834625322\n",
      "Lift: 7.282123561193329\n",
      "=====================================\n",
      "Rule: acute -> syndrome\n",
      "Support: 0.0133\n",
      "Confidence: 0.34366925064599485\n",
      "Lift: 12.186852859787052\n",
      "=====================================\n",
      "Rule: avian -> influenza\n",
      "Support: 0.0118\n",
      "Confidence: 0.6900584795321637\n",
      "Lift: 8.669076376032207\n",
      "=====================================\n",
      "Rule: virus -> avian\n",
      "Support: 0.0066\n",
      "Confidence: 0.38596491228070173\n",
      "Lift: 2.953059772614397\n",
      "=====================================\n",
      "Rule: infectious -> bronchitis\n",
      "Support: 0.005\n",
      "Confidence: 0.8771929824561403\n",
      "Lift: 33.48064818534886\n",
      "=====================================\n",
      "Rule: care -> intensive\n",
      "Support: 0.0083\n",
      "Confidence: 0.43005181347150256\n",
      "Lift: 50.00602482226774\n",
      "=====================================\n",
      "Rule: report -> case\n",
      "Support: 0.0068\n",
      "Confidence: 0.47552447552447547\n",
      "Lift: 47.552447552447546\n",
      "=====================================\n",
      "Rule: stem -> cell\n",
      "Support: 0.0053\n",
      "Confidence: 0.15634218289085547\n",
      "Lift: 20.304179596214997\n",
      "=====================================\n",
      "Rule: cells -> human\n",
      "Support: 0.0079\n",
      "Confidence: 0.21122994652406418\n",
      "Lift: 3.977965094615145\n",
      "=====================================\n",
      "Rule: infection -> cells\n",
      "Support: 0.0051\n",
      "Confidence: 0.13636363636363635\n",
      "Lift: 2.011263073209976\n",
      "=====================================\n",
      "Rule: ill -> critically\n",
      "Support: 0.0069\n",
      "Confidence: 0.9718309859154929\n",
      "Lift: 136.8776036500694\n",
      "=====================================\n",
      "Rule: critically -> patients\n",
      "Support: 0.0052\n",
      "Confidence: 0.732394366197183\n",
      "Lift: 16.31167853445842\n",
      "=====================================\n",
      "Rule: der -> und\n",
      "Support: 0.0062\n",
      "Confidence: 0.49599999999999994\n",
      "Lift: 43.89380530973451\n",
      "=====================================\n",
      "Rule: infectious -> disease\n",
      "Support: 0.0063\n",
      "Confidence: 0.13695652173913045\n",
      "Lift: 5.227348157982078\n",
      "=====================================\n",
      "Rule: diseases -> infectious\n",
      "Support: 0.0092\n",
      "Confidence: 0.4717948717948718\n",
      "Lift: 18.0074378547661\n",
      "=====================================\n",
      "Rule: respiratory -> distress\n",
      "Support: 0.0114\n",
      "Confidence: 0.991304347826087\n",
      "Lift: 18.12256577378587\n",
      "=====================================\n",
      "Rule: syndrome -> distress\n",
      "Support: 0.0112\n",
      "Confidence: 0.9739130434782609\n",
      "Lift: 34.53592352759791\n",
      "=====================================\n",
      "Rule: virus -> ebola\n",
      "Support: 0.0073\n",
      "Confidence: 0.5934959349593496\n",
      "Lift: 4.54090233327735\n",
      "=====================================\n",
      "Rule: expression -> gene\n",
      "Support: 0.005\n",
      "Confidence: 0.21645021645021648\n",
      "Lift: 12.298307752853209\n",
      "=====================================\n",
      "Rule: h1n1 -> influenza\n",
      "Support: 0.0114\n",
      "Confidence: 0.7808219178082192\n",
      "Lift: 9.80932057548014\n",
      "=====================================\n",
      "Rule: h1n1 -> pandemic\n",
      "Support: 0.006\n",
      "Confidence: 0.410958904109589\n",
      "Lift: 17.487612940833575\n",
      "=====================================\n",
      "Rule: virus -> h1n1\n",
      "Support: 0.0053\n",
      "Confidence: 0.363013698630137\n",
      "Lift: 2.7774575258617977\n",
      "=====================================\n",
      "Rule: h5n1 -> influenza\n",
      "Support: 0.0057\n",
      "Confidence: 0.8382352941176472\n",
      "Lift: 10.530594147206623\n",
      "=====================================\n",
      "Rule: public -> health\n",
      "Support: 0.0097\n",
      "Confidence: 0.3050314465408805\n",
      "Lift: 23.830581761006286\n",
      "=====================================\n",
      "Rule: virus -> hepatitis\n",
      "Support: 0.0098\n",
      "Confidence: 0.6666666666666666\n",
      "Lift: 5.1007396072430495\n",
      "=====================================\n",
      "Rule: virus -> host\n",
      "Support: 0.0053\n",
      "Confidence: 0.33125\n",
      "Lift: 2.5344299923488904\n",
      "=====================================\n",
      "Rule: ill -> patients\n",
      "Support: 0.0051\n",
      "Confidence: 0.7183098591549296\n",
      "Lift: 15.99799240879576\n",
      "=====================================\n",
      "Rule: infection -> influenza\n",
      "Support: 0.0128\n",
      "Confidence: 0.18879056047197643\n",
      "Lift: 2.37174070944694\n",
      "=====================================\n",
      "Rule: respiratory -> infection\n",
      "Support: 0.0078\n",
      "Confidence: 0.11504424778761062\n",
      "Lift: 2.103185517140962\n",
      "=====================================\n",
      "Rule: virus -> infection\n",
      "Support: 0.0263\n",
      "Confidence: 0.38790560471976404\n",
      "Lift: 2.9679082227985005\n",
      "=====================================\n",
      "Rule: respiratory -> infections\n",
      "Support: 0.0085\n",
      "Confidence: 0.27868852459016397\n",
      "Lift: 5.0948541972607675\n",
      "=====================================\n",
      "Rule: infections -> viral\n",
      "Support: 0.0054\n",
      "Confidence: 0.17704918032786887\n",
      "Lift: 4.404208465867385\n",
      "=====================================\n",
      "Rule: pandemic -> influenza\n",
      "Support: 0.0173\n",
      "Confidence: 0.2173366834170854\n",
      "Lift: 9.248369507110016\n",
      "=====================================\n",
      "Rule: virus -> influenza\n",
      "Support: 0.0282\n",
      "Confidence: 0.3542713567839196\n",
      "Lift: 2.7105689118892085\n",
      "=====================================\n",
      "Rule: viruses -> influenza\n",
      "Support: 0.0062\n",
      "Confidence: 0.0778894472361809\n",
      "Lift: 3.218572199842186\n",
      "=====================================\n",
      "Rule: lung -> injury\n",
      "Support: 0.0075\n",
      "Confidence: 0.576923076923077\n",
      "Lift: 26.223776223776227\n",
      "=====================================\n",
      "Rule: virus -> mice\n",
      "Support: 0.0057\n",
      "Confidence: 0.30158730158730157\n",
      "Lift: 2.307477441371856\n",
      "=====================================\n",
      "Rule: virus -> mouse\n",
      "Support: 0.0051\n",
      "Confidence: 0.42500000000000004\n",
      "Lift: 3.2517214996174446\n",
      "=====================================\n",
      "Rule: respiratory -> patients\n",
      "Support: 0.0064\n",
      "Confidence: 0.14253897550111358\n",
      "Lift: 2.6058313619947637\n",
      "=====================================\n",
      "Rule: study -> patients\n",
      "Support: 0.0066\n",
      "Confidence: 0.14699331848552338\n",
      "Lift: 4.400997559446808\n",
      "=====================================\n",
      "Rule: virus -> porcine\n",
      "Support: 0.0073\n",
      "Confidence: 0.5572519083969465\n",
      "Lift: 4.263595320558121\n",
      "=====================================\n",
      "Rule: virus -> protein\n",
      "Support: 0.0095\n",
      "Confidence: 0.2810650887573965\n",
      "Lift: 2.150459745657203\n",
      "=====================================\n",
      "Rule: respiratory -> severe\n",
      "Support: 0.0075\n",
      "Confidence: 0.13711151736745886\n",
      "Lift: 6.232341698520857\n",
      "=====================================\n",
      "Rule: respiratory -> syncytial\n",
      "Support: 0.0065\n",
      "Confidence: 0.11882998171846434\n",
      "Lift: 17.474997311538875\n",
      "=====================================\n",
      "Rule: respiratory -> syndrome\n",
      "Support: 0.0194\n",
      "Confidence: 0.3546617915904936\n",
      "Lift: 12.576659276258638\n",
      "=====================================\n",
      "Rule: tract -> respiratory\n",
      "Support: 0.006\n",
      "Confidence: 0.1096892138939671\n",
      "Lift: 14.432791301837776\n",
      "=====================================\n",
      "Rule: systematic -> review\n",
      "Support: 0.0069\n",
      "Confidence: 0.31797235023041476\n",
      "Lift: 37.408511791813496\n",
      "=====================================\n",
      "Rule: syndrome -> severe\n",
      "Support: 0.0052\n",
      "Confidence: 0.23636363636363636\n",
      "Lift: 8.381689232753063\n",
      "=====================================\n",
      "Rule: virus -> syncytial\n",
      "Support: 0.006\n",
      "Confidence: 0.8823529411764707\n",
      "Lift: 6.750978891939331\n",
      "=====================================\n",
      "Rule: respiratory -> acute\n",
      "Support: 0.0104\n",
      "Confidence: 0.268733850129199\n",
      "Lift: 23.57314474817535\n",
      "=====================================\n",
      "Rule: syndrome -> acute\n",
      "Support: 0.0103\n",
      "Confidence: 0.2661498708010336\n",
      "Lift: 23.763381321520857\n",
      "=====================================\n",
      "Rule: lung -> injury\n",
      "Support: 0.0059\n",
      "Confidence: 0.1524547803617571\n",
      "Lift: 20.327304048234282\n",
      "=====================================\n",
      "Rule: respiratory -> acute\n",
      "Support: 0.0055\n",
      "Confidence: 0.1421188630490956\n",
      "Lift: 18.949181739879414\n",
      "=====================================\n",
      "Rule: respiratory -> acute\n",
      "Support: 0.013\n",
      "Confidence: 0.3359173126614987\n",
      "Lift: 17.315325394922613\n",
      "=====================================\n",
      "Rule: ill -> critically\n",
      "Support: 0.0051\n",
      "Confidence: 0.7183098591549296\n",
      "Lift: 140.8450704225352\n",
      "=====================================\n",
      "Rule: syndrome -> respiratory\n",
      "Support: 0.0112\n",
      "Confidence: 0.9739130434782609\n",
      "Lift: 50.20170327207531\n",
      "=====================================\n",
      "Rule: virus -> infection\n",
      "Support: 0.0078\n",
      "Confidence: 0.11504424778761062\n",
      "Lift: 4.079583254879809\n",
      "=====================================\n",
      "Rule: virus -> respiratory\n",
      "Support: 0.0057\n",
      "Confidence: 0.10420475319926875\n",
      "Lift: 17.36745886654479\n",
      "=====================================\n",
      "Rule: respiratory -> syndrome\n",
      "Support: 0.0103\n",
      "Confidence: 0.2661498708010336\n",
      "Lift: 23.763381321520857\n",
      "=====================================\n"
     ]
    }
   ],
   "source": [
    "print_association_results(association_results1)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 3a-2). Interpretation of Any One Rule : \n",
    "\n",
    "### Taking the First Rule in the Output above:\n",
    "\n",
    "### Rule: acute -> distress\n",
    "### Support: 0.0104\n",
    "### Confidence: 0.268733850129199\n",
    "### Lift: 23.368160880799913\n",
    "\n",
    "### Narration : \n",
    "### i). The word 'acute' has a support of 0.0104 (1.04%). This means that the word 'acute' occurs in 1.04% of the titles from the overall number of 'Titles'\n",
    "\n",
    "### ii). The value Confidence of 0.268 (26.8%) indicates how frequently the word 'distress' occurs after the word 'acute' in the same 'Title'.\n",
    "\n",
    "### iii). The Lift value of 23.36 indicates that the word 'distress' is very likely to follow the word 'acute' in the 'Titles'. "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# 3b). Draw a line graph with Y-axis as number of Association Rules of minimum length 2, and X-axis as Confidence Percentage (ranging from 0%, 10%, 20%, ...., 100%). \n",
    "# Plot different coloured lines for different support percentage (take values as 10%, 20%, and 50%) [2 pt] "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.legend.Legend at 0x180a67039a0>"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "results1 = pd.DataFrame(columns = ['Support(%)', 'Confidence(%)', 'Total Association Results'])\n",
    "results2 = results1\n",
    "results3 = results1\n",
    "        \n",
    "#Define Confidence Range from 0% to 100%\n",
    "confidence_range = [0.0,0.1,0.2,0.3,0.4,0.5,0.6,0.7,0.8,0.9,1.0]\n",
    "\n",
    "for i in confidence_range:\n",
    "    \n",
    "    #Support value 10%\n",
    "    association_results = apply_apriori(records, min_support=0.1, min_confidence=i, min_lift=2, min_length=2)\n",
    "    results1 = results1.append({'Support(%)' : j*100, 'Confidence(%)' : i*100, 'Total Association Results' : len(association_results)}, ignore_index = True)\n",
    "\n",
    "    #Support value 20%\n",
    "    association_results = apply_apriori(records, min_support=0.2, min_confidence=i, min_lift=2, min_length=2)\n",
    "    results2 = results2.append({'Support(%)' : j*100, 'Confidence(%)' : i*100, 'Total Association Results' : len(association_results)}, ignore_index = True)\n",
    "\n",
    "    #Support value 50%\n",
    "    association_results = apply_apriori(records, min_support=0.5, min_confidence=i, min_lift=2, min_length=2)\n",
    "    results3 = results3.append({'Support(%)' : j*100, 'Confidence(%)' : i*100, 'Total Association Results' : len(association_results)}, ignore_index = True)\n",
    "        \n",
    "plt.plot('Confidence(%)', 'Total Association Results', data=results1, marker='o', markerfacecolor='blue', markersize=9, color='skyblue', linewidth=3,label=\"Support 10%\")\n",
    "plt.plot('Confidence(%)', 'Total Association Results', data=results2, marker='o', color='red', linewidth=2,label=\"Support 20%\")\n",
    "plt.plot('Confidence(%)', 'Total Association Results', data=results3, marker='o', color='green', linewidth=2, linestyle='dashed', label=\"Support 50%\")\n",
    "plt.xlabel('Confidence %')\n",
    "plt.ylabel('Number of Association Rules')\n",
    "plt.title('Plot of Confidence %  Vs  # of Association Rules')\n",
    "plt.legend()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Important Note For BITS Pilani TA and Professor : \n",
    "## 1). After observing the Plot above for Support %, Confidence %, Total Association Results, we find that for Support of 10%, 20% and 50% the Total Association Results are coming as 0. \n",
    "\n",
    "## 2). Based on #1 above, it is not possible to Plot graphs as mentioned in Question 3b.\n",
    "\n",
    "## 3). Therefore Group1 has made a decision to consider Support % as 0.5, 1 and 2."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.legend.Legend at 0x180a66c50d0>"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "results1 = pd.DataFrame(columns = ['Support(%)', 'Confidence(%)', 'Total Association Results'])\n",
    "results2 = results1\n",
    "results3 = results1\n",
    "\n",
    "#Define Confidence Range from 0% to 100%\n",
    "confidence_range = [0.0,0.1,0.2,0.3,0.4,0.5,0.6,0.7,0.8,0.9,1.0]\n",
    "\n",
    "for i in confidence_range:\n",
    "\n",
    "    #Support value 0.5%\n",
    "    association_results = apply_apriori(records, min_support=0.005, min_confidence=i, min_lift=2, min_length=2)\n",
    "    results1 = results1.append({'Support(%)' : j*100, 'Confidence(%)' : i*100, 'Total Association Results' : len(association_results)}, ignore_index = True)\n",
    "\n",
    "    #Support value 1%\n",
    "    association_results = apply_apriori(records, min_support=0.01, min_confidence=i, min_lift=2, min_length=2)\n",
    "    results2 = results2.append({'Support(%)' : j*100, 'Confidence(%)' : i*100, 'Total Association Results' : len(association_results)}, ignore_index = True)\n",
    "\n",
    "    #Support value 2%\n",
    "    association_results = apply_apriori(records, min_support=0.02, min_confidence=i, min_lift=2, min_length=2)\n",
    "    results3 = results3.append({'Support(%)' : j*100, 'Confidence(%)' : i*100, 'Total Association Results' : len(association_results)}, ignore_index = True)\n",
    "        \n",
    "plt.plot('Confidence(%)', 'Total Association Results', data=results1, marker='o', markerfacecolor='blue', markersize=9, color='skyblue', linewidth=3,label=\"Support 0.5%\")\n",
    "plt.plot('Confidence(%)', 'Total Association Results', data=results2, marker='o', color='red', linewidth=2,label=\"Support 1%\")\n",
    "plt.plot('Confidence(%)', 'Total Association Results', data=results3, marker='o', color='green', linewidth=2, linestyle='dashed', label=\"Support 2%\")\n",
    "plt.xlabel('Confidence %')\n",
    "plt.ylabel('Number of Association Rules')\n",
    "plt.title('Plot of Confidence %  Vs  # of Association Rules')\n",
    "plt.legend()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
